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Abstract 
Programming living cells with synthetic gene circuits to perform desired tasks has 
been a major theme in the emerging field of synthetic biology. However, gene circuit 
engineering currently lacks the same predictability and reliability as seen in other 
mature engineering disciplines. This thesis focuses on the design and engineering of 
novel modular and orthogonal biological devices, and the predictable functional 
assembly of modular biological elements (BioParts) into customisable larger 
biological devices. 
 
The thesis introduces the design methodology for engineering modular and 
orthogonal biological devices. A set of modular biological devices with digital logic 
functions, including the AND, NOT and combinatorial NAND gates, were 
constructed and quantitatively characterised. In particular, a novel genetic AND gate 
was engineered in Escherichia coli by redesigning the natural HrpR/HrpS hetero-
regulation motif in the hrp system of Pseudomonas syringae. The AND gate is 
orthogonal to E. coli chassis, and employs the alternative σ54-dependent gene 
transcription to achieve tight transcriptional control. Results obtained show that 
context has a large impact on part and device behaviour, established through the 
systematic characterisation of a series of biological parts and devices in various 
biophysical and genetic contexts. A new, effective strategy is presented for the 
assembly of BioParts into functional customised systems using engineered ‘in-
context’ characterised modules aided by modelling, which can significantly increase 
the predictability of circuit construction by characterising the component parts and 
modules in the same biophysical and genetic contexts as anticipated in their final 
systems. Finally, the thesis presents the design and construction of an application-
oriented integrated system – the cell density-dependent microbe-based biosensor. The 
in vivo biosensor was programmed to be able to integrate its own cell density signal 
through an engineered cell-cell communication module and a second environmental 
signal through an environment-responsive promoter in the logic AND manner, with 
GFP as the output readout.  
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1.1 Thesis Statement and Summary of Contributions 
1.1.1 Thesis statement 
The thesis focuses on the design, construction and characterisation of novel modular 
and orthogonal biological devices with digital logic functions, and the assembly of 
modular biological elements (BioParts) into customisable larger biological systems. 
One central goal is to be able to rationally engineer organisms with desired properties 
in a more predictable manner using these synthetic biological circuits. The thesis 
makes the following claim: 
The functional assembly of synthetic biological parts and devices into customised 
biological systems can be performed more predictably using engineered ‘in-context’ 
(i.e. in the same biophysical and genetic contexts as anticipated in their final system) 
characterised modules. 
 
1.1.2 Summary of contributions 
In this thesis, I make the following main contributions: 
(1) Design and engineering of a set of novel modular and orthogonal devices: 
I present the design principles for constructing novel modular (interchangeable) and 
orthogonal (i.e. no cross talk) biological devices with a particular focus on the 
transformation of natural biological discoveries into useful functional modules. I 
engineer a set of such digital logic devices including the AND gates, the NOT gates 
and the composite NAND gates in Escherichia coli with novel gene regulation 
components from Pseudomonas syringae. These fundamental synthetic devices 
represent new contributions made to expand the currently limited toolkit of synthetic 
biology for constructing larger scale systems with complex circuitry. 
 
(2) Determining the effect of context on part and device behaviour: 
I systematically characterise a set of component biological parts (i.e. promoters and 
ribosome binding sites etc) and devices in various contexts (both biophysical and 
genetic) and determine the effect of context (both biophysical and genetic) on the part 
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and device behaviour. I show that the context has a large impact on the behaviour of 
the involved parts and modules, suggesting that we have to take the context effect into 
account to increase the likelihood of producing functional circuits from the assembly 
of individual components. The current scope for characterising synthetic parts and 
devices are also extended by including homogeneity, metabolic load and chassis 
compatibility characterisation. 
 
(3) An effective strategy for the functional assembly of BioParts: 
I develop an effective strategy for the assembly of BioParts into functional customised 
systems using engineered ‘in-context’ characterised modules. By characterising the 
candidate component parts and modules in the same biophysical or abiotic 
environment (e.g. media, temperature, carbon source) and genetic (e.g. embedded 
sequence context, chassis background) contexts as anticipated for their final target 
system, I have successfully assembled a set of functional logic circuits as mentioned 
before in a more predictable manner aided by modelling. This approach minimises the 
unexpected or high-order effects which could occur during circuit construction by 
eliminating or reducing the variations arising from the difference of contexts, and thus 
greatly increase the predictability for the functional assembly of BioParts into 
synthetic circuits. This semi-empirical approach has merit in that an operational 
system is arrived at. 
 
(4) An in vivo biosensor for practical applications: 
I present the design and construction of a cell density-dependent module from 
standardised biological parts based on the lux quorum sensing mechanism. I then 
engineer a modular cell density-dependent E. coli-based biosensor assembled from 
multiple characterised parts and modules. The in vivo biosensor is programmed to be 
able to integrate its own cell density signal through a cell-cell communication module 
and a second environmental signal through an environment-responsive promoter in 
the logic AND manner, with GFP level as the output readout. This modular sensing 
device can be customised to have application in many areas such as biotechnology 
including fermentation. Thus the work demonstrates the great potential of engineering 
synthetic circuits to program organisms for real world applications. 
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1.1.3 Thesis outline 
In the remainder of the thesis, Chapter 1 introduces the advances in synthetic biology, 
and the current design principles and existing challenges for engineering gene circuits, 
followed by a description of the main objectives of this study. Chapter 2 summarises 
the materials and methods that are used for both the experiment and modelling in this 
study. Chapter 3 describes the principles used to design and engineer modular and 
orthogonal biological devices as well as the designs and functional assembly strategy 
for the synthetic modules constructed in the following two chapters. Derivations of 
the transfer functions of designed modules are then described. Chapter 4 presents the 
systematic characterisation of component parts, i.e. promoters and RBSs, in various 
live cell biophysical and genetic contexts to illustrate the impact of context on their 
behaviour. The chapter next presents the forward engineering and thorough 
characterisation of the designed modular logic AND gate. Chapter 5 presents the 
engineering of the three types of modular logic NOT gates and the composite logic 
NAND gates. Chapter 6 presents the design and construction of a cell density-
dependent module based on the lux quorum sensing system. The chapter next 
describes the engineering of a modular cell-density dependent in vivo biosensor using 
the modules that have been constructed with arabinose sensing as an example. 
Chapter 7 summarises the study and discusses possible future directions. 
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1.2 Synthetic Biology and the State-of-the-Art 
This section introduces the emerging discipline of synthetic biology, which forms the 
basis of the study in this thesis, and reviews the latest advances in this field. 
Particularly, the studies on the engineering of synthetic gene circuits in living cells – 
the major theme in synthetic biology – are presented and discussed. 
1.2.1 Synthetic biology – an emerging discipline 
In the past 60 years we have seen enormous advances in biology, in particular 
molecular biology. Not only has there been a rapid accumulation of various genetic 
data and biological information (encompassing genes, proteins, and their interactions 
in many organisms) particularly following the sequencing of many microbial genomes 
as well as the human genome, but, also, the great advancement in the technologies 
that allows us to manipulate genetic materials. One such technology is genetic 
engineering, which has enabled us to use specific pieces of DNA to modify or 
improve existing cellular functions. This is achieved by modifying the endogenous 
gene regulation networks inside a cell using technologies such as DNA recombination, 
DNA sequencing and synthesis, DNA amplification and site-directed mutagenesis. 
Following these advances, it is now possible to design novel genetic circuits from 
scratch and embed them into living cells to enable them with desired properties in a 
nearly predictable manner. This has led to the birth of a new field called synthetic 
biology, which has been established as an engineering discipline and targets designing 
and constructing synthetic biological systems from genetic components with desired 
functionalities and characteristics. 
Synthetic biology is defined as the design and construction of new biological 
parts, devices and systems, and the redesign of existing, natural biological systems for 
useful purposes (Synthetic Biology Organisation, 2008). The goal is to extend or 
modify the behaviour of organisms and engineer them to perform new customised 
tasks, such as producing drugs, chemicals and biofuels.  
Figure 1.1 (Andrianantoandro et al., 2006) illustrates the goal and methods of 
synthetic biology by making analogy to computer engineering at the different levels  
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Figure 1.1 An analogy between synthetic biology and computer engineering. The 
diagram is from (Andrianantoandro et al., 2006). 
 
of a hierarchy. In this hierarchy, they both take a bottom-up approach  to  build   more 
complex systems by integrating constituent parts. At the bottom are genes, proteins 
and chemical molecules analogous to the physical layer of transistors, resistors and 
capacitors in computer engineering. At the next layer, biochemical reactions regulate 
the information flow, equivalent to logic gates in a computer. At the module layer, 
complex pathways can be assembled from a library of biological devices with varying 
functions and function like integrated circuits. By integrating these modules into cells, 
the cells will be programmed with desired behaviour. More complex tasks can be 
accomplished by using a cell population, in which cells communicate each other to 
perform in a coordinated way, much like the case of computer networks. 
A deep understanding of the role and significance of synthetic biology can be 
obtained by comparing it to the well established disciplines of systems biology, 
synthetic organic chemistry and electrical engineering. 
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Synthetic biology builds upon biology. It can be treated as a bottom up 
approach to study biological systems by assembling engineered modular components 
to form larger or more complex systems that mimic the natural ones. But the approach 
used in synthetic biology places it apart from other, existing biological studies; i.e. by 
the extensive use of engineering principles and tools. There are some similarities to 
systems biology, which also involves the application of engineering theory to biology 
studies. However, while systems biology focuses on the comprehensive study of 
natural biological systems, often within a biomedical context, synthetic biology seeks 
to build novel and artificial biological systems for specific purposes. It is described as 
the engineering application of the biomedical science, rather than the extension of 
bioscience research (The Academy of Medical Sciences and the Royal Academy of 
Engineering, 2007). It is better to see that they are two complementary ways, as the 
system design principles found by systems biology will guide the forward engineering 
of novel biological systems for synthetic biology, which in return help prove and 
support former discoveries. 
By making the comparison to organic chemistry, synthetic biology is to biology 
what synthetic organic chemistry is to chemistry. It is the combination of the synthetic 
approach with the traditional analytical approach that revolutionized chemistry, 
leading to a deep understanding of the fundamental principles of chemical structure 
and reactivity (Yeh and Lim, 2007). Similarly, the synthetic approach taken by 
synthetic biology is a necessary complement to the analytical approach currently 
taken by most biologists to elucidate the design principles of biological systems. 
Finally, from an engineering point of view, what synthetic biologists are doing 
now is quite like what electrical engineers have been doing for many years, designing 
electronic circuits using standard components, such as resistors, capacitors and 
transistors. The difference lies in the building blocks that are used. Synthetic 
biologists design genetic circuits with specified functions using standard engineered 
biological parts such as genes, promoters, ribosome binding sites and terminators. In 
this regard, synthetic biology is to biology what electrical engineering is to physics, 
which both deal with electrons but one focuses on the understanding of their nature 
and the other aims to make use of them to build useful applications.  
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1.2.2 The state-of-the-art of synthetic biology 
The beginning of synthetic biology era is hallmarked by the three independent studies 
published in Nature journal in 2000 (Becskei and Serrano, 2000; Elowitz and Leibler, 
2000; Gardner et al., 2000), which introduced the first synthetic gene circuits. As 
shown in Figure 1.2, they are all transcriptional regulation circuits constructed in E. 
coli. The negative autoregulation circuit (Figure 1.2a) was shown to increase the 
stability of gene expression and reduce the noise by an artificially constructed 
negative feedback. The toggle switch circuit (Figure 1.2b) was shown to exhibit 
bistability through two mutually repressed gene regulation modules. The synthetic 
oscillatory circuit (Figure 1.2c) was shown to display damped oscillatory behaviour in 
terms of fluorescent output in individual cells by linking three repressing modules in a 
ring topology. After these successes, there has been continuous effort in designing 
switches (Ajo-Franklin et al., 2007; Atkinson et al., 2003; Becskei, 2001) and 
oscillators (Atkinson et al., 2003; Danino et al., 2010; Kitney et al., 2007; Stricker et 
al., 2008; Tigges et al., 2009) by incorporating various negative and positive 
feedbacks in the engineered synthetic circuits either in prokaryotic or eukaryotic cells. 
 
PLtetO-1
tetR-gfp PLtetO-1
lacI
Ptrc-2
tetR gfp
PLlacO1
tetR
PLtetO1
cI
PR
lacI
PLtetO1
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c
ba
 
 
Figure 1.2 The architectures of first constructed synthetic gene circuits. a, The 
negative autoregulation circuit (Becskei and Serrano, 2000). b, The genetic toggle 
switch (Gardner et al., 2000). c, The synthetic oscillator (Elowitz and Leibler, 2000). 
 
Hence, it has been no more than ten years since the first pieces of proof-of-
principle work came out in synthetic biology. However, a rapid growth has taken 
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place in this field in the past decade and many examples have been produced to 
demonstrate the principles of gene circuit engineering and the promising applications 
it allows to have. The following gives a brief review of the major advances in this 
field by grouping them into several aspects that are currently prevalent in the synthetic 
biology community. 
 
Intracellular vs. Intercellular or Interspecies circuits  
Although most of the circuits constructed so far are dependent on individual cellular 
behaviour alone, some pieces of work have applied cell-cell communication with 
synthetic intercellular circuits to achieve coordinated responses among a population of 
cells or different species. This is a major advance because it could not only achieve 
spatial-temporal control over a population of cells to fulfil complex tasks, but, also, 
help overcome cell to cell variations due to the stochastic nature of gene expression in 
individual cells (Elowitz et al., 2002) by synchronised cellular behaviour (Danino et 
al., 2010). Most of these intercellular systems used a quorum sensing circuit module 
derived from the symbiotic bacterium Vibrio fischeri (Bassler, 2002; Waters and 
Bassler, 2005). The module is composed of LuxI, an enzyme which catalyzes the 
synthesis of the freely diffusible signalling molecule – AHL, LuxR, a transcriptional 
activator dependent on AHL, and the LuxR-AHL complex responsive LuxI promoter. 
In response to high concentrations of AHL (for example, due to a high cell density), 
genes located downstream of the LuxI promoter will be transcribed.  
One classic example is the pattern formation system which has been constructed 
in E. coli by utilising such intercellular communication module to form specified 
spatial patterns over a bacterial lawn grown on an agar plate. As shown in Figure 1.3 
(Basu et al., 2005), the system comprises the sender cells and the receiver cells. The 
sender cells placed in the plate centre contain LuxI and synthesise AHL molecules 
which diffuse into surrounding medium, while the plated receiver cells contain band-
detect circuits and respond to the AHL signalling molecules secreted from the sender 
cells, but only express GFP at certain ranges of AHL level. Since the level of AHL 
forms a spatial gradient that decreases with the distance away from the sender cells, 
only the receiver cells that are located within the range of the band-detecting window 
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express fluorescent proteins and thus form a ring pattern. The bullseye spatial pattern 
formed by two strains of receiver cells with different band detecting windows and 
fluorescent reporters is displayed on the top right in Figure 1.3.  
 
 
 
Figure 1.3 Spatial pattern formation using a band-detect circuit based on 
intercellular communication. The diagram is adapted from (Basu et al., 2005). 
 
Other engineered intercellular circuits include the transient pulse generating 
circuit containing a feed forward network module (Basu et al., 2004), and the 
programmed population control circuit which autonomously controls the density of E. 
coli cell population (You et al., 2004). Kobayashi et al. (Kobayashi et al., 2004) have 
engineered cells that activated protein synthesis when only the cell population reaches 
a critical density. Tabor et al. (Tabor et al., 2009) have created a synthetic genetic 
edge detection circuit which enabled cells to have the capability of detecting the edges 
between light and dark regions based on intercellular communication and a synthetic 
light sensor. Synthetic ecosystems using two engineered populations of E. coli cells 
(Balagadde et al., 2008; Brenner et al., 2007; Chuang et al., 2010; Song et al., 2009) 
have also been constructed. Other synthetic ecosystems, allowing communication 
across different species or kingdoms, were shown to enable quorum sensing between 
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and among mammalian cells, bacteria, yeast, and even plants through multistep 
airborne communication (Weber et al., 2007). And the signals used for intercellular 
signalling in the study were expanded as well including volatile aldehydes, small 
vitamin-derived molecules, or antibiotics that diffuse either by gas or liquid phase. 
 
Transcriptional vs. Post-transcriptional control 
Gene expression control underlies the construction of synthetic gene circuits. So far 
transcription regulation is the dominating method to control gene expression in 
designing functional circuits, which normally uses trans-acting transcription factors or 
cis-acting DNA elements to regulate the mRNA transcription of the gene of interest. 
However, a series of studies carried out exhibits the potential of regulating gene 
expression at the post-transcriptional level for designing biological circuits, which 
mainly controls target protein synthesis from transcribed mRNAs  (Isaacs et al., 2006). 
One such example is the riboswitches (Winkler, 2005), which include aptamer 
domains in the mRNAs to control gene expression in a ligand-dependent manner. The 
specific binding of the ligand to the aptamer domain of the riboswitch induces a 
conformational change in the 5' UTR of its own mRNA, thereby regulating gene 
translation. An engineered theophylline-dependent riboswitch has been shown to 
control chemotactic gene expression in E. coli and thus guide the bacterial movement 
(Topp and Gallivan, 2007) toward the theophylline signal. The riboregulator designed 
by Bayer et al. (Bayer and Smolke, 2005) uses trans-acting antisense RNAs that bind 
target mRNA to regulate eukaryotic gene expression in a ligand-responsive manner. 
Ribozyme based synthetic RNA switches have also been shown to be able to tightly 
regulate gene expression in a programmable manner (Win and Smolke, 2007; Yen et 
al., 2004), such as the control of mammalian T-cell proliferation (Chen et al., 2010). 
More recently, a type of small regulatory RNA, named microRNAs, was exploited to 
control the transcription of the mRNA of interest via a RNA interference pathway in a 
programmable logic manner (Leisner et al., 2010). Figure 1.4 shows the logic AND 
gate constructed on the basis of this mechanism. The transcription factors regulate 
synthetic genes coding for the microRNAs, which in turn bind their corresponding 
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microRNA target sequences in the 3' UTR of the output gene transcript to inhibit its 
degradation caused by these microRNA target sequences. 
 
 
 
Figure 1.4 Genetic logic using microRNAs to control the translation of target 
mRNA transcripts. The diagram is adapted from (Leisner et al., 2010). 
 
Rackham et al. (Rackham and Chin, 2005b) designed orthogonal ribosome 
mRNA pairs by evolving natural ribosome to new versions with altered mRNA-
binding sites (orthogonal ribosomes) which exclusively translate mRNAs that are not 
substrates for the endogenous ribosome (orthogonal mRNAs). These new pairs are 
orthogonal to their wide type, and can be used to programme cellular logic (Rackham 
and Chin, 2005a). A modular AND gate has been constructed by including amper stop 
codons into the T7 RNA polymerase gene under an inducible promoter (Anderson et 
al., 2007). Thereby the transcribed T7 mRNAs are not translated to polymerase until 
the nonsense amber codon suppressor tRNA supD is also transcribed. There is also 
work on controlling gene expression both at the transcriptional and translational levels 
to achieve tight and tunable control. An engineered, tunable genetic switch that 
couples repressor proteins and an RNAi target design has been shown to effectively 
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turn any gene off in mouse and human cells (Deans et al., 2007). Post translational 
regulation is demonstrated as well by engineering scaffold protein interactions to 
systematically reshape signalling dynamics of the yeast mating MAP kinase pathway 
(Bashor et al., 2008). 
 
Bottom up vs. Top down approaches 
Constructing artificial gene circuits with basic genetic elements from scratch can be 
considered as the bottom up approach in synthetic biology. With the construction of 
larger and more complex genetic systems, we could imagine a totally artificial 
organism in the future, in which every part is synthetic, including the genome. Efforts 
toward such a synthetic organism have been ongoing. Generally this work starts from 
the top level or targets the top level, i.e. the whole genome and the organism, which is 
considered as the top down approach at present.  
Initial work has been carried out by Venter and his colleagues in identifying 
essential genes of the minimal bacterium Mycoplasma genitalium (Glass et al., 2006; 
Hutchison et al., 1999). Engineered E. coli with genome reduction up to 15% is 
studied (Kolisnychenko et al., 2002; Posfai et al., 2006), which displayed some 
emergent and unexpected beneficial properties. Forster et al. (Forster and Church, 
2006) are using well-defined essential genes to synthesize a minimal cell which owns 
replication and other essential biological pathways, and is fed only by small molecule 
nutrients. The bacteriophage T7 genome has also been redesigned by replacing around 
30% natural genetic elements with engineered DNA (Chan et al., 2005). Whole 
genome transition between different bacterial species (Lartigue et al., 2007; Lartigue 
et al., 2009) and the first assembled synthetic genome (Gibson et al., 2008) have been 
accomplished by the pioneers in this field, which are the first two steps towards a final 
whole synthetic organism. More recently, the researchers at the J. Craig Venter 
Institute have successfully created a so-called synthetic bacterial cell, which is 
controlled wholly by the chemically synthesised genome (Gibson et al., 2010). As 
shown in Figure 1.5, they first ordered 1078 DNA fragments (around 1 kb each) of the 
whole M. mycoides genome from a DNA synthesis company. The ordered cassettes 
are 1 kb size around with overlaps to adjacent cassettes but there are designed 
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sequences like the watermarks within some of them. They next used a hierarchical 
approach to assemble the cassettes into the final chromosome in three steps in yeast 
by transformation and homologous recombination. The extracted synthetic genome 
was then transformed into recipient M. capricolum cells. The transformed colonies 
were screened to select the ones containing only the synthetic genome. The synthetic 
M. mycoides bacterium was confirmed by sequence analysis to contain only the 
designed synthetic DNA sequences and has expected phenotypic properties.  
 
 
 
Figure 1.5 The assembly of a synthetic M. mycoides genome. The 1.08-Mbp 
synthetic M. mycoides genome was assembled from 1078 overlapping DNA cassettes 
in three steps by transformation and homologous recombination in yeast. The diagram 
is from (Gibson et al., 2010). 
 
The results of these projects are all of great importance for synthetic biologists 
as they can not only offer insights on which components on the genome are essential, 
but also can help provide an engineered standard chassis with known features which 
synthetic biologists can use in the future. Other genome engineering examples include 
making automated multiple targeted changes to a genome to optimise a synthetic 
metabolic pathway (Wang et al., 2009b), and generating genome scale modified 
bacteria with modified expression of almost every gene in E. coli (Warner et al., 
2010). 
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Fundamental vs. Application-oriented systems 
Most of the systems that have been constructed in synthetic biology are fundamental, 
without a direct practical application and could be called “toy systems”. But one 
major aim of synthetic biology is to have diverse practical applications in many areas 
by engineering biology. Up to now there are already a few application-oriented 
synthetic systems that have been demonstrated although this field should be more 
driven by engineering applications.  
 
    
 
Figure 1.6 Environmentally controlled invasion of cancer cells by engineered 
bacteria. Invasion is induced when bacteria are above a critical cell density or in a 
hypoxic environment. On the left is the engineered circuit working in a cell density-
dependent manner. The diagrams are from (Anderson et al., 2006). 
 
Kobayashi et al. (Kobayashi et al., 2004) have coupled the engineered genetic 
toggle switch to the cell’s natural SOS signalling pathway to form biofilms upon 
response to DNA-damaging agents. The engineered E. coli bacteria with a synthetic 
quorum sensing circuit are trigged to invade tumor cells under certain conditions as 
shown in Figure 1.6 (Anderson et al., 2006). A proof-of-principle bacterial 
photographing system is constructed in E. coli, which uses a synthetic protein made 
by fusing a light-sensing domain of one protein to a signal transduction domain of 
another. As a result, the engineered bacterium can express a certain enzyme to turn 
the media black when exposed to light (Levskaya et al., 2005).  
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Another major application area comes from the combination of synthetic 
biology with metabolic engineering. For instance, Keasling et al. have demonstrated 
how to produce the precursor chemical compounds for anti-malaria drug artemisinin 
in E. coli using an engineered metabolic pathway from the yeast strain (Martin et al., 
2003) and later in engineered yeast (Ro et al., 2006). Bayer et al. (Bayer et al., 2009) 
used synthetic metagenomic approach to seek optimised versions of methyl halide 
transferase (MHT) enzyme from many natural sources for the synthesis of methyl 
halides from biomass in a symbiotic co-culture of the engineered yeast and the 
cellulolytic bacterium Actinotalea fermentans. Other examples include using 
engineered cyanobacterium Synechococcus elongatus to produce isobutyraldehyde 
and isobutanol directly from carbon dioxide (Atsumi et al., 2009), and optimising the 
1-deoxy-d-xylulose-5-phosphate (DXP) biosynthesis pathway in E. coli to improve 
lycopene production using a genome engineering approach (Wang et al., 2009b).  
These application-oriented systems have shown the enormous potential of 
engineering synthetic biological systems for practical applications. The prospective 
application areas could span a wide range from microbial biosensors (Khalil and 
Collins, 2010), biofuels production (Lee et al., 2008; Savage et al., 2008), 
biopharmaceuticals and biomaterials synthesis (Bayer et al., 2009) to gene therapy, 
tissue engineering and bio-computing (Haynes et al., 2008).  
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1.3 Current Design Principles and Challenges of 
Engineering Gene Circuits 
This section briefly reviews the design principles currently used in the synthetic 
biology community to engineer synthetic gene circuits with desired functions and 
discuss their advantages and disadvantages. The existing challenges in gene circuit 
design and construction are discussed subsequently. 
1.3.1 Current design principles for engineering synthetic gene circuits 
Lacking the predictability found in other mature engineering disciplines, constructing 
synthetic gene circuits with desired properties from discrete gene components is non-
trivial and usually involves an iterative process of design, construction, testing and 
verification. Thus to increase the likelihood of producing functional gene circuits and 
to reduce the associated cost and effort, there are several design principles that is 
currently prevalent in this field to guide the process of gene circuit engineering. The 
following introduces these design principles and their successful applications. 
 
Rational design 
One such approach is iterative rational design (Purnick and Weiss, 2009), which 
involves building and analysing a computational model of a designed system, 
experimentally constructing the relevant circuit and verifying the system behaviour, 
fine-tuning the circuit guided by the modelling until the desired performance is 
achieved. The genetic toggle switch (Gardner et al., 2000), repressilator (Elowitz and 
Leibler, 2000), negative auto-regulation (Becskei and Serrano, 2000) and pattern 
formation circuits (Basu et al., 2005) are among the examples of the application of 
this design principle. This approach was further developed using well-characterised 
and modelled components to predict the target synthetic system behaviour (Guido et 
al., 2006; Rosenfeld et al., 2007; Tabor et al., 2009). However, in practice, this 
method normally involves an iterative and labourious process of trial-and-error to fine 
tune the target circuit because the model parameters of the components in the system 
are not always available, and the emergent effect (unexpected system behaviour) may 
occur even when the components are well characterised. 
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Directed evolution 
Another method widely used in creating or fine tuning functional gene circuits is 
directed evolution (Haseltine and Arnold, 2007), which subjects a given component or 
circuit to random mutagenesis (by error-prone PCR or PCR with designer variant 
oligonucleotides), followed by a screen or selection to isolate mutants that meet the 
desired behavioural criteria (McDaniel and Weiss, 2005). Arnold et al. have applied 
directed evolution to evolve an original unmatched genetic circuit to the functional 
one by mutating the protein coding sequence of a gene and its RBS within the circuit 
(Yokobayashi et al., 2002), and to evolve the transcriptional activator LuxR leading to 
improved response to quorum sensing signals (Hawkins et al., 2007). Other examples 
include the engineered cancer cell invasion circuit (Anderson et al., 2006) and the 
genetic logic AND gate (Anderson et al., 2007), which were constructed by selecting 
the circuit variants generated with libraries of mutant RBS sequences for a certain 
gene in the systems. Thus this approach harnesses the advantages of genetic diversity 
and selection to engineer functional circuit without having detailed knowledge of the 
underlying components. But it may require many rounds of evolution and screening 
before the objective performance is achieved. It is also of low efficiency if the space 
for evolution is large, and the mutant library size increases combinatorially with the 
number of components to be evolved. 
 
Combinatorial synthesis 
The third approach which is used is known as combinatorial synthesis, which 
constructs circuit variants with parts in predefined different combinations and 
configurations and then selects out the functional ones with the desired performance 
(Michalodimitrakis and Isalan, 2009; Purnick and Weiss, 2009). This combinatorial 
approach was first demonstrated in a study of randomly shuffling the connectivity of 
the three transcriptional regulators (TetR, LacI and CI) and their respective promoters 
(Guet et al., 2002). The generated transcriptional networks displayed varying 
phenotypic behaviour resembling different logic functions of NAND, NOR and NOT 
IF. Thus by changing the underlying gene network architecture, combinatorial 
synthesis provides an alternative method for generating diverse phenotypes, as well as 
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for studying biological networks. In another study, researches combinatorially 
constructed around 600 recombinations of bacterial promoters with different 
transcription or sigma factors ORFs on plasmids in E. coli and thus added new links 
to the wild-type bacterial global transcription network (Isalan et al., 2008). They 
surprisingly found that the rewired bacteria can tolerate most of the added links 
without growth defects, and some even acquired survival benefits against certain 
selection pressures. Other examples include combinatorial promoter design by adding 
and rearranging multiple operator sites within a promoter (Cox et al., 2007; Murphy et 
al., 2007) to generate diverse promoter regulatory functions. 
 
Hybrid approaches 
Besides the design principles described, there are also hybrid approaches developed to 
improve the efficiency of gene circuit engineering by combining the advantages of the 
three approaches mentioned above. For example, the rational design-combinatorial 
approach (Dueber et al., 2009; Ellis et al., 2009; Ramalingam et al., 2009) improves 
the likelihood of successful construction using quantitative modelling to guide the 
choice of the component combinations in the circuit. The integrated rational design-
directed evolution approach (Feng et al., 2004; Lou et al., 2010; Sayut et al., 2009; 
Zhan et al., 2010) uses the modelling results of rational design to help narrow down 
the number of targets in the system to be mutated and evolved, and thus increases the 
efficiency. Another one is the combinatorial-evolutionary approach (Atsumi and Little, 
2006; Pfleger et al., 2006; Wang et al., 2009b), which normally subjects multiple sites 
in a gene network to be evolved in parallel to produce an optimised combination of 
the network components for the selected characteristics.  
 
1.3.2 Challenges for engineering gene circuits 
As introduced in the previous section, synthetic biologists have accomplished a great 
deal in a short time. A number of synthetic biological parts with basic functions 
(Voigt, 2006) have been developed and assembled to construct some proof-of-
principle circuits, such as switches (Ajo-Franklin et al., 2007; Gardner et al., 2000; 
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Winkler, 2005), oscillators (Elowitz and Leibler, 2000; Fung et al., 2005; Stricker et 
al., 2008; Tigges et al., 2009), digital logic devices (Anderson et al., 2007; Bronson et 
al., 2008; Zhan et al., 2010), cell-cell communicators (Basu et al., 2005; Danino et al., 
2010; You et al., 2004) and sensors (Anderson et al., 2006; Bayer and Smolke, 2005; 
Kobayashi et al., 2004; Tabor et al., 2009). However, the majority of these are 
constructed in an ad hoc way and our ability to predictably and reliably engineer 
synthetic biological systems remains quite limited. As summarised in a statistical 
analysis of the current publications in this field till 2009 (Purnick and Weiss, 2009), 
the complexity in terms of the number of regulatory promoters in the synthetic 
circuitries seems to have reached a plateau with a maximum of 6 promoters. The 
construction of synthetic biological systems with desired properties is still an 
expensive, and to some extent unpredictable and labourious research process at 
present (Endy, 2005; Kwok, 2010; Lu et al., 2009), and is far from an engineering 
routine with lots of trial-and-error. Here I summarize the major obstacles and 
challenges that remain to be overcome before the engineering of biology becomes 
routine. 
 
(1) Standardisation, characterisation and modularity: The immediate challenges 
to be tackled are the modularity and reusability problems. Most of the parts and 
modules used for constructing biological systems are currently undefined, i.e. not 
standardised and quantitatively characterised, and thus lack modularity and reusability. 
The current standard for defining parts and modules needs to be revised to improve 
the modularity and to facilitate the physical and functional assemblies of them. 
Furthermore, a part or module characterised in one context may change its behaviour 
in a new working condition and configuration. New standard and method for 
characterisation need to be developed, which can reduce or eliminate such context 
dependency issue and thus increases the reusability of the characterisation data across 
different locations and conditions (Kelly et al., 2009).  
 
 (2) Orthogonality: Another challenge which needs to be addressed is the so called 
orthogonality problem. Orthogonality means that the newly added parts and modules 
should not interfere with existing ones in the designed biological systems as well as 
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the genetic background of the host chassis, i.e. no crosstalk. Although biological 
devices are expected to work in a similar manner to their electronic equivalents, a key 
difference is that unlike electronic digital circuits the individual components are not 
connected by wires. The parts and devices sit in a melange of different substances, 
and the interactions of biological components have to depend on the chemical 
specificity between them. Unfortunately, the toolkit of synthetic biology now contains 
only a small repertoire of orthogonal regulatory elements such as the LacI, TetR and 
phage lambda CI regulatory proteins and their cognate promoters. This greatly 
constrains the development of larger scale systems with high level functions, which 
normally comprise many components. Thus, a pressing need is to expand the 
currently limited number of orthogonal parts and modules available in the toolbox and 
to systematically characterise them in certain model chassis, like E. coli and yeast. 
Though most of genes among different species are homologous, the gene evolution 
process, for example, speciation, gene duplication, gene loss and horizontal gene 
transfer (Koonin, 2005), has led to the formation of various specialised functional 
genes or gene clusters in many species. These genes usually exist to enable the hosts 
to develop some exclusive functions or survive in their corresponding niches such as 
the virulence related genes in the plant pathogenic Pseudomonas syringae and the 
heat resistant genes in certain thermophilic bacteria. Therefore, these specialised 
genes are likely to be orthogonal to the chassis of species without the relevant 
exclusive characteristics. The diverse range of natural building blocks in the myriad of 
prokaryotic and eukaryotic species provides a rich source from which to engineer 
orthogonal devices with a variety functions. 
 
(3) Functional assembly of BioParts:   The functional assembly problem poses 
another great challenge. The current design principles including rational design, 
directed evolution, combinatorial synthesis and their hybrids have been shown to 
work in designing some small scale biological systems, but they still involves a large 
amount of tinkering work and there are lots of trial-and-error. Our ability to assemble 
individual biological parts and modules into a customised system with desired 
functionality remains of low efficiency and lacks enough predictability. To transform 
gene circuit design and construction into a predictable and reliable engineering 
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process, more efficient strategies need to be developed to guide the assembly of 
BioParts into functional biological circuits and the fine-tuning of them.  
 
(4) Variation:     The fourth great challenge may be the variation problem, which is 
brought by evolution and noise inherent in biological systems. The engineered 
biological circuits are subject to potential mutations during the evolution process of 
the host organisms, which can crash the whole system completely. In addition, the 
function of the engineered circuit is affected by the cellular context, which 
continuously evolves according to the environmental conditions as shown in a study 
(Dekel and Alon, 2005). Thus the variation of the cellular context may lead to the 
change of circuit behaviour. Another issue is noise, which can make the engineered 
circuit behave unstably and non-homogeneously. The gene expression is a stochastic 
process and protein concentrations fluctuate in cells. There is also cell to cell variation. 
Therefore, news solutions are required to combat the effect of evolution and noise to 
make synthetic circuits function stably and robustly (Andrianantoandro et al., 2006; 
Weiss, 2004). 
 
(5) Supporting technologies and platforms: Another major challenge is the 
supporting technologies and platforms associated with the construction and testing of 
synthetic biological systems. Construction is one bottleneck at present. Synthetic 
biologists spend a large portion of their time on the cloning and assembling of genetic 
parts and modules. Thus more efficient standards and methods for the rapid physical 
assembly of large gene fragments are required. The BioBrick standard assembly 
(Knight, 2003) and the recent Gibson assembly (Gibson et al., 2009) represent the 
efforts towards this goal. Technologies which lead to high throughput and cheaper 
DNA sequencing and synthesis will great facilitate the speed of construction and 
bring down the relevant cost. New measurement technologies and platforms are also 
required to rapidly and easily probe the circuit dynamics, such as using new gene 
reporters (Martin et al., 2009) and the microfluidic platforms (Balagadde et al., 2005; 
Bennett and Hasty, 2009; Cookson et al., 2005; Danino et al., 2010; Gulati et al., 2009) 
to test kinetic cellular processes and behaviour.  
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1.4 Objectives of This Study 
As described in the previous sections, synthetic biology is still at a relatively early 
stage. Many challenges and obstacles remain to be overcome before the art of 
engineering gene circuits has the same predictability and reliability as seen in the 
design and construction of electronic circuits. Efforts both at the biological and 
engineering sides are required for the maturation of this interdisciplinary discipline. 
Novel genetic parts and modules, and efficient design principles for assembling them 
are needed at present. New gene regulation modes are also expected at each step of 
the whole gene expression process, from DNAs, RNAs, transcription factors, to sigma 
factors, RNA polymerases and ribosomes, to achieve tight and flexible control of the 
genetic information flow in cells. An extensive use of engineering concepts, theories 
and tools, such as predictive modelling, will be of great value for constructing larger 
and more complex synthetic gene circuits. 
The objectives of this study are to overcome some of the aforementioned major 
challenges for engineering gene circuits. First, as a way to expand the currently 
limited toolkit of synthetic biology, the study presents the design and engineering of 
some novel modular and orthogonal logic devices by redesigning a natural biological 
module (i.e. the HrpR/HrpS hetero-regulation motif in the hrp system of 
Pseudomonas syringae) and using an alternative regulation mode (i.e. the σ54-
dependent gene transcription) to achieve tight gene expression control (see Chapter 
3). Second, this study examines the effect of context (both biophysical and genetic 
contexts) on part and device behaviour and determines new methods and standards for 
the characterisation of parts and devices (see Chapter 4). Third, through the 
engineering of the designed logic circuits, the study aims to seek and verify a new 
strategy for functionally assembling synthetic parts and modules in a more predictable 
manner (see Chapter 3, 4 & 5). Last, the study also aims to design and construct an 
application-oriented system (i.e. the cell density-dependent in vivo biosensor) by 
systematically integrating the parts and modules engineered in the thesis (see Chapter 
6). 
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2.1 Materials 
2.1.1 Media 
The media used for growing the bacteria strains in this study are shown in Table 2.1.  
All media were autoclaved (121 °C for 15 minutes) or filtered (0.22 µm filter) for 
sterilisation purposes.  
Table 2.1 Bacterial growth media used in this study. 
Medium Contents Used for 
LB (Luria-Bertani Broth) 10 g/L peptone, 5 g/L NaCl, 5 g/L yeast extract General growth 
in liquid media 
LB agar 10 g/L peptone, 5 g/L NaCl, 5 g/L yeast extract, 
18 g/L agar 
General growth 
in solid media 
M9 minimal media with 
0.4% glycerol 
11.28 g/L M9 salts, 1mM thiamine 
hydrochloride, 0.4% (v/v) glycerol, 0.2% (w/v) 
casamino acids, 2mM MgSO4, 0.1mM CaCl2 
Characterisation 
M9 minimal media with 
0.01% glucose 
11.28 g/L M9 salts, 1mM thiamine 
hydrochloride, 0.01% (v/v) glucose, 0.2% (w/v) 
casamino acids, 2mM MgSO4, 0.1mM CaCl2 
Characterisation 
 
2.1.2 Antibiotics 
The Antibiotics used are summarised in Table 2.2. They were filter sterilised and used 
at the following target concentrations in media. 
Table 2.2 Antibiotics used in this study. 
Antibiotics Concentrations 
Ampicillin 25 µg/ml 
Kanamycin 25 µg/ml 
Chloramphenicol 25 µg/ml 
Tetracycline 10 µg ml 
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2.1.3 Kits 
The commercially available kits in Table 2.3 were used in this study. 
Table 2.3 Kits used in this study. 
Kit Company Used for 
QIAprep Spin Miniprep Kit QIAgen Purification of plasmid DNA  
QIAquick PCR Purification Kit QIAgen Gel extraction of DNA 
E.Z.N.A. Plasmid Miniprep Kit  Omega Bio-tek Purification of plasmid DNA 
 
2.1.4 Dyes, chemicals and enzymes 
The commercially available dyes, chemicals and enzymes in Table 2.4 were used in 
this study. 
Table 2.4 Dyes, chemicals and enzymes used in this study. 
Dyes, chemicals and enzymes Company Used for 
SYBR Safe Invitrogen DNA gel stain  
5× loading buffer Sigma DNA gel loading 
100 bp/1 kb DNA ladder Invitrogen DNA gel electrophoresis 
Isopropyl-D-1-thiogalactopyranoside 
(IPTG) 
Fisher Scientific Induction of gene expression 
arabinose Sigma Induction of gene expression 
N-(3-Oxohexanoyl)-L-homoserine lactone 
(AHL) 
Sigma Induction of gene expression 
5× M9 minimal Salts Sigma Making M9 media 
Thiamine hydrochloride Sigma Making M9 media 
Casamino acids  Fisher Scientific Making M9 media 
D-glucose Sigma M9 media carbon source 
Glycerol VWR BDH M9 media carbon source 
Dulbecco’s Phosphate Buffered Saline, 
Ca2+ and Mg2+ free (D-PBS buffer) 
Invitrogen GIBCO 
Cell washing and dilution 
for FACS assay 
Cloned Pfu DNA polymerase  Stratagene DNA amplification in PCR 
Restriction enzymes; T4 DNA ligase  New England Biolabs DNA digestion;  ligation 
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2.1.5 Bacterial strains 
All strains used in this study are listed in Table 2.5. Bacterial strains were streaked for 
single colonies from glycerol stocks onto solid agar media and grown overnight at 
37 °C. Liquid cultures (see Section 2.3.1) were inoculated with single bacterial 
colonies and grown overnight at 37 °C with shaking (200 rpm). The day liquid 
cultures were then inoculated from the overnight cultures and grown at 37 °C or 30 °C 
with shaking (200 rpm). 
Table 2.5 Bacterial strains used in this study. 
Strain Genotype Reference
XL1-Blue 
endA1 gyrA96 thi-1 recA1 lac glnV44 F'[ ::Tn10 (Tetr)  proAB+ lacIq 
Δ(lacZ)M15] hsdR17(rK- mK+) 
Stratagene 
MG1655 F- λ- ilvG- rfb-50 rph-1 
Laboratory 
collection 
MC4100 
F- [araD139] Δ(argF-lac)169 λ- e14- flhD5301 Δ(fruK-yeiR)725 
(fruA25) relA1 rpsL150(strR) rbsR22 Δ(fimB-fimE)632(::IS1) deoC1 
Laboratory 
collection 
MC1061 
F- Δ(ara-leu)7697 [araD139] Δ(codB-lacI)3 galK16 galE15 λ- e14- 
mcrA0 relA1 rpsL150(strR) spoT1 mcrB1 hsdR2(r- m+) 
Laboratory 
collection 
TOP10 
F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 ΔlacX74 nupG recA1 
araD139 Δ(ara-leu)7697 galE15 galK16 rpsL(StrR) endA1 λ- 
Invitrogen 
DH5α 
F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG 
Φ80dlacZΔM15 Δ(lacZYA-argF)U169, hsdR17(rK- mK+), λ– 
Laboratory 
collection 
BW25113 rrnB DElacZ4787 HsdR514 DE(araBAD)567 DE(rhaBAD)568 rph-1 
Keio 
collection 
BL21-Gold 
(DE3) 
E. coli B F- ompT hsdS(rB– mB–) dcm+ Tetr gal λ(DE3 [lacI lacUV5-
T7 gene 1 ind1 sam7 nin5]) endA Hte 
Stratagene 
 
 
2.2 DNA Methods 
An overview of DNA manipulations 
The target genes used in this study were first either synthesised (by GENEART; see 
Section 2.2.8) according to their sequenced sequences in the public database (e.g. 
http://pseudomonas.com) or amplified from chromosomal or plasmid DNA (see 
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Section 2.2.1 for plasmid DNA purification) via Polymerase Chain Reaction (PCR; 
see Section 2.2.2) using gene-specific sets of primers harbouring desired restriction 
sites and modifications. DNAs obtained from PCR were subjected to agarose gel 
electrophoresis (see Section 2.2.3) and the target DNA bands were extracted and gel 
purified (see Section 2.2.4). The purified DNA from either plasmid or PCR was 
digested with appropriate restriction enzymes (see Section 2.2.5) and ligated into the 
cloning or other desired vector (see Section 2.2.6). The DNA construct was then 
verified by DNA sequencing (see Section 2.2.8). Following transformation into the 
target cell strain using the heat-shock method (see Section 2.2.10), several clones 
were selected for antibiotic resistance and re-streaked on fresh LB agar plate under 
antibiotic selection. The purified plasmids from these clones were again checked by 
restriction digestion before being used in subsequent studies. Typically, DNA was run 
on 1.0% (w/v) agarose (BDH) gels in 1× TBE supplemented with 10 µl SYBR Safe 
DNA Stain for 100 ml gel (see Section 2.2.3). For short DNAs below 200 bp, 1.2-
1.5% (w/v) agarose gels were used for visualising them. For BioBrick constructs, 
specific assembly strategy was used (see Section 2.2.7). All plasmids and oligo DNAs 
(primers) used in this study are listed in Appendix A and B.  
 
2.2.1 DNA purification 
Plasmid DNAs were purified from target bacterial cells grown in a 5 ml overnight LB 
culture supplemented with the appropriate antibiotic using the QIAprep Spin 
Miniprep Kit (Qiagen) according to the manufacturer’s instructions.  The plasmids 
were eluted in a final volume of 50 µl deionized water. 
 
2.2.2 Polymerase Chain Reaction (PCR) 
Specific primers were used to amplify the desired DNA fragment from plasmid DNA 
using Pfu DNA polymerase (Stratagene). Pfu DNA polymerase is a proofreading 
DNA polymerase and used here to increase the fidelity of DNA synthesis during PCR 
compared to the normal Taq DNA polymerase. The reaction mixture for PCR 
amplification from a plasmid DNA used in this study is listed in Table 2.6. 
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Table 2.6 Reaction mix for PCR amplification used in this study. 
Component Amount per reaction 
Distilled H2O 38 µl 
10× pfu buffer 5 µl 
dNTPs (10 mM each) 1 µl 
Forward primer (10 µM) 2 µl 
Reverse primer (10 µM) 2 µl 
DNA template (10× diluted miniprep DNA) 1 µl 
Cloned Pfu DNA polymerase (2.5 U/µl) 1 µl 
Total reaction volume 50 µl 
 
The PCR reaction was performed in an Eppendorf Mastercycler gradient thermal 
cycler PCR machine with the following parameters: 
Table 2.7 Operating parameters for PCR reactions in this study. 
PCR Step Condition 
Initial denaturation 94 °C for 2 min  
Denaturation 94 °C for 30 sec 
Annealing 
Tm – 4 °C (Tm is the calculated melting 
temperature of applied primers)  
Extension 72 °C for 60 sec (for 1 kb around fragment) 
Final extension 72 °C for 10 min 
Cycle number 30 (for the middle 3 cycling steps only) 
 
2.2.3 Agarose gel electrophoresis 
DNA fragments were separated and analysed using agarose gel electrophoresis. The 
agarose gels were prepared according to the size of the DNA fragments to be 
separated. Typically, 1.0% (w/v) agarose (BDH) were dissolved by heating in 100 ml 
1× TBE buffer (Sigma). SYBR Safe DNA Gel Stain was added to the melted solution 
with a final concentration of 1:10,000. The solution was then poured into a gel tank 
with a comb and left to cool down. DNA samples were mixed with 5× loading buffer 
(Sigma) and loaded onto the gel together with the appropriate DNA ladder 
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(Invitrogen). The gel was run at 100 volts in 1× TBE buffer until the dye front of the 
ladder reached the bottom of the gel or the bands were clearly separated. The gel was 
then visualised under blue light using a Bio-Rad gel imaging system. 
 
2.2.4 Gel extraction and purification of DNA 
If needed, the DNA fragments were extracted from agarose gels and purified using a 
QIAquick PCR Purification Kit (Qiagen) according to the manufacturer’s instructions. 
The DNA was finally eluted in 30 µl distilled water. 
 
2.2.5 Restriction digest 
7-10 µl of purified plasmid DNA were digested in a 20 µl reaction volume 
supplemented with the corresponding buffer (New England Biolabs (NEB) or 
Fermentas) at 37 °C for 1.5 hours using 1 µl per restriction enzyme (NEB or 
Fermentas). The digest was then analyzed on an agarose gel and the desired DNA 
fragments were excised and purified using a QIAGEN PCR Purification Kit for 
subsequent cloning.  
 
2.2.6 Ligation 
Following restriction digest, the cut vector and insert DNA fragments (ideal molar 
ratio of vector to insert = 1:3) were ligated in a reaction volume of 20 µl either at 4 °C 
overnight using 1µl T4 DNA ligase and the 10× reaction buffer (NEB) or at room 
temperature for 30 min using 1µl Quick T4 DNA ligase and the 2× reaction buffer. 
The reaction mix was brought up to a final volume of 20 µl with distilled water and 
mixed thoroughly. Different ratios of DNA insert to vector were tried if the first 
ligation failed. After ligation, 10 µl of the reaction solution was used to transform the 
chemically competent E. coli cells and transformants were obtained using the 
appropriate antibiotic selection. 
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2.2.7 Assembly strategy for DNA constructs 
Besides the normal cloning strategy based on restriction enzyme digest, gel 
purification and ligation, the BioBrick standard assembly method was used for 
producing some of the DNA constructs in this study. BioBrick is a standard for 
interchangeable DNA parts and is invented as a way of applying engineering 
principles of abstraction and standardisation to the design of composable biological 
components for easy and standard assembly of them (Knight, 2003; Shetty et al., 
2008). BioBrick parts are designed to be flanked with the same BioBrick prefix 
(carrying EcoRI and XbaI restriction sites) and BioBrick suffix (carrying SpeI and 
PstI restriction sites) sequences as listed below.  
 
BioBrick prefix:    GAATTCGCGGCCGCTTCTAGAG 
BioBrick suffix:    TACTAGTAGCGGCCGCTGCAG 
The scar between two joint BioBrick parts:        TACTAGAG 
 
The BioBrick standard assembly is based on conventional cloning methods and 
utilises the compatible sticky sequence (CTAG) generated from the SpeI (ACTAGT) 
and XbaI (TCTAGA) digested sites. When two BioBrick parts join together, the 
assembly results in a scar between them, as indicated above, which cannot be cut by 
XbaI or SpeI restriction enzyme. As shown in Figure 2.1, the BioBrick standard 
assembly is used to piece two BioBrick parts together, one blue and one green. The 
two BioBrick parts are buried in their corresponding BioBrick plasmid backones 
which have the same BioBrick flanking sequences. The blue part was first cut out 
using EcoRI and SpeI restriction enzymes. The plasmid harbouring the green part was 
digested with EcoRI and XbaI restriction enzymes to generate a gap and to be ligated 
with the digested blue part. Following gel electrophoresis and purification, the insert 
of the blue part and the cut plasmid containing the green part were ligated under 
appropriate conditions to allow the EcoRI sticky ends to join together and the SpeI 
sticky end to join together with the XbaI sticky end. In this way, the two BioBrick 
parts are combined together and a new composite part is generated though the 
assembly results in a scar in the middle. The composite part itself is a new BioBrick 
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part, flanked with standard BioBrick prefix and suffix, and can be used to join with 
other BioBrick parts in the same way to form a larger construct. Thus, BioBrick 
standard assembly is a simple and easy method to assemble as many BioBrick parts in 
a desired order. The disadvantage is that the parts and plasmid backbones have to 
conform to BioBrick standard. In some cases the natural parts themselves contain the 
four restriction sites used here and so have to undergo synonymous codon exchange 
either by site directed mutagenesis or de novo synthesis.  Further, ligating BioBrick 
parts leads to an 8 bp (base pairs) scar between two joined parts preventing protein 
fusion formation. 
 
 
 
Figure 2.1 BioBrick Standard Assembly method (Registry of Standard  Biological 
Parts, 2010a).  
 
To increase the cloning efficiency, a three way ligation method was used in this 
study to assemble two separate BioBrick constructs into one desired vector in a single 
reaction. As shown in Figure 2.2, the two BioBrick parts (Part 1 in blue plasmid and 
Part 2 in green plasmid) and the construction plasmid (in red) was cut with 
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appropriate restriction enzymes and gel purified in parallel. The two parts and the 
construction vector were then mixed and ligated in one reaction to save time and 
effort, instead of using the two way ligation approach in two serial steps, to complete 
the assembly. 
 
 
 
Figure 2.2 Three way ligation method. The method is used for assembling two 
separately digested BioBrick parts and one cut BioBrick plasmid backbone in one 
ligation reaction (Registry of Standard  Biological Parts, 2010b). 
 
2.2.8 DNA sequencing and synthesis 
For sequencing, DNA samples were prepared in a total volume of 15 µl comprising 
13.5 µl purified plasmid DNA and 1.5 µl sequencing primer (10 pmol/µl). The 
samples were sent to and sequenced by Eurofins MWG Operon. The sequences were 
then analysed using the BioEdit Sequence Alignment Edit software.  
For gene synthesis, the DNA sequences were designed according to the 
specification and flanked with BioBrick standard restriction sites. The designed DNA 
fragments were sent to and synthesised by GENEART. The synthesised DNAs came 
back in GENEART commercial cloning vectors and were cut out for subsequent 
usage. The primers used in this study were ordered from Eurofins MWG Operon. The 
sequences of the essential gene elements used in this study are listed in Appendix C. 
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2.2.9 Competent cell preparation 
Chemically competent cells were used in this study and prepared using the calcium 
chloride method for heat shock transformation. A single colony of the required 
bacterial strain was inoculated in 5 ml LB media within a 14 ml Falcon tube 
containing the appropriate antibiotic for overnight growth at 37 °C with shaking (200 
rpm). The overnight culture was diluted 100 fold to 200 ml fresh LB media 
supplemented with appropriate antibiotic and grown to mid log phase (OD600 between 
0.3 – 0.4) at 37 °C.  The culture was then transferred to pre-cooled 50 ml Falcon tubes 
and incubated on ice for 10 min before being centrifuged (5578 × g, 6 min, 0 °C). The 
harvested cells were washed gently with cold CaCl2 solution (50 mM) and pelleted by 
centrifugation (5578 × g, 6 min, 0 °C). The washed pellet was resuspended in cold 
CaCl2 solution (50 mM), left on ice for 30 min and pelleted again. The pellet was 
resuspended in 1 ml cold solution (50 mM CaCl2, 15% (v/v) glycerol) and incubated 
on ice for 2 hours. The cells were then dispensed into 1.5 ml microtubes in 100 µl 
aliquots and stored at -80 °C for later heat shock transformation.  
 
2.2.10 Heat shock transformation 
Either 1 µl plasmid DNA (around 20 ng/µl) or 10 µl ligation mix was added to 50 µl 
chemically competent cells which had been thawed on ice. The mix was gently mixed 
and incubated on ice for 30 min before being heat shocked at 42 °C for 90 sec. The 
cells were then incubated on ice for 2 min and recovered in 0.5 ml LB for 1 hour with 
shaking (100 rpm) at 37 °C. 100 µl of the recovered cells was spread onto a LB agar 
plate containing the appropriate antibiotic to select transformants harbouring the 
plasmid of interest. The plate was incubated overnight at 37 °C.  
 
2.3 In Vivo Assay Methods 
2.3.1 Growth of bacteria cells 
Unless otherwise stated, the cells were grown in 5 ml LB in 30 ml universal tubes for 
general purpose and in 4 ml M9 minimal media (glycerol or glucose as the carbon 
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source) in 14 ml Falcon tubes for characterisation purpose at 37 °C and 200 rpm in an 
Innova shaking incubator (New Brunswick Scientific). All media were supplemented 
with appropriate antibiotics related to the plasmids residing in the bacterial cells. The 
overnight cultures were inoculated with a single colony from a freshly streaked LB 
agar plate containing the appropriate antibiotics. Day-cultures were inoculated from 
overnight cultures and diluted to OD600 = 0.05, and grown to mid log phase (OD600 ~ 
0.4 – 0.7) or for required length of time prior to analysis. 
For characterisation using a fluorometric assay of GFP synthesis, day-cultures 
were grown and monitored in 96 well micro-assay-plates. Diluted day-cultures were 
initially loaded into wells and induced with various levels of inducers in a final 
volume of 200 µl per well. The plate was then immediately incubated in the 
microplate reader (BMG POLARstar Omega) at 30 °C or 37 °C as required with 
programmed shaking (200 rpm, linear mode) between each 20 min cycle of 
absorbance and fluorescence readings. 
 
2.3.2 Fluorescence assay for gene expression in living cells 
As this study involves intensive assay of gene expression and regulation, it is 
important to choose the appropriate gene reporter. There are several gene reporters 
that have been widely used for gene expression quantification. For example, the β-
galactosidase (β-gal) enzymatic assay has enabled sensitive quantification and high 
throughput screening of gene expression strength. This reporter requires the addition 
of exogenous reagents to lyse and penetrate living cells to produce the enzymatic 
reactions required for the colorimetric enzyme assay. Thus, it is better suited as cell 
population-averaged assay and cannot be easily adapted for quantification of gene 
expression within single cells and for long time dynamic assay unless used in a 
microfluidic set up. Another popular reporter is the luciferase derived from 
bioluminescent organisms like Vibrio fischeri. However, bacterial luciferase assay 
either needs the addition of an exogenous substrate by expressing only the luxA and 
luxB genes or without exogenous substrate by expressing a set of five genes 
(luxCDABE) of the lux operon to result in the bioluminescence – the blue-green light 
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with maximum intensity at 490 nm (Amos, 2004). This enables it can be easily 
quantified by measuring the brightness of the emitted light. But the expression of 
several genes imposes extra burden on living cells and the stability of lux-encoded 
products is not high. In this study, Green Fluorescent Protein (GFP) is used as needed. 
GFP emits a detectable fluorescent signal after excited with light of specific 
wavelengths and the addition of exogenous substrate or cofactors is not required. GFP 
is very stable after being expressed and works well across a wide range of organisms 
including bacteria, yeast, mammals, etc. Therefore, GFP can be used in vivo for 
population level measurement of expression strength using fluorometry and for high 
throughput single-cell level quantification using fluorescence activated cell sorting 
(FACS).  In addition, it normally does not interfere with the growth of the host and 
can be dynamically assayed using a time-lapse microscopy or programmed robotic 
fluorometer. 
 
2.3.2.1 The GFP reporter gene – gfpmut3b (encoding GFPmut3b) 
Green fluorescent protein was originally isolated from jellyfish Aequorea Victoria and 
contains an intrinsic chromophore to emit the fluorescence after excitation. It only 
needs oxygen to maturate and have little or very low toxicity on the cell host. The 
wild type (WT) GFP has an excitation spectrum peak at 395 nm with a minor peak at 
475 nm, and an emission peak at 509 nm with a minor peak at 475 nm (Amos, 2004). 
In order to be adapted for the various research purposes, there are many variants 
derived from the WT GFP, like GFPmut2, GFPmut3, EGFP, etc. These mutants 
usually have mutations around the chromophore region (amino acids 65-67: Ser-Tye-
Gly) of the protein, which results in the change of maturation time, the shift of 
excitation and emission spectrum. The mutant GFP used in this study is GFPmut3b 
carrying triple mutations from the WT one (S2R, S65G, S72A), which is 20 times 
more fluorescent than the WT one when excited at 488 nm and folds more efficiently 
when expressed in E. coli (Andersen et al., 1998; Cormack et al., 1996). Thus, 
GFPmut3b can be excited by the normally used light source – Argon laser with 
excitation light wavelength of 488 nm, well suited for the fluorometry and FACS 
based assays used throughout this study. 
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2.3.2.2 Cell population-averaged assay using fluorometry 
Population-averaged fluorescence measurement is used for characterising promoter 
and device output response in this study by a BMG POLARstar microplate 
fluorometer. 4 ml M9 cultures (0.4% glycerol or 0.01% glucose as the carbon source 
where appropriate) were inoculated with single colonies from freshly streak plates and 
supplemented with the appropriate antibiotics. The overnight cultures after 16 h 
growth were diluted into fresh pre-warmed M9 media containing the right antibiotics 
in a final volume of 4 ml with target concentration of OD600 = 0.05. The diluted 
sample-cultures were dispensed as 195 µl per well (190 µl per well for culture 
requiring double inductions) in a 96 well micro-assay-plate (Bio-Greiner, chimney 
black, flat clear bottom). The loaded sample cultures were rapidly induced by addition 
of 5 µl per well of each appropriate inducer in various concentrations, which resulted 
in various final induction levels, using a multichannel pipette. The blank wells were 
loaded with 200 µl per well M9 media, and the negative and positive control wells 
were loaded with 200 µl per well appropriate diluted cultures of OD600 = 0.05. The 
induced plate was then immediately placed into the fluorometer with a programmed 
protocol of repeated absorbance (OD at 600 nm) and fluorescence (485 nm for 
excitation, 520 ± 10nm for emission, Gain = 1000) readings. There was continuous 
shaking (200 rpm, linear mode) between repeated measurements (20 min/cycle) and 
the plate incubation was set at 30 °C or 37 °C as required. To compensate the effect of 
evaporation, absorbance readings at a specific time were calibrated according to the 
tested evaporation speed (4 µl/h per well at 30 °C, 8 µl/h per well at 37 °C). The 
medium backgrounds of absorbance and fluorescence were determined from the wells 
loaded with blank M9 media and were subtracted from the readings of other wells. 
The calculated fluorescence per OD600 at a specific time for a sample culture was 
determined after subtracting its triplicate-averaged counterpart of the negative control 
cultures (GFP-free) at the same time. The data were first processed in BMG Omega 
Data Analysis Software (v1.10) and were analysed in Microsoft Excel 2007 and 
MathWorks Matlab (R2010a) after exported. 
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2.3.2.3 Single-cell level assay using FACS 
To investigate the heterogeneity of gene expression amongst individual cells, FACS 
(fluorescence activated cell sorting) was used in this study for high throughput single-
cell quantification of GFP expression. The BD (Becton-Dickinson) FACSCalibur 
flow cytometer was used to assay the bacterial samples here. BD FACSCalibur having 
an Argon blue laser for excitation at 488 nm and the FL1 detector centred at 530 nm 
with 30 nm bandpass filter fits well for the GFP fluorescence quantification.    
 
Protocol: 
The overnight cultures grown in 4 ml M9 media in Falcon tubes were diluted into 
fresh pre-warmed M9 media (supplemented with appropriate antibiotics) in a final 
volume of 4 ml with OD600 = 0.05 in 14 ml Falcon tubes. The diluted day cultures 
were induced with appropriate inducers and placed in an Innova shaking incubator at 
30 °C or 37 °C as required with 200 rpm shaking. After 5 hours when cells were 
grown to mid log phase (OD600 around 0.3 – 0.5), cells were pelleted using 
centrifugation (5578 × g, 6 min). The supernatants were removed and the pellets were 
resuspended in 3 ml filtered dPBS buffer (0.22 µm filter) before being transferred to 
BD Falcon 5 ml round bottom tubes. The cultures were then placed on ice prior to be 
analysed by the BD FACSCalibur flow cytometer. The pre-warmed up flow 
cytometer (Argon laser 488 nm, FL1 detector 530/30 nm) were tuned with dPBS and 
negative control cultures (same strain but GFP free) till appropriate instrument 
settings settled using the BD CellQuest Pro software on a MAC workstation. The 
settings for forward and side scatter detectors were adjusted to place the acquired cells 
in the proper location on the scatter graph. The gain for FL1 detector was further 
tuned using the negative (GFP-free) control culture to let the cellular fluorescence of 
the negative control distributed within the first decade under log mode. Thus the 
FACS assay of the negative control under such configuration was treated as the 
background auto-fluorescence of the cells. Normally 20,000 total events were 
collected for each culture with low flow rate at room temperature. The acquired data 
were analyzed using the FlowJo software (v7.2 for windows platform) with an 
appropriate gate on the forward-scattering and side-scattering graph for all cultures. 
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2.4 Modelling and Data Analysis Methods 
Modelling approaches and system analysis techniques have been widely used not only 
for the building of complex engineering systems, but, also, for studying the 
underlying mechanisms of many complicated biological systems, especially in the 
case of systems biology studies. Recently, computational modelling as an essential 
engineering tool has also been extensively applied to the construction and analysis of 
engineered gene circuits (Elowitz and Leibler, 2000; Gardner et al., 2000; Hasty et al., 
2001) to increase the probability to succeed, improve the robustness of constructed 
systems and reduce the cost through quantitative prediction. There are numerous 
modelling approaches which can be used to model biological systems. The choice of 
modelling method is generally determined by the questions studied. The two 
modelling approaches widely used to model gene expression are the deterministic 
continuous model based on ODEs (ordinary differential equations) and the stochastic 
discrete model based on chemical master equation. Gene expression stochasticity has 
been demonstrated in some gene regulation networks (Choi et al., 2008; Elowitz et al., 
2002; Kaern et al., 2005) and can lead to some interesting experimental phenomena 
like bistability (Becskei and Serrano, 2000; Veening et al., 2008). In this study it is 
mainly focused on the average behaviour of the prokaryotic cell (E. coli) populations 
to demonstrate the performance of our engineered circuits, both temporal and at a 
steady state; therefore the deterministic model based on ODEs is used for the 
mathematical modelling here. The model formulation and the essential biochemical 
kinetics for modelling biological reactions are introduced below before a simple gene 
expression modelling example is illustrated at the end.  
 
2.4.1 Deterministic approach using ODE-based rate equations 
By assuming the reactions occur in a well mixed system, the production and depletion 
of each species in the system could be described by an ordinary differential equation. 
The dynamics of the whole system then can be represented by a set of coupled ODEs: 
( ,  ,  )d t
dt
=x f x θ                  (2.1) 
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where x  is a vector of the concentrations of reacting species, θ  is a vector of model 
parameters, and ( ,  ,  )tf x θ is a vector of function describing the rate expressions of 
each species.  
This approach is deterministic, as given the same parameter values and initial 
conditions, different rounds of simulations will generate the same time evolution for 
each species in the system.  
 
2.4.2 Basic biochemical kinetics  
As for the kinetic modelling of a biological system, it is treated that the system is 
composed of a series of biochemical reactions, whose kinetics can be described by 
rate expressions. The multiple reactions in living system span from elementary ones to 
enzyme catalysed ones, which can be modelled using biochemical kinetic laws. In the 
following, the essential kinetic laws for modelling biochemical reactions are described, 
i.e. the law of mass action, Michaelis-Menten enzyme kinetics and Hill kinetics. 
 
Law of Mass Action 
If the biochemical reactions in the system are elementary reactions, the rate of 
reactions can be described by the mass action law that the reaction rate is proportional 
to the product of the reactant concentrations, as shown in the following. 
[ ] [ ]reaction:             reaction rate: [ ]d A d BkA B k A
dt dt
⎯⎯→ = − = −            (2.2) 
 
Michaelis-Menten Kinetics 
Commonly, biological reactions are complicated and enzyme-catalysed. In this way, 
one reaction model used to describe the enzymatic reactions is the Michaelis-Menten 
kinetics. In this model, it assumes that the enzyme is not consumed and its total 
concentration level stays constant. The enzyme only interacts with the substrates to 
form an enzyme-substrate (E·S) complex, which leads to the synthesis of product as 
shown below. 
·f p
r
k k
k
E S E S E P⎯⎯→+ ⎯⎯→ +←⎯⎯  
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Suppose that the intermediate complex (E·S) is at the quasi-steady state and the 
substrate is far more than the enzyme. The rate of product synthesis could be 
described by the Michaelis-Menten equation: 
max[ ][ ]
[ ] M
V Sd P
dt S K
= +                  (2.3) 
where maxV (= [ ]p Tk E ,where [ ]TE  is the total enzyme concentration) is the maximum 
reaction rate and MK  is the Michaelis-Menten constant ( MK = ( ) /r p fk k k+ ), the 
concentration of substrate needed for reaching half maximal expression. 
 
Hill Kinetics 
If the enzyme has multiple binding sites and can bind substrate simultaneously, the 
Hill kinetics is commonly used to derive the reaction rate: 
·f p
r
k k
k
E nS nS E E P⎯⎯→+ ⎯⎯→ +←⎯⎯  max[ ][ ] [ ]
n
n n
M
v Sd P
dt S K
= + (Hill equation)   (2.4) 
where n is the Hill coefficient, which describes the cooperativity of the reacting 
substrate. For n = 1, Hill kinetics is reduced to Michaelis-Menten kinetics. Generally, 
the larger the n, the sharper the response curve described by Hill kinetics will be.  
 
2.4.3 Modelling a constitutive single gene expression 
 
 
   (2.5) 
 
  
 
 
Figure 2.3 A single gene expression modelling. (The picture is by courtesy of 
(Ozbudak et al., 2002)) 
 
[ ]  [ ] [ ]
[ ]   [ ]
P P
R R
d protein k mRNA protein
dt
d mRNA k mRNA
dt
γ
γ
= −
= −
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Taking a constitutive single gene expression as an example, mRNA molecules are 
transcribed from DNA template at rate Rk  and proteins are translated from each 
mRNA at the rate of Pk  (Figure 2.3). Proteins and mRNA degrade at rates of Pγ  and 
Rγ  respectively. Two coupled ODEs (Equation 2.5) can be used to represent this 
process in a deterministic manner as what displayed on the right of Figure 2.3. Using 
this deterministic model, a short time evolution of mRNA and protein is simulated, as 
shown in Figure 2.4. 
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Figure 2.4 Modelling of a single gene expression dynamics. The gene expression 
was simulated using the deterministic approach based on the ODEs with typical 
parameter values of gene expression). 
 
Referring to Figure 2.4, the deterministic simulation reveals mRNA synthesis 
reaches steady state much faster than protein production, the same as what the 
experiments have demonstrated. Therefore, the model for a single gene expression 
could be simplified by combing the transcription and translation as a single step using 
the following ODE equation. 
        [ ]  [ ]P
d protein k protein
dt
γ= −                                            (2.6) 
Equation 2.6 is derived from Equation 2.5 by following a steady state 
assumption for the [mRNA] and defining the constant k as P R Rk k k γ= . This is 
reasonable if the response delay induced by mRNA transcription is not a concerned 
issue in the study and also because the mRNAs follow a much faster dynamics than 
Chapter 2 - Materials and Methods 
 
 
55
the proteins. In case that the promoter of the gene is under the regulation of other 
transcription factors, Michaellis-Menten or Hill kinetics can be applied to the model 
where appropriate ( max max [ ] ( [ ] )
n n n
Mk k k A K Aα= ⋅ + ⋅ +  for positive regulation by 
activators and max max ( [ ] )
n n n
M Mk k k K K Aα= ⋅ + ⋅ +  for negative regulation by 
repressors, where [ ]A  is the regulator’s concentration, MK  is Hill constant relating to 
the regulator’s binding affinity, n is Hill coefficient relating to the regulator’s 
cooperativity, maxk  is the maximum expression rate and α  is the basal expression rate 
due to the promoter’s leakage). All modelling work in this study was implemented in 
MathWorks Matlab (R2010a). 
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In this chapter, the methods which were used to design and engineer novel synthetic 
biological devices as well as the design of the modular logic devices constructed in 
this study are presented. In Section 3.1, the current approaches to design modular and 
orthogonal biological devices, particularly the devices with logic functions, are 
discussed. In Section 3.2, the two paradigms for bacterial gene transcription, i.e. the 
σ70-dependent and σ54-dependent transcription, are introduced first with a focus on the 
potential advantages of the latter one for designing transcription-based logic devices. 
A σ54-dependent hetero-regulation module in the hrp regulatory system in 
Pseudomonas syringae pv tomato DC3000 are next described. In Section 3.3, a set of 
modular logic devices are designed on the basis of the described natural biological 
modules. The transfer functions of the designed genetic devices are then derived in 
Section 3.4. 
 
3.1 Approaches to Design Modular and Orthogonal 
Biological Devices 
In principle, fully characterised modular biological devices have standardised 
interfaces and can be easily incorporated into larger and more complex systems. 
However, most of the synthetic gene circuits constructed currently are just for their 
own specific purposes in a particular context and they often lack modularity and 
reusability. In addition, these biological circuits are usually constructed from a limited 
number of commonly used regulatory components, like the LacI, TetR and phage 
lambda CI repressor proteins and their regulatory promoters (Lu et al., 2009). Thus, 
only a small repertoire of orthogonal regulatory elements are available in the current 
toolkit of synthetic biology. This constrains the development of more complicated 
systems that might comprise many components because the use of non-orthogonal 
components in one system is likely to lead to unintended interactions. Since biological 
systems lack the same physical isolation as occurs in electronic and mechanical 
engineering, the interactions of biological components have to depend on the 
chemical specificity between them. There is a pressing need to expand the synthetic 
biology toolkit of available parts and modules which are truly modular and orthogonal.  
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As for biological systems, natural genetic networks are typically described as 
circuits of interconnected functional modules consisting of interacting DNAs, RNAs, 
proteins and small molecules. Taking the prokaryotic transcriptional regulatory 
module as an example, the module generally consists of three major elements: a 
promoter region; the gene or genes expressed from that promoter (a gene sequence 
usually comprises several functional parts – ribosome binding site, protein coding 
sequence and terminator); and the transcriptional factor proteins that bind to their 
cognate sites in the promoter to positively or negatively regulate the expression of that 
gene(s), as shown in Figure 3.1.  
 
TF protein
promoter gene  
 
Figure 3.1 Simplified architecture of a prokaryotic transcriptional regulatory 
module (TF stands for transcription factor protein. , , ,  stand for 
the promoter, ribosome binding site (RBS), protein coding sequence and terminator 
respectively). 
 
Owing to this inherent modularity in biology, a biological component can be 
treated as a module with a specific function, so long as its sensitivities to abiotic 
factors (e.g. heat, salt, pH) and biotic factors (e.g. proteases, chaperones, competing 
ligands) are sufficiently well catalogued and understood. Many functional sub-
modules are then assembled together to construct a larger module with a more 
complicated function. Referring to Figure 3.1, a promoter, RBS, protein coding 
sequence and a terminator, connected in a row, construct a protein generator module, 
of which both the input and output are protein concentrations. 
It would be ideal that the designed biological modules have standard inputs and 
outputs in order to promote their reusability and modularity. The inputs and outputs 
are best if they are generic. Proposed units supporting modular design in the synthetic 
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biology community currently include PoPS (polymerase per second) for transcription-
based devices (Canton et al., 2008) and RiPS (ribosomes per second) for translation-
based devices, as shown in Figure 3.2. PoPS represents the rate at which RNA 
polymerase moves past a given position in the DNA. RiPS is used as a standard unit 
to measure translational activity of an mRNA molecule and is related to rate of 
ribosome initiation and elongation. In some sense, they can be thought of as 
analogous to current flowing through a particular point in a wire. By using PoPS or 
RiPS as the inputs and outputs of designed modules, they could be arbitrarily hooked 
up together to compose more complex devices or systems. Thus, devices using PoPS 
or RiPS as the signal carrier are composable and modular. Modular devices are 
strongly suggested in this study for designing synthetic gene circuits with reusability 
and modularity. However, both PoPS and RiPS cannot be measured directly during an 
experiment. They are usually estimated from protein concentration, e.g. the GFP level, 
in practice. As the devices and modules designed in this study are transcription-based, 
the modular design based on PoPS was adopted here but using protein concentration 
level as the signal carrier for both the input and output, which can be directly derived 
from the corresponding characterisation data. 
 
Modular design
PoPS PoPS
RiPS RiPS
Standard
Inputs
Standard
Outputs
 
 
Figure 3.2 Modular design supports standard inputs and outputs of the designed 
biological modules. 
 
There are normally two ways to develop modules with orthogonality, i.e. the 
evolution and the genetically distinct natural modules. Here the orthogonality means 
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that the modules should not interfere with existing parts and modules in the designed 
biological systems as well as the genetic background circuit of the host. For the 
pathway using evolution, the original functional module is generally subject to 
mutations in positions with interaction specificity to generate alternative mutants 
which can keep the basic function of the original module but cannot interact with it, 
i.e. lose an energetically favourable interaction with the original partner molecules. As 
shown in a study of developing orthogonal variants of the LacI and its operator Olac 
interacting pair (Zhan et al., 2010), several of these non-interacting variant repression 
pairs can be used in one system to develop transcriptional logic gates. However, many 
biological modules are usually not well studied and the space of evolution is generally 
large. This method is time-consuming and of low efficiency and requires many rounds 
of screening. For the pathway using genetically distinct natural modules, the module 
components are generally derived from sources with different cellular background (i.e. 
different species). Like the tetR and cI genes commonly used in the E. coli chassis, 
they are not endogenous genetic elements of the host and thus likely orthogonal to the 
host background genetic circuit, whereas the lacI gene is endogenous and non-
orthogonal to E. coli and should be used in specific E. coli strains which have mutated 
lac operon on the chromosome to avoid potential interference with the chassis 
background. This method has great advantages as the natural diversity has generated 
thousands of genetically distinct species and normally there are thousands of different 
genetic modules of specific functions within each species. Other successful examples 
of this method include the Vibrio fischeri LuxR/LuxI (Basu et al., 2005; You et al., 
2004) and Pseudomonas aeruginosa LasR/LasI (Balagadde et al., 2008; Brenner et al., 
2007) quorum sensing elements, and the T7 and T3 RNA polymerases and their 
cognate regulatory promoters (Anderson et al., 2007; Friedland et al., 2009).  
For the study in this thesis, the second method using genetically distinct natural 
modules was applied to develop novel modular and orthogonal devices as a way to 
expand the limited toolkit of synthetic biology at the moment. In contrast to the 
currently dominated σ70-dependent gene regulation used in constructing synthetic 
parts and modules, a different regulatory mechanism of gene activation (i.e. the σ54-
dependent gene transcription) was exploited to engineer transcriptional logic devices, 
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which allows more tight control of the underlying regulation since its transcription 
system is fully dependent on activation and is otherwise very much in an off state. 
The difference between these two paradigms of bacterial gene transcription is 
introduced in the following section. 
 
 
3.2 The Two Paradigms of Bacterial Gene Transcription and 
the hrp Regulatory System in Pseudomonas syringae 
3.2.1 The two mechanistic paradigms of bacterial gene transcription 
Transcription is one of the fundamental processes in biology and a major control point 
for regulating gene expression to establish coordinated responses of living cells in an 
ever changing environment. The regulation of transcription is often achieved by the 
control of transcription initiation. The transcription initiation in bacteria is a multistep 
process which involves several components, i.e. the multisubunit RNA polymerase 
(RNAP), sigma factor (σ) protein and the target promoter DNA. The bacterial RNAP 
core enzyme comprises five conserved subunits (α2ββ΄ω; E) and associates with a 
range of σ factors to form the RNAP holoenzyme (Eσ) which can bind specific 
promoters (Schumacher et al., 2006). The dissociable σ factor in the holoenzyme is 
responsible for promoter recognition and thus determines which genes are transcribed. 
There are two major classes of σ factors in bacteria, σ70 and σ54, which confer 
different regulatory properties to the core RNAP enzyme for transcription initiation. 
This represents the two distinct paradigms of bacterial gene transcription (Figure 3.3).  
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a 
-35       -10     +1
σ70RNAP
-35       -10      +1
σ70 specific  promoter
+
transcription competent 
open promoter complex  
b 
-24       -12      +1
σ54RNAP
-24       -12      +1
σ54 specific  promoter
+
transcription silent 
closed promoter complex 
 
Figure 3.3 The two paradigms of gene transcription in bacteria. a, The σ70-
dependent gene transcription. b, The σ54-dependent gene transcription. 
 
Referring to Figure 3.3a, the σ70-dependent gene transcription represents the 
first paradigm in which the σ70-RNAP holoenzyme (Eσ70) binds the σ70 specific 
promoter at conserved positions -35 (TTGACA) and -10 (TATAAT) from the 
transcription start site (TSS) at +1. The Eσ70-promoter DNA complex can 
spontaneously isomerise to form the open complex competent for transcription. The 
regulation of this type of gene transcription is usually achieved by regulatory proteins 
that either recruit (for activators) or obstruct (for repressors) the RNAP to the 
promoter sites. Referring to Figure 3.3b, the σ54-dependent gene transcription 
represents the second paradigm in which the σ54-RNAP holoenzyme (Eσ54) binds the 
σ54 specific promoter at conserved positions -24 (GG) and -12 (TGC) from the TSS 
(Schumacher et al., 2006). The Eσ54-promoter DNA complex cannot spontaneously 
isomerise to form the open complex and is instead transcriptionally silent (Buck et al., 
2006; Joly et al., 2010; Wigneshweraraj et al., 2008).  
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Figure 3.4 The σ54-dependent transcription activation. The cartoon is adapted from 
(Buck et al., 2006). 
 
The activation of Eσ54-promoter DNA complex requires the bacterial enhancer 
binding protein (bEBP), which hydrolyses ATP to catalyse the formation of the open 
promoter complex (Figure 3.4). The bEBP binds to the upstream enhancer DNA 
sequences located approximately 150 bp upstream from the TSS and contacts the 
Eσ54-promoter complex via DNA looping, which is facilitated by the DNA bending 
protein – integration host factor (IHF). The bEBPs are AAA+ (ATPase associated 
with various cellular activities) proteins that catalyse ATP hydrolysis and convert the 
derived chemical energy to a mechanical force needed to remodel the conformation of 
the closed complex and trigger the formation of the open complex (Buck et al., 2006). 
Therefore, the σ54-dependent gene transcription allows more tight control of the 
underlying regulation, which absolutely requires an activator with the default activity 
close to zero in contrast to the σ70-dependent gene transcription. This is particularly 
useful for developing transcription-based devices for which the low basal expression 
level is highly appreciated and enables tight and precise control of the output target 
gene expression.  
 
3.2.2 The hrp gene regulation system in Pseudomonas syringae 
In this section, a σ54-dependent hetero-regulation module in the hrp gene regulatory 
system for Type III secretion in Pseudomonas syringae (P. syringae) is introduced in 
an intention to utilise it to design novel orthogonal transcription-based devices. The 
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Type III secretion system in P. syringae is described below before the extracted hrp 
gene regulation network in Pseudomonas syringae pv tomato DC3000 is illustrated. 
Type III secretion systems (T3SS) underlie the pathogenicity of many Gram-
negative bacteria, including both many important animal and plant pathogens. 
Pseudomonas syringae is a widely used and representative plant pathogen in studying 
plant-pathogen interactions. P. syringae elicits leaf spots and foliar necrosis in host 
plants (e.g. tomato and Arabidopsis thaliana) and the hypersensitive response (HR) in 
non-hosts, which is characterised by the defence-associated rapid programmed cell 
death of the plant cells in contact with the bacteria. The T3SS in P. syringae is 
encoded by the hrp (hypersensitive response and pathogenicity) genes and hrc 
(hypersensitive response and conserved) genes residing in pathogenic gene clusters in 
the chromosome (Collmer et al., 2000). As shown in Figure 3.5, the Type III secretion 
system is a complex proteinaceous injection machine that can translocate secreted 
intracelluar effector proteins into the plant cell directly through the assembled 
secretion apparatus on the surface of the pathogen. The extracellular filamentous 
appendage named ‘Hrp pilus’ (hypersensitive response and pathogenicity pilus) spans 
the bacterial membranes, intercellular milieu, the plant cell wall and plasma 
membrane, and serves as a long-distance transport device (Buttner and Bonas, 2006). 
The regulation of hrp gene expression in P. syringae is primarily through 
regulatory proteins HrpL (L), HrpR (R), HrpS (S) and HrpV (V) (Figure 3.5). An 
unknown plant derived signal activates a signalling transduction pathway, which 
consists of the HrpR, HrpS and HrpL. This leads to the transcription of both the 
hrc/hrp type III secretion genes and the effector genes. The two enhancer binding 
proteins, HrpR and HrpS, bind upstream of the σ54-dependent hrpL promoter to 
activate the expression of HrpL (a member of the extracytoplasmic function family of 
σ factors). hrp gene expression is negatively regulated by the Lon protease which 
degrades HrpR (Bretz et al., 2002) and by the negative regulator HrpV – this acts 
upstream of HrpR and HrpS. The alternative σ factor HrpL then drives the expression 
of hrc/hrp type III secretion genes, which leads to the assembly of the T3SS across 
the bacterial envelope, plant cell wall, and the plant plasma membrane. The assembled 
T3SS translocates effector proteins into the plant cell to initiate the hypersensitive 
Chapter 3 - The Design and Engineering of Modular Biological Devices 
 
 
65
response, or to suppress plant defence, or, possibly, to release nutrients and/or water 
via unknown mechanisms (Jin et al., 2003). 
 
 
 
Figure 3.5 hrp gene regulation in the type III secretion system of P. syringae (Jin 
et al., 2003). 
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Figure 3.6 The extracted hrp gene regulation model in P. syringae. R, S and V are 
the shorthand versions of HrpR, HrpS and HrpV proteins respectively. The diagram is 
adapted from a gift from M. Buck and M. Jovanovic. 
 
 
Since the purpose in this study is to utilise transcriptional regulation to mimic 
the integration of digital logic devices, the focus here is only on the primary 
regulatory factors that are responsible for regulating the T3SS secretion. The extracted 
gene regulation model for the hrp regulatory system in P. syringae is shown in Figure 
3.6. Based on the current knowledge of the hrp gene regulation, the HrpR, HrpS, 
HrpL and HrpV proteins have been identified as the primary regulatory components 
for controlling the expression of hrp gene clusters that encode the type III protein 
export complex. Evidence has shown that HrpR and HrpS are two homologous DNA 
binding proteins and expressed as an operon1, and both are required to activate hrpL 
transcription from the σ54-dependent hrpL promoter (Hutcheson et al., 2001). HrpL is 
the primary transcriptional factor controlling the expression of hrp regulon genes. 
HrpV is a negative regulator for hrp regulon and acts upstream of the HrpR/HrpS-
HrpL regulatory cascade (Preston et al., 1998). A recent work reported that the HrpV 
66                                                 
 
1 operon – a genetic unit or cluster that consists of one or more genes that are transcribed as a unit and 
are expressed in a coordinated manner. 
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interacts specifically with HrpS to negatively regulate the hrpL promoter (Jovanovic 
et al., 2011). 
The gene regulation model introduced above has several potential advantages 
for developing transcription-based genetic logic devices. Firstly, there are multiple 
regulation factors co-regulating one single promoter (hrpL) in the system, which 
increases the flexibility to rewire the network to create multiple-input transcriptional 
logic devices. Secondly, the central promoter hrpL is σ54-dependent and therefore 
allows tight control of the output gene expression with default basal expression 
activity being very close to zero. Thirdly, the two activator proteins HrpR and HrpS 
are both enhancer binding proteins, which usually exist in high-order oligomeric 
forms at their active states and thus can potentially increase the cooperativity and 
sensitivity of the underlying transcriptional activation.   
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3.3 Designing a Set of Modular Logic Devices and 
Functional Assembly of BioParts 
In this section, a set of modular transcription-based logic devices are designed on the 
basis of the hrp hetero regulation module introduced in the previous section and other 
classic biological modules. Particularly, a modular tight-controlled and hypersensitive 
genetic circuit with digital logic AND function and a combinatorial modular NAND 
gate circuit are rationally designed. The proposed functional assembly approach for 
engineering gene circuits with predictable functions is described and discussed in the 
end. 
3.3.1 The design of a modular logic AND gate 
The logic AND gate is rationally designed based on the σ54-dependent HrpR/HrpS 
hetero-regulation module in the hrp gene regulatory system for Type III secretion in 
Pseudomonas syringae (Wang et al., 2009a). As shown in Figure 3.7a, the two-input 
AND gate comprises two genes (i.e. hrpR and hrpS) and one regulatory promoter 
(hrpL). The hrpR and hrpS genes are placed under the control of two separate σ70-
dependent promoters and a reporter gene acts as the measurable output (as GFP 
protein) in the experiments. Thus the output reporter can now be expressed only when 
both of the two input promoters are activated otherwise the default output remains 
close to the zero level. The σ54-dependent hetero regulation allows the AND gate to be 
tightly regulated and sensitive. In addition, the design is modular because the inputs 
and output of the AND gate are both promoters, and the inputs can be reconnected to 
different input sensors and the output can be used to drive various cellular responses. 
As illustrated in Figure 3.7b, the function of the AND gate can be tested using two 
environment-responsive promoters as the inputs and the gfp as the output reporter. 
There is high fluorescent output, i.e. the output promoter hrpL is turned on, only when 
the logic AND combination of input inducers appears as the truth table shows. Figure 
3.7c shows the functional sequence of hrpL promoter of Pseudomonas syringae pv. 
tomato DC3000. The conserved -12 and -24 sites are where the σ54 binds specifically. 
The sequence in red is the putative UAS (upstream activator sequence) where HrpR 
and HrpS bind, and the sequence in bold face is the IHF binding site.  
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c 
-205 
GCCGGATTATGTCCGCTGAGTGGGTCACGGTCCCGGATCAGTTCCCTTGCGAAGCTGACCGATGTTTTTGT 
UAS 
GCCAAAAGCTGTTGTGGCAAAAAACGGTTTGCGCAAAGTTTTGTATTACAAAGAATTTCACATTTTAAAAT 
    IHF       -24      -12         +1(TSS) 
ATCTTTATAAATCAATCAGTTATTTCTATTTTTAAGCTGGCATGGTTATCGCTATAGGGCTTGTAC 
 
Figure 3.7 The rational design of the modular logic AND gate. The AND gate is 
devised by redesigning the natural HrpR/HrpS hetero-regulation motif. 
 
More logic AND gate devices can be designed by including the negative 
regulatory hrpV gene in the circuit (Wang et al., 2009a). A two-input logic AND gate 
with one-input inverted can be developed by placing hrpR and hrpS as an operon 
under one input promoter while hrpV under the other input promoter (Figure 3.8a). A 
three-input logic AND gate with one-input inverted can be developed by placing hrpR, 
hrpS and hrpV under the control of three separate input promoters to co-regulate the 
output hrpL promoter (Figure 3.8b).  
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Figure 3.8 The two- and three-input modular AND gates with one input inverted.  
 
 
3.3.2 The design of a set of modular NOT gates and the composite 
NAND gate 
Biological modules mimicking digital logic gates are necessary to realise the practical 
potentials of being able to systematically and synthetically control the genetic 
information flow within living cells. Therefore here a set of modular genetic NOT 
gates and a genetic NAND gate, which implement the essential digital logic NOT and 
NAND functions respectively, were designed to expand the available transcriptional 
logic devices in the synthetic biology toolkit. 
As shown in Figure 3.9a, the modular NOT gate is developed using a biological 
repressor module (e.g. the lacI/Plac, tetR/Ptet, cI/Plam pairs), in which the repressor I 
binds to its cognate promoter PNOT and inhibit the transcription of the output promoter 
significantly. The NOT gate function can be characterised under an environment-
responsive promoter (I1-inducible P1) using a reporter gene like the gfp as the output. 
As a result, the output level (e.g. fluorescence) is in reverse proportion to the amount 
of the inducer input. The modular NAND gate (Figure 3.9b) is designed to be a 
combinatorial circuit comprising an AND gate and a NOT gate. The component AND 
gate is the same as the one in Figure 3.7 and the NOT gate is the same as the one in 
Figure 3.9a. Thus it results from the direct coupling together of two gates by 
harnessing the modularity and reusability of the component modules. The composite 
NAND gate function can be characterised using two environment-responsive 
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promoters (I1-inducible P1 and I2-inducible P2) as the inputs and the gfp reporter as the 
output. It is expected this device has the ‘NOT AND’ function, i.e. the logic NAND 
gate.  
a 
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[I1] R1
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Inputs OutputModular NOT gate
gfp
RBS II
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Figure 3.9 The design of a set of modular NOT gates and the composite NAND 
gate. a, The modular logic NOT gate is composed of a biological repressor module 
(the I/PNOT pair). b, The composite logic NAND gate comprises a modular AND gate 
and a modular NOT gate, and is modular itself. 
 
3.3.3 Functional assembly of BioParts using engineered in-context 
characterised modules 
Synthetic biology uses the idea that modular biological elements (BioParts) exist 
which can be combined and modified to construct novel devices. Figure 3.10 
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illustrates this approach, where two biological modules with the AND gate (module I) 
and NOT gate (module II) functions can be easily combined physically to form a 
larger composite module. It is expected that the composite module will naturally has 
the NAND gate function. Here the modularity of biological elements spans two 
aspects, i.e. physical level and functional level. The physical modularity can be 
achieved through imposing standard interface on the component modules, like PoPS 
or RiPS, allowing for the easy exchange and physical assembly of them. The 
functional modularity assumes that the functions of the modules persist when used in 
a new condition or configuration, while the functional assembly of them into a large 
customised system depends on the proper matching of the characteristics of the 
underlying component modules.  
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Figure 3.10 The physical and functional assemblies of synthetic biological 
modules. 
 
However, rationally designed biological devices often do not initially function 
as intended and a large amount of trial-and-error are required to tinker with them 
before the desired performance is achieved. This is partly because the individual 
modules are not sufficiently well characterised for purpose and the functional 
assembly of them is not straightforward due to their different characteristics. 
Moreover, the component modules characterised in one context may vary quite 
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differently in another working condition (Klumpp et al., 2009; Tan et al., 2009) and 
configuration (Salis et al., 2009). This is illustrated by the difficulties encountered and 
the progress made in synthetic biology over the last decade (Lu et al., 2009; Purnick 
and Weiss, 2009). Although a number of synthetic biological parts with basic 
functions (Voigt, 2006) have been developed and assembled to construct some proof-
of-principle circuits, the majority of them are constructed in an ad hoc way and the 
construction of synthetic gene circuits with desired functions is far from an 
engineering routine and requires lots of tweaking. The current design principles for 
engineering gene circuits, which include rational design  (Gardner et al., 2000; Guido 
et al., 2006), directed evolution (Dougherty and Arnold, 2009; Haseltine and Arnold, 
2007; Yokobayashi et al., 2002), combinatorial synthesis (Guet et al., 2002) and their 
hybrids (Atsumi and Little, 2004; Dueber et al., 2009), have been shown to work in 
designing some small gene circuits, but often require iterative refining and screenings, 
do not take into account the impact between cellular context and engineered circuits, 
and the scale of the networks is usually small. Thus, our ability for engineering gene 
circuits is limited by the lack of a number of well-characterised interchangeable parts 
that behave with predictable functions across various contexts and efficient strategies 
for the functional assembly of individual parts into large scale customisable systems. 
To address this issue, a new approach, which uses engineered in-context 
quantitatively characterised modules, is proposed here for the functional assembly of 
BioParts into customisable larger systems. As both the biophysical, biological and 
genetic contexts in which the biological parts and modules behave might well be 
expected to have a large impact on their functionalities, the candidate component parts 
and modules for a target synthetic system ideally should be characterised in those 
biophysical (e.g. media, temperature, carbon source) and genetic (e.g. embedded 
sequence context, chassis background) contexts as anticipated for their final 
system(s). This approach minimises the unexpected or high-order effects which could 
occur during circuit construction by eliminating or reducing the variations arising 
from the difference of contexts. We can also characterise the synthetic parts and 
modules in various contexts and model their behaviour correspondingly. The 
behaviour of the assembled circuit comprising characterised parts and modules in a 
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certain context then can be predicted reliably from the individual models of the 
components in the same context. As a result, the functional assembly of synthetic 
parts into customisable larger systems can be performed more predictably using these 
engineered in-context characterised modules aided by modelling. 
 
 
3.4 Deriving Transfer Functions of the Designed Logic 
Devices 
One of the aims of this study is to develop models of individual parts and modules to 
allow the predictable assembly of them into customised systems. The deterministic 
model based on ODEs is used for the mathematical modelling of the gene expression 
and regulation in this study as described in Chapter 2. The following describes the 
derivation of the transfer function models for the modules designed in the previous 
section. 
3.4.1 Deriving the transfer function of environment-responsive 
promoters 
Since environment-responsive promoters function as the inputs of the designed 
genetic devices, it is necessary to derive their transfer function first. As the case in the 
following diagram shows (Figure 3.11), the promoter P1 is negatively regulated by its 
constitutively expressed repressor R1 and responsive to the exogenous inducer I1 to 
turn on the transcription of the downstream reporter gene G.  
 
P
R1 reporter G
P1
[I1] 
 
Figure 3.11 The architecture of an environment-responsive negatively regulated 
promoter (P1). 
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The reporter gene expression can be modelled by (Alon, 2007; Zoltan et al., 
2006): 
1
1 1
1 1
1 1
1 1
[ ][ ]  = [ ]
[ ]
n
n n
k Id G k d G
dt I K
α ⋅⋅ + − ⋅+                                                          (3.1) 
where 1 1kα ⋅  is the basal constitutive activity of the promoter, 1 1 11 1 1 1[ ] ([ ] )n n nk I I K⋅ +  
is the activity due to cooperative transcription activation by assuming the 
concentration of the repressor is constant to model the effect of varying the 
concentration of the inducer 1I , and [ ]d G⋅ is the constitutive degradation activity of 
protein G. Here the concentrations of the inducer I1 and reporter protein G are denoted 
by [ 1I ] and [G] respectively; 1K  and 1n  are the Hill constant and coefficient relating 
to the promoter-regulator/inducer interaction; 1k  is the maximum expression rate of 
the promoter due to induction and 1α  is a constant relating to the basal level of the 
promoter due to leakage (0≤ 1α <1); and d  is the degradation rate of G.  
The steady state solution of Equation 1 is given by: 
1 1 1'
1 1 1 1 1 1([ ]) = [ ]  = ( [ ] ( [ ] ))
n n n
ssf I G k I K Iα + +     (3.2) 
where '1 1k k d=  represents the maximum expression level due to induction. Equation 
3.2 gives the reporter protein level at steady state for the inducible promoter P1 and is 
also the transfer function of P1. 
 
3.4.2 Deriving the transfer function of the AND gate 
 
P
R1 hrpR
P1
[I1] 
P
R2 hrpS
P2
[I2] reporter G
PhrpL
 
 
Figure 3.12 The architecture of the genetic logic AND gate circuit. 
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As shown in Figure 3.12, the σ54-dependent hrpL promoter is synergistically co-
activated by the hetero proteins HrpR and HrpS, which mimics the two-input logic 
AND function. Based on the currently known mechanism underlying this hetero-
regulated module, both the bacterial enhancer-binding proteins are required to bind 
the UAS of hrpL to remodel the conformation of σ54-RNAP-hrpL closed complex to 
an open one for the activation of transcription. The hrpL regulation in the designed 
AND gate is represented by the product of two Hill function curves as the following 
model of the output reporter gene expression shows. 
([ ] ) ([ ] )[ ]   [ ]
1 ([ ] ) 1 ([ ] )
R S
SR
n n
l SR
nn
R S
k R K S Kd G d G
dt R K S K
⋅= ⋅ − ⋅+ +     (3.3) 
Thus the normalised transfer function of the AND gate is derived as: 
max
([ ] )[ ] ([ ] )([ ] ,  [ ] )    
[ ] 1 ([ ] ) 1 ([ ] )
R S
SR
n n
ssss ss SR
ss ss nn
ss ss R ss S
R KG S Kf R S
G R K S K
= = ⋅+ +   (3.4) 
where RK , SK  and Rn , Sn  are the Hill constants and coefficients for HrpR and HrpS 
respectively. [ ]ssR  and [ ]ssS  are the steady levels of HrpR and HrpS, whose levels are 
under the control of two separate inducible promoters (P1 and P2) as indicated by 
Equation 3.2. max[ ]ss lG k d=  is the maximum output level of the AND gate at steady 
state, in which lk  is the maximum expression rate due to activation and d  is the 
degradation rate of G.  
 
3.4.3 Deriving the transfer function of the NOT gate  
The NOT gate in this study is designed on the basis of biological repressor modules. 
The R3/P3 based NOT gate shown in Figure 3.13 is characterised under the inducible 
promoter P1 in response to inducer I1 with gene G as the output reporter.  
 
P
R1
P1
[I1] 
R3
P3
reporter G
 
 
Figure 3.13 The architecture of the genetic logic NOT gate circuit. 
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The reporter gene expression in this NOT gate circuit can be modelled by: 
3
3 3
3 3
3 3
3 3
[ ]  = [ ]
[ ]
n
n n
k Kd G k d G
dt K R
α ⋅⋅ + − ⋅+      (3.5) 
Thus the transfer function of the NOT gate is derived as: 
3 3 3'
3 3 3 3 3 3([ ] ) [ ] ( ( [ ] ))
n n n
ss ss ssf R G k K K Rα= = + +     (3.6) 
where 3K  and 3n  are the Hill constant and coefficient relating to R3/P3 interaction, 
'
3 3k k d=  represents the maximum expression level of P3 due to repression relief and 
3[ ]ssR  is the steady levels of R3, whose level is under the control of the inducible 
promoter as indicated by Equation 3.2. 
 
3.4.4 Deriving the transfer function of the composite NAND gate 
 
P
R1 hrpR
P1
[I1] 
P
R2 hrpS
P2
[I2] 
PhrpL
reporter GR3
P3
 
 
Figure 3.14 The architecture of the genetic logic NAND gate circuit. 
 
 
Figure 3.14 shows the architecture of the composite logic NAND gate circuit, which 
comprises the two environment-responsive promoters P1 and P2 as the inputs, the 
modular logic AND gate and NOT gate modules, and the reporter G as the output. 
The transfer function of the NAND gate can be derived by directly coupling the 
transfer functions of the individual modules, i.e. the NOT gate, AND gate and 
environment-responsive promoters, in the system. The output of a forward module 
acts as the input of the next module in the system cascade. Thus the NAND gate 
transfer function is obtained as: 
3 3 3'
NAND 3 3 3 3 3 3[ ] ([ ] ) ( ( [ ] ))
n n n
ss ssG f R k K K Rα= = + +     (3.7) 
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where '3k  represents the maximum expression level of P3 due to repression relief and 
3 ANDmax
([ ] ) ([ ] )
[ ] ([ ] ,  [ ] ) [ ]
(1 ([ ] ) )(1 ([ ] ) )
SR
SR
nn
SS SS SR
SS SS SS nn
SS R SS S
R K S K
R f R S G
R K S K
= = + +  
where ANDmax[ ]G  is the maximum output level of the AND gate at steady state; 
1 1 1'
1 1 1 1 1 1[ ] ([ ])  ( [ ] ( [ ] ))
n n n
SSR f I k I K Iα= = + + and I1 is the inducer of the inducible 
promoter for the regulation of hrpR; 2 2 2'2 2 2 2 2 2[ ] ([ ])  ( [ ] ( [ ] ))
n n n
SSS f I k I K Iα= = + +  
and I2 is the inducer of the inducible promoter for the regulation of hrpS in the system. 
All other parameters in the model have the same meaning as described in sections 
3.4.1-3.4.3. 
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The objective in this chapter is to verify the functional assembly approach proposed in 
this thesis by engineering the novel genetic AND gate that was designed in Chapter 3. 
Both the rational design and the functional assembly approaches have been applied to 
construct this modular AND gate. By quantitatively characterising a set of parts and 
modules in various live cell bio-physical and genetic contexts, the impact of the 
context on their behaviour was illustrated. The engineered AND gate was then subject 
to thorough characterisation including the homogeneity, metabolic load and chassis 
compatibility assays. 
 
4.1 The Initial Implementation of the AND Gate 
Once the modular genetic AND gate had been rationally designed based on the σ54-
dependent HrpR/HrpS hetero-regulation module in the hrp regulatory system in 
Pseudomonas syringae, the next step was to select the appropriate genetic elements to 
construct it for experimental characterisation and validation. In this section, the 
rational design approach was applied to implement the AND gate without 
quantitatively characterising the component elements on route. 
Firstly, the two well studied inducible promoters Plac and PBAD were chosen as 
the driving inputs for the designed AND gate, and the gfp reporter gene as the output. 
In conforming to the BioBrick standard, the core components hrpR, hrpS and the 
promoter hrpL were sent for synthesis by GENEART to eliminate the four restriction 
sites (i.e. EcoRI, XbaI, SpeI and PstI) used in this assembly standard through 
synonymous codon exchange. As an initial trial, the two genes were flanked with the 
same ribosome binding site rbsH (Table 4.1) and the BioBrick double terminator 
BBa_B0015. As shown in Figure 4.1, the hrpR and hrpS fragments are placed under 
the control of the IPTG inducible Plac and the arabinose inducible PBAD promoters 
respectively and the rbs30-gfp is placed downstream of the hrpL as the output 
reporter. The AND gate functions such that the output is on (in terms of high 
fluorescence) only when both of the inputs are high, i.e. Plac and PBAD are both highly 
induced by IPTG and arabinose respectively. 
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hrpR
hrpS
R
S PhrpL
R S
Plac
[Arab.] araC
PBAD
rbsH
rbsH
rbs30
[IPTG] lacI
gfp
 
 
Figure 4.1 Schematic diagram for the construction of the genetic AND gate. The 
engineered AND gate uses inducible promoters Plac and PBAD as the inputs, the same 
RBS (rbsH) upstream the hrpR and hrpS genes, and rbs30-gfp as the output reporter. 
 
Two-input AND gate using Plac and PBAD as the inputs 
Input 1    Input 2     Output 
                   
 
Figure 4.2 Plasmid maps showing the circuit constructs used for the initial 
version of the AND gate as designed in Figure 4.1. 
 
To construct the AND gate, the synthesised hrpR gene fragment was cloned into 
plasmid pAPT110 (p15A ori, Kanr) (Polard and Chandler, 1995) under the IPTG 
inducible Plac as the first input; the hrpS fragment was cloned into plasmid pBAD18-
cm (pBR322 ori, Cmr) (Guzman et al., 1995) under the arabinose inducible PBAD as 
the second input; while the hrpL-rbs30-gfp construct was carried on the pSB4A3 
(pSC101 ori, Ampr) (Shetty et al., 2008) vector as the output of the AND gate. Figure 
4.2 shows the plasmid maps for the constructs used for this AND gate. The plasmid 
constructs were next transformed into E. coli MC1061. The result of full 
characterisation of the device in this cell chassis is shown in Figure 4.3, where the 
cells were assayed for 64 combinations of the two-input inductions in the fluorometer. 
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The data are the normalised average of three repeats in E. coli MC1061 in M9-
glycerol at 30 °C with variations less than 10% between biological replicates. The 
detailed experimental protocols for the characterisation are described in Chapter 2. 
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Figure 4.3 The systematic characterisation of the AND gate. The response of the 
AND gate for 64 combinations of input inductions. The data are shown for induction 
by (left to right) 0, 3.9 × 10-4, 1.6 × 10-3, 6.3 × 10-3, 2.5 × 10-2, 0.1, 0.4 and 1.6mM 
IPTG, and induction by (bottom to top) 0, 3.3 × 10-4, 1.3 × 10-3, 5.2 × 10-3, 2.1 × 10-2, 
8.3 × 10-2, 0.33 and 1.3 mM arabinose. 
 
Since the component parts were not characterised, perhaps not surprisingly, this 
rationally designed AND gate failed to work precisely as intended as shown in Figure 
4.3, where a distorted device behaviour was observed. Difficulties in engineering the 
functional AND gate circuit are largely due to that the individual components are not 
sufficiently characterised in the relevant context and the functional assembly of them 
is not straightforward due to their different characteristics. In addition, the behaviour 
of components may vary in different working conditions (Klumpp et al., 2009; Tan et 
al., 2009) and configurations (Salis et al., 2009) because there are many factors which 
can affect gene expression in living cells, for example, cell chassis, growth medium 
including carbon source, embedded sequence context like 5' UTR (five prime 
untranslated region) and RBS (ribosome binding site), temperature. As examining the 
impact of each of these factors on the behaviour of the engineered circuit is a non-
trivial undertaking, it was decided to characterise each basic part and sub-module of 
the circuit in various contexts (both physical and genetic), which will provide a 
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reliable choice of the components for constructing the functional device in the 
corresponding context.   
 
4.2 Characterising a Set of Inducible Promoters and RBSs 
In this section, a set of basic parts, i.e. the inducible promoters and RBSs, were 
characterised in various biophysical (e.g. temperature variations) and genetic contexts 
in order to see to what extent these contexts could affect their behaviour. The 
characterisation work here serves as the basis for the rational forward engineering of 
the designed genetic AND gate in Section 4.3. 
4.2.1 Promoter characterisation setting up 
Due to the requirement of modularity, both the inputs and the output of the AND gate 
are designed to be promoters. Thus, the inputs can be any interchangeable promoters 
and the output promoter can be connected to various genes to drive different cellular 
responses. To verify the required integrative behaviour of the AND gate, three 
environment-responsive promoters, i.e. the IPTG inducible Plac, the arabinose 
inducible PBAD and the N-(3-Oxohexanoyl)-L-homoserine lactone (AHL) inducible 
Plux (Figure 4.4), were chosen as the candidate inputs and systematically 
characterised. The Plac and PBAD are endogenous E. coli promoters, while the Plux is a 
synthetic promoter built from the quorum sensing lux operon in Vibrio fischeri and the 
tet promoter (Canton et al., 2008) and can be potentially used as the receiver for the 
AHL signalling molecule secreted by other cells. The two cell strains E. coli MC4100 
and E. coli MC1061, which have destructive mutations of both the Plac and PBAD 
promoters on their genome (Table 2.5, Chapter 2), were chosen as the candidate hosts. 
The chemically well-defined M9 medium was used and supplemented with either 
0.01% glucose (M9-glucose) or 0.4% glycerol (M9-glycerol) as the carbon source. 
The detailed compositions of the two media are as described in Chapter 2 (Materials 
and Methods). Two normally used temperatures for E. coli culture, 30 °C and 37 °C, 
were used to evaluate the effect of temperature variations. In addition, for the purpose 
of the experiments, 6 versions of RBS of various strengths (Table 4.1) were used to 
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characterise each promoter in a way to find balanced promoter/RBS pairs acting as the 
driving inputs for the AND gate. Referring to Table 4.1, the first 5 RBSs are from the 
Registry of Standard Biological Parts (i.e. rbs30, rbs31, rbs32, rbs33, rbs34) and are 
initially reported to have distinct strengths by the community (Registry of Standard  
Biological Parts, 2010c). The last one, rbsH, is designed here as a homemade version. 
 
PlacIq
lacI gfp
Plac
[IPTG] 
ParaC
araC
PBAD
[Arab.] 
Ptet
luxR
Plux
[AHL] 
gfp
gfp
    
Promoter
Ribosome binding site
Protein coding sequence
Terminator
 
 
Figure 4.4 Schematic diagram for the characterisation of the three inducible 
promoters: Plac, PBAD and Plux. The gfp reporter gene (gfpmut3b) bearing a set of 
RBSs with various strengths was used to characterise the three inducible promoters: 
the IPTG-responsive Plac promoter (top), the arabinose-responsive PBAD promoter 
(middle) and the AHL-responsive synthetic Plux promoter (bottom). The sequences of 
RBSs used are listed in Table 4.1. The BioBrick double terminator BBa_B0015 
following gfp was used to terminate the transcription in all cases. 
 
Table 4.1 The RBS sequences used for the promoter characterisation.  
Identifier Sequence of RBS Strength 
rbs30 (BBa_B0030) TCTAGAGATTAAAGAGGAGAAATACTAGATG  Strong 
rbs31 (BBa_B0031) TCTAGAGTCACACAGGAAACCTACTAGATG  Weak 
rbs32 (BBa_B0032) TCTAGAGTCACACAGGAAAGTACTAGATG  medium weak 
rbs33 (BBa_B0033) TCTAGAGTCACACAGGACTACTAGATG  weakest 
rbs34 (BBa_B0034) TCTAGAGAAAGAGGAGAAATACTAGATG  very strong 
rbsH (Homemade) TCTAGAAGGAGATATACCATG -  
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Figure 4.5 shows the three constructs used for the characterisation of Plac, PBAD 
and Plux with the RBSs of rbsH, rbs33 and rbs33 shown for each. Plasmid 
pBW105lac-gfp (p15A ori, Kanr) containing the IPTG inducible Plac was used for Plac 
promoter characterisation. Plasmid pBW203ara-gfp (pBR322 ori, Cmr) containing the 
arabinose inducible PBAD was used for PBAD promoter characterisation. The synthetic 
AHL-inducible Plux promoter (BBa_F2620 (Canton et al., 2008)) was cloned into 
pSB3K3 (p15A ori, Kanr) (Shetty et al., 2008) and characterised with plasmid 
pBW303lux-gfp. All data (fluorescence/OD600) were acquired 5 hours after induction 
from the cells grown in 96 well microplates, when cells were in the phase of 
exponential growth and the steady state assumption for protein expression is applied. 
Cells were grown and subjected to continuous shaking (200 rpm, linear mode) and 
repeated absorbance and fluorescence readings were made. Figure 4.6 shows the cell 
growth curves and dynamic responses of Plac promoter in one experimental 
characterisation over 20 hours. It can be seen that the exponential growth phase lasts 
several hours, i.e. from the 2 to 5 hours. The fluorescent responses of the promoter 
first reached to a plateau between the 5 and 8 hours and then decrease slowly over 
time. Thus the fluorescence/OD600 value after 5 hours growth was used to determine 
the response level of the cells at steady state. 
 
Promoter characterisation for the input transfer functions 
Plac input   PBAD input      Plux input 
              
 
Figure 4.5 Plasmid maps showing some of the circuit constructs used for the 
characterisation of the three promoter inputs. 
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Figure 4.6 Dynamics of the Plac promoter in response to various levels of 
induction. a, Growth curves of the Plac-rbs30-gfp characterisation strain with various 
IPTG inductions. The host is E. coli MC1061 grown in a 96 well plate in the 
fluorometer set at 30 °C and with repeating absorbance and fluorescence readings (20 
min/cycle). b, The fluorescence/OD600 values over time. 
 
4.2.2 Characterisation results and analysis 
As a first step, to evaluate the promoter responses in different chassis and media, the 
three promoters were characterised in response to various induction levels in the two 
cell chassis (E. coli MC4100 and E. coli MC1061) in the two media (M9-glucose and 
M9-glycerol) at 30 °C. The gfp with a strong RBS (rbs30-gfp) was used as the output 
reporter. As shown in Figure 4.7, promoter Plac is nearly open and does not produce 
the desired inducer dependent switching characteristic from the low to high induction 
levels in E. coli MC4100 grown in M9-glycerol. The reason behind this phenomenon 
is complicated and it might be due to an unintended interaction of the Plac with the 
endogenous genetic background of this chosen host. While in E. coli MC4100 grown 
in M9-glucose, it can be seen (Figure 4.7b) that promoter PBAD is inhibited a lot due to 
the catabolite repression effect of glucose although low (0.01%) in the medium. 
However, the Plac is not sensitive to this effect at this level of glucose and is inducible 
(Figure 4.7a), and Plux is slightly inhibited (Figure 4.7c). While in E. coli MC1061 
grown in M9-glycerol, all the three promoters responded with the desired switching  
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Figure 4.7 The dose responses of the Plac (a), PBAD (b) and Plux (c) promoters to various induction levels in the two cell chassis (E. coli 
MC4100 or E. coli MC1061) in M9 media (M9-glycerol or M9-glucose). a, Plac induced by (left to right) 0, 3.9 × 10-4, 1.6 × 10-3, 6.3 × 10-3, 2.5 
× 10-2, 0.1, 0.4 and 1.6 mM IPTG. b, PBAD induced by (left to right) 0, 3.3 × 10-4, 1.3 × 10-3, 5.2 × 10-3, 2.1 × 10-2, 8.3 × 10-2, 0.33 and 1.3 mM 
arabinose. c, Plux induced by (left to right) 0, 2.4 × 10-2, 9.8 × 10-2, 3.9 × 10-1, 1.6, 6.3, 25 and 100 nM AHL. The data (fluorescence/OD600) were 
the average of three independent repeats with error bars denoting the standard deviations. 
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Figure 4.8 The characterisation results of Plac (a), PBAD (b) and Plux (c) using 6 versions of RBS in response to various inductions (by 0, 3.9 
× 10-4, 1.6 × 10-3, 6.3 × 10-3, 2.5 × 10-2, 0.1, 0.4, 1.6, 6.4 and 12.8 mM IPTG; 0, 3.3 × 10-4, 1.3 × 10-3, 5.2 × 10-3, 2.1 × 10-2, 8.3 × 10-2, 0.33, 1.3, 
5.3 and 10.7 mM arabinose; and 0, 1.5 × 10-3, 6.1 × 10-3, 2.4 × 10-2, 9.8 × 10-2, 3.9 × 10-1, 1.6, 6.3, 25 and 100 nM AHL respectively), and the fits 
to a Hill function model (solid lines) of the promoter response. All data (fluorescence/OD600) were the average of three independent repeats in E. 
coli MC1061 in M9-glycerol at 30 °C. Error bars, s.d. (n = 3). 
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characteristics although their maximum response levels in terms of 
fluorescence/OD600 are different. Thus, this context (E. coli MC1061, M9-glycerol, 30 
°C) was selected as the standard condition for the characterisation in the subsequent 
stages. 
In the second step, in search of the appropriate promoter/RBS pairs for each 
inducible promoter, the 6 RBSs spanning a large range of translation efficiencies, i.e. 
rbs30-34 plus rbsH (Table 4.1), were used to characterise the three promoters under 
the selected standard condition. It can be seen that (Figure 4.8a–c), the maximum 
output dependent upon each promoter varied widely using different versions of the 
RBS. This provides valuable information for choosing matched promoter/RBS pairs 
as the driving inputs for the designed AND gate. Strikingly, it shows that the order of 
the strengths of the 6 RBSs across the three promoters varies. This is largely due to 
the different 5' UTR following each promoter as shown in Figure 4.9, which can vary 
the secondary structure and the stability of the gene transcript. The observation 
suggests that the same part (like RBS) used in different sequence contexts might lead 
to varying behaviour, as also shown by another study (Salis et al., 2009). Figure 4.10 
shows that the responses of each promoter using the 6 RBSs become similar after 
being normalised, which establishes that the RBS can be used like a linear amplifier to 
adjust the expression level of proteins in cells at steady state.  
 
 
 
Figure 4.9 The core promoter regions and 5' UTR (five prime untranslated 
region) sequences of the three characterised promoters. The 5' UTR shown 
starting from +1 site is the sequence between the core promoter region and the RBS 
used for the characterisation. 
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Figure 4.10 Normalised dose responses of the three characterised promoters with 
6 RBSs of various strengths: the IPTG-responsive Plac promoter (a), the arabinose-
responsive PBAD promoter (b) and the AHL-responsive Plux promoter (c). All curves 
have very similar Hill coefficients apart from the Plac-rbs33-gfp construct due to no 
response. 
 
The data were fitted to the Hill function model for the promoter steady state 
response in the form 1 1 1'1 1 1 1 1 1([ ]) = ( [ ] ( [ ] ))
n n nf I k I K Iα + +  as derived in Chapter 3, 
where 1[ ]I  is the concentration of the inducer, 1K and 1n  are the Hill constant and 
coefficient respectively relating to the promoter-regulator/inducer interaction, '1k  is 
the maximum expression level due to induction and 1α  is a constant relating to the 
basal level of the promoter due to leakage. The nonlinear least square curve fitting 
function in Matlab was used for the data fitting here and the obtained best fit 
coefficients are listed in Table 4.2 as well as the plotted fitted curves shown in Figure 
4.8. It can be seen that the Hill constant ( 1K ) and coefficient ( 1n ) tend to be close to 
each other for the same promoter characterised using different RBSs although the 
maximum response level ( '1k ) varies. 
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Table 4.2 The model fits for promoter characterisation using various RBSs in the 
standard condition with 95% confidence bounds otherwise fixed at bound. Note the 
last three were the model fits for the characterisation at 37 °C. R2 represents the 
goodness of the fitting. 
Promoter/RBS   '1k  (au)      1α       n1 K1 (mM)    R2 
Plac/rbs30 9456 ± 487 0.0012 ± 0.0276 1.37 ±0.27 0. 228 ± 0.039 0.9983 
Plac/rbs31 525.8 ± 36.2 0.1335 ± 0.0411 1.363 ± 0.366 0. 294 ± 0.065 0.9972 
Plac/rbs32 195.5 ± 17.7 0.1487 ± 0.0609 1.637 ± 0.62 0. 218 ± 0.065 0.994 
Plac/rbs33 27.61 ± 1.2e9 0.975 ± 6.5e7 1.933e-10 0. 100 -2.4e-10 
Plac/rbs34 7648 ± 152 1.472e-9  1.369 ± 0.124 0. 259 ± 0.021 0.9991 
Plac/rbsH 2071 ± 100 0.0037 ± 0.0241 1.282 ± 0.231 0.287 ± 0.045 0.9987 
PBAD/rbs30 1.048e5 ± 0.026e5 0.0055 ± 0.0104 1.228 ± 0.104 0.370 ±0.028 0.9997 
PBAD/rbs31 8.521e4 ± 0.434e4 0.0051 ± 0.0229 1.512 ± 0.314 0.417 ± 0.062 0.9986 
PBAD/rbs32 5.208e4 ± 0.098e4 0.0026 ± 0.0072 1.268 ± 0.078 0.516 ± 0.029 0.9999 
PBAD/rbs33 1.29e4 ± 0.046e4 0.0013 ± 0.014 1.323 ± 0.161 0.513 ± 0.055 0.9994 
PBAD/rbs34 1.411e5 ± 0.063e5 0.0050 ± 0.0163 1.173 ± 0.162 0.524 ± 0.072 0.9992 
PBAD/rbsH 9.229e4 ± 0.189e4 0.0033 ± 0.0086 1.415 ± 0.107 0.480 ± 0.029 0.9998 
Plux/rbs30 1.221e5 ± 0.084e5 0.0095 ± 0.032 1.584 ± 0.422 3.073e-6 0.9955 
Plux/rbs31 7.693e4 ± 0.21e4 0.0126 ± 0.013 1.771 ± 0.193 2.955e-6 0.9993 
Plux/rbs32 5.143e4 ± 0.161e4 0.0113 ± 0.0143 1.655 ± 0.202 3.509e-6 0.9991 
Plux/rbs33 1970 ± 61 0.0308 ± 0.0148 1.742 ± 0.212 3.366e-6 0.9991 
Plux/rbs34 1.349e5 ± 0.103e5 0.0149 ± 0.0373 1.898 ± 059 2.890e-6 0.9944 
Plux/rbsH 3.194e4 ± 0.137e4 0.0114 ± 0.0192 1.616 ± 0.269 3.784e-6 0.9984 
Plac/rbsH at 37 °C 2946 ± 32 0.0160 ± 0.019 1.697 ± 0.271 0.116 ± 0.011 0.9993 
PBAD/rbs33 at 37 °C 1.203e4 ± 0.017e4 4.69e-10 1.396 ± 0.078 0.525 ± 0.026 0.9998 
Plux/rbs33 at 37 °C 1987 ± 142 2.2e-7 ± 0.0381 1.776 ± 0.682 5.27e-6 ± 2.9e-6 0.9964 
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Figure 4.11 The characterised responses of Plac (a), PBAD (b) and Plux (c) under 
two temperatures 30 °C and 37 °C respectively, and the model fits. The inducer 
concentrations used for the inductions are the same as in Figure 4.8. All data 
(fluorescence/OD600) were the average of three independent repeats in E. coli 
MC1061 in M9-glycerol. Error bars, s.d. (n = 3). 
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Finally, to test the effect of temperature upon each promoter’s behaviour, the 
three inducible promoters were characterised at two temperatures 30 °C and 37 °C 
under the otherwise standard culturing condition. Here rbsH was chosen for Plac, and 
rbs33 for PBAD and Plux. Referring to Figure 4.11a–c, it can be seen that the effect of 
temperature shift on the three promoter responses are different. In the case of PBAD, a 
change in temperature from 30 °C to 37 °C has only a small effect. But Plux becomes 
leakier at 30 °C than at 37 °C, and Plac has a higher response at 37 °C than at 30 °C as 
reflected by the results of data fitting to the Hill function model (Table 4.2). One 
reason behind these different variations might be due to the different effect of 
temperature on the binding affinities between the transcription factor proteins and 
their cognate DNA binding sites of these three inducible promoters. The result shown 
here suggests that a change of the physical context can have varying impacts on 
different parts in the system. 
 
 
 
4.3 Engineering the Functional AND Gates 
4.3.1 Construction and characterisation of the AND gate 
Based on the results of part characterisation (i.e. the promoters and RBSs), it 
proceeded to apply them to the systematic design process of the AND gate. In the 
initial trial version of the AND gate (Figure 4.1 and Figure 4.3), the input of 
PBAD/rbsH pair, maximum response level around 90000 A.U. (Figure 4.8b), is much 
stronger than the input of Plac/rbsH pair, maximum response level around 2000 A.U. 
(Figure 4.8a), in the selected context. Thus the distorted asymmetric response of this 
AND gate (Figure 4.3) is largely due to the unmatched two inputs. In order to balance 
the two inputs, the PBAD/rbsH pair was replaced with the PBAD/rbs33 pair as rbs33 is a 
much weaker RBS compared to rbsH and can tune the input down to a much lower 
level as shown in Figure 4.8b. Figure 4.12 are the plasmids maps showing the 
constructs built for the circuit. This engineered version of the AND gate produced the 
Chapter 4 - Part Characterisation and the Engineering of a Modular Genetic AND Gate 
 
 
 
94
desired classic AND gate response in the standard condition as the characterisation 
data shown in Figure 4.13, where the output is turned on only when both inputs are 
highly induced. It can be seen that the output response is very sharp in the transition 
from the “off” (low fluorescence) to “on” (high fluorescence) state and is close to the 
one of a digital logic AND gate. The engineered AND gate has many merits of an 
ideal biological AND logic gate, e.g. rapid output state switching across a narrow 
transition region of the inputs, a relatively large dynamic range and almost zero level 
of the output at “off” state. The device behaviour was also subject to FACS assay as 
described in Chapter 2 and the results are shown in Figure 4.13c, where the entire 
population of cells is turned on in the presence of both inducers (1.6 Mm IPTG and 
1.3 mM arabinose respectively) and the entire population is off when either inducer is 
not added. Comparing Figure 4.13b to Figure 4.3, it can be seen that the forward 
engineered AND gate based on quantitatively characterised parts can lead to more 
predictable system behaviour than the rationally designed AND gate. 
 
 
 
Two-input AND gate using Plac and PBAD as the inputs 
Input 1    Input 2     Output 
              
 
Figure 4.12 Plasmid maps showing the circuit constructs used for the 
characterisation of the AND gate as the results shown in Figure 4.13. 
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Figure 4.13 The systematic characterisation of the modular AND gate. a, The 
schematic of the engineered AND gate. b, The fluorescent response of the AND gate 
for 72 combinations of input inductions measured in the fluorometer. The data are 
shown for the AND gate induction by (left to right) 0, 3.9 × 10-4, 1.6 × 10-3, 6.3 × 10-3, 
2.5 × 10-2, 0.1, 0.4 and 1.6 mM IPTG, and induction by (bottom to top) 0, 3.3 × 10-4, 
1.3 × 10-3, 5.2 × 10-3, 2.1 × 10-2, 8.3 × 10-2, 0.33, 1.3 and 5.3 mM arabinose. The data 
were the average of three independent repeats in E. coli MC1061 in M9-glycerol at 30 
°C with variations less than 10%. c, The flow cytometry assay of the AND gate to 
determine the fluorescent responses at individual cells for the four logic combinations 
of input inductions. 
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4.3.2 Parameterisation of the AND gate transfer function 
The data of this functional device was used to parameterise the normalised transfer 
function model of the AND gate as derived in Chapter 3: 
max([ ] ,  [ ] ) [ ] [ ] ([ ] ) ([ ] ) ((1 ([ ] ) )(1 ([ ] ) ))S SR R
n nn n
ss ss ss ss ss ss S ss R ssR Sf R S G G R K S K R K S K= = + +  
where max[ ]ssG  is the maximum activity observed for the output; RK , SK  and Rn , Sn  
are the Hill constants and coefficients for HrpR and HrpS, respectively. The steady 
state levels of the activators were derived from the characterised responses of the two 
input promoters with the same RBSs as in the characterised AND gate. The 
parameterisation was implemented by fitting to the characterised response of the 
engineered AND gate shown in Figure 4.13b together with the fitted transfer functions 
of the one-dimensional input promoters (Table 4.2). The best fit coefficients with 95% 
confidence bounds by nonlinear least square optimisation were obtained as shown on 
the right of Figure 4.14 and the parametrised transfer function was plotted on the left. 
In order to be easily compared with the experimental data, the fitted transfer function 
models are plotted with the same concentrations of inducers as used for the 
characterisation. 
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Figure 4.14 Fitted transfer function of the AND gate. The transfer function model 
of the engineered AND gate was parameterised by fitting to the experimental data as 
shown in Figure 4.13b. 
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4.3.3 The modularity of the AND gate circuit 
To verify the modularity of the AND gate, the Plac input was next swapped to the 
AHL-responsive Plux input. As Plux has been characterised as a strong promoter 
(Figure 4.8c), the input of Plux/rbs33 pair (maximum response 2000 A.U.) was used to 
drive the AND gate, to get close to the input of the Plac/rbsH pair. This version of 
AND gate was first characterised under the standard condition and produced a 
response as shown on the bottom left of Figure 4.15. It shows that it is similar to logic 
AND response but with a leaky response on the side of the Plux input. This might not 
be surprising as there is greater leakage for Plux at low levels of AHL at 30 °C than at 
37 °C (Figure 4.11c). By shifting the temperature of characterisation to 37 °C, the 
same device then produced an improved AND gate characteristic as shown on the 
bottom right of Figure 4.15. These data show that the context, in which the circuit 
behaves, has an impact on its behaviour and the construction can be facilitated using 
the parts that have been characterised in various contexts. In addition, the right 
performance of the AND gate with this new promoter input verified the input 
modularity of the device. The observations of this AND gate in the two conditions 
were consistent with the predictions of the fitted AND gate model as shown in Figure 
4.16a, b. 
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Figure 4.15 The engineering and systematic characterisation of the modular 
AND gate with alternative inputs. The top is the schematic for the AND gate 
engineered using Plux and PBAD as inputs and the weakest RBS (rbs33) for the 
interfacing of both. The device was characterised at 30 °C and 37 °C respectively as 
shown on the bottom left and right. The data shown are for the induction by (left to 
right) 0, 2.4 × 10-2, 9.8 × 10-2, 3.9 × 10-1, 1.6, 6.3, 25 and 100 nM AHL , and by 
(bottom to top) 0, 3.3 × 10-4, 1.3 × 10-3, 5.2 × 10-3, 2.1 × 10-2, 8.3 × 10-2, 0.33 and 1.3 
mM arabinose. All data are the normalised average of three repeats in E. coli MC1061 
in M9-glycerol with variations less than 10%. 
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4.3.4 Fitted model predictions of the AND gate behaviour 
To test the prediction capability of the parametrised transfer function, the AND gate 
behaviour in the two new configurations and conditions as shown in Figure 4.15 were 
compared with the model predictions by coupling the fitted transfer fucntions of the 
characterised input promoters (Table 4.2) and the AND gate (Figure 4.14). The fitted 
model predictions of the AND gate in these two new configurations and conditions 
are shown Figure 4.16a, b. It can be seen that the predictions capture well the major 
expreimental characteristics of the engineered AND gate as shown in Figure 4.15, 
particularly the leakiness of Plux input at the lower temperature 30 °C. In order to be 
easily compared with the experimental data, the model predictions are plotted with the 
same concentrations of inducers as used for the experimental characterisations. 
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Figure 4.16 Predictions of the AND gate behaviour using fitted transfer 
functions. a, The predicted characteristics for the AND gate in a new configuration 
using Plux and PBAD as the two inputs. The prediction is based on the AND gate model 
by coupling the fitted transfer function of the AND gate in Section 4.3.2 and the fitted 
transfer functions of promoter Plux and PBAD with the corresponding RBSs at 30 °C in 
Table 4.2. The experimental validation for this prediction is shown on the bottom left 
of Figure 4.15. b, The predicted behaviour for the AND gate as in a but in the 
condition of 37 °C. The prediction is based on the AND gate model by coupling the 
fitted transfer function of the AND gate in Section 4.3.2 and the fitted transfer 
functions of characterised input promoters with the corresponding RBSs at 37 °C in 
Table 4.2. The experimental validation for this prediction is shown on the bottom 
right of Figure 4.15. 
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4.4 Homogeneity, Metabolic Load and Chassis Compatibility 
Assays of the Circuits 
4.4.1 Cell homogeneity assay of parts and devices 
In this section, cells harbouring the environmental-responsive promoters and the 
engineered circuits were subjected to analysis by flow cytometry (i.e. the fluorescence 
of individual cells measured) to examine the GFP expression homogeneity from the 
parts and modules, and to verify that the circuits function at the single cell level as 
well as at the ensemble level. 
The E. coli MC1061 cells harbouring the plasmid construct containing the 
IPTG-inducible promoter Plac (plasmid pBW105lac-gfp), or the arabinose-inducible 
PBAD (plasmid pBW203ara-gfp), or the AHL-inducible Plux (plasmid pBW303lux-gfp) 
were assayed by flow cytometry, with the results shown in Figure 4.17. Referring to 
Figure 4.17, the cells harbouring promoter PBAD is non-homogenous at intermediate 
induction levels, i.e. a bimodal distribution of the cell population, while the cells 
harbouring Plac and Plux promoters have unimodal responses at all graded induction 
levels, i.e. homogenous. This behaviour is consistent with the findings of a previous 
study (Siegele and Hu, 1997), which also shows that gene expression from plasmids 
containing the PBAD promoter represents mixed population at subsaturating inducer 
concentrations in E. coli MC1061. The non-homogeneity of the PBAD promoter in E. 
coli MC1061 is used to illustrate the similar behaviour of the cells containing the 
engineered AND gate as observed below. 
The cells harbouring the functional AND gate circuit were subject to analysis by 
flow cytometry and the results are shown in Figure 4.18 and Figure 4.19. Referring to 
Figure 4.18, the AND gate is confirmed to behave with the logic AND function at 
individual cells, i.e. the output is high when both of the two inputs are fully activated. 
But the AND gate behaved with bimodal response at intermediate induction levels of 
PBAD as shown in Figure 4.18b, c. This is because the PBAD promoter response is non-
homogeneous in this cell host (E. coli MC1061), while Plac promoter is homogeneous 
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as shown in Figure 4.18a where the responses are unimodal at all IPTG induction 
levels under full arabinose induction. The similar behaviour was observed in the assay 
of another version of the AND gate using Plux and PBAD as the two inputs as shown in 
Figure 4.19. Combined with the assays of the promoter responses shown in  
 
a             b 
       
 
    c 
 
 
Figure 4.17 FACS assays of the promoter Plac (a), PBAD (b) and Plux (c) in E. coli 
MC1061 after 5 hours growth in M9-glycerol at 37 °C. a, The responses of cells 
harbouring Plac-rbsH-gfp construct induced by (bottom to top) 0, 3.9 × 10-4, 1.6 × 10-3, 
6.3 × 10-3, 2.5 × 10-2, 0.1, 0.4, 1.6, 6.4 and 12.8 mM IPTG. b, Cellular response of 
PBAD-rbs33-gfp induced by (bottom to top) 0, 3.3 × 10-4, 1.3 × 10-3, 5.2 × 10-3, 2.1 × 
10-2, 8.3 × 10-2, 0.33, 1.3, 5.3 and 10.7 mM arabinose. c, Cellular response of Plux-
rbs33-gfp induced by (bottom to top) 0, 6.1 × 10-3, 2.4 × 10-2, 9.8 × 10-2, 3.9 × 10-1, 
1.6, 6.3, 25, 100 and 400 nM AHL. 
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Figure 4.17, it can be concluded that the AND gate itself is homogenous but the 
homogeneity of the whole functional circuit largely relies on the environment-
responsive promoters used as the inputs.  
 
a             b 
       
    
c 
 
 
Figure 4.18 FACS assays of the engineered AND gate using Plac and PBAD as the 
two inputs in E. coli MC1061 after 5 hours growth in M9-glycerol at 30 °C. a, 
FACS assay of the AND gate with full induction of the PBAD input (1.33 mM 
arabinose) and graded induction of the Plac input by (bottom to top) 0, 3.9 × 10-4, 1.6 × 
10-3, 6.3 × 10-3, 2.5 × 10-2, 0.1, 0.4 and 1.6 mM IPTG. b, FACS assay of the AND 
gate with full induction of the Plac input (1.6 mM IPTG) and graded induction of the 
PBAD input by (bottom to top) 0, 3.3 × 10-4, 1.3 × 10-3, 5.2 × 10-3, 2.1 × 10-2, 8.3 × 10-2, 
0.33  and 1.33 mM arabinose. c, FACS assay of the AND gate with graded inductions 
for both of the inputs Plac and PBAD. 
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a              b             c  
    
 
Figure 4.19 FACS assays of the engineered AND gate using Plux and PBAD as the 
two inputs in E. coli MC1061 after 7 hours growth in M9-glycerol at 37 °C. a, 
The AND gate assay with induction by 1.33 mM arabinose and graded induction by 
(bottom to top) 0, 2.4 × 10-2, 9.8 × 10-2, 3.9 × 10-1, 1.6, 6.3, 25 and 100 nM AHL. b, 
The AND gate assay with induction by 100 nM AHL and graded induction by 
(bottom to top) 0, 3.3 × 10-4, 1.3 × 10-3, 5.2 × 10-3, 2.1 × 10-2, 8.3 × 10-2, 0.33  and 
1.33 mM arabinose. c, The AND gate assay with graded inductions for both of the 
inputs Plux and PBAD. 
 
4.4.2 Metabolic load assay of circuit constructs 
Just like characterising the power consumption of an electrical device, it is important 
to evaluate the metabolic load of an engineered biological device. An ideal biological 
device is expected to place negligible load on the host metabolism. Otherwise the host 
fitness will be severely affected by a device having heavy metabolic load. This section 
considers how the engineered AND gate circuit affects the fitness of the host in which 
it performs. The experiments were implemented to examine the growth curves of cells 
containing various circuit constructs to evaluate the metabolic load of the circuit on 
the host. For the purpose of these experiments, one control (E. coli MC1061, wild 
type) was used; one reference carrying the empty vectors without the circuit 
constructs, and one carrying the three plasmids with the functional AND gate circuit 
using Plac and PBAD as the two inputs. The growth curves of the control, the reference, 
and the cells harbouring the AND gate at the induced (1.33 mM arabinose plus 1.6 
mM IPTG) and non-induced (no inductions) conditions are shown in Figure 4.20. The 
cells diluted from overnight cultures with OD600 = 0.05 were grown in a 96 well 
microplate in the fluorometer with shaking (200 rpm, linear mode) for 20 hours. The 
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absorbance (OD600) of the cell cultures was read every 1h. The data were the average 
of three repeats from the three bacterial colonies of each strain. 
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Figure 4.20 Growth curves of E. coli MC1061 harbouring various circuit 
constructs in M9-glycerol at 30 °C. Error bars denote the standard deviations of 
three repeats. 
 
Referring to Figure 4.20, over a 20 hour period, the greatest growth was 
achieved by E. coli MC1061. The three growth characteristics with the plasmids 
inserted (ref. - empty vectors, AND - noninduced and AND - induced) have growth 
characteristics which are very similar. Two key points can be made regarding these 
results: (i) for all four conditions the growth characteristics show that the cells are 
viable and that whilst the insertion of the plasmids does affect growth rate, the 
reduction in growth rate is not catastrophic; (ii) referring again to the figure, the 
characteristics for the three conditions where the plasmids have been inserted are very 
similar. This shows that the loss in growth rate is due to the impact of the plasmid 
carriers in the cell instead of the function of the AND gate circuit. Thus, our 
engineered AND gate actually placed little metabolic burden on the host. However, 
the plasmids used for carrying the circuit constructs can reduce the rate of cell growth, 
which is likely due in a large to the costs of establishing antibiotic resistance for 
maintaining the plasmids inside the cells. 
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4.4.3 Chassis compatibility assay of engineered circuits 
This section examines the functionality of the AND gate in various E. coli cell chassis 
to evaluate the chassis compatibility of the engineered circuits. Here, the response of 
the engineered AND gate circuit was tested in seven normally used E. coli strains 
using three inducible promoters, i.e. Plac, PBAD and Plux, as the driving inputs. The 
results in the seven cell hosts carrying the AND gate circuit are shown in Figure 4.21 
and Figure 4.22.  
Referring to Figure 4.21, four input conditions were studied – arabinose plus 
IPTG; arabinose only; IPTG only; and no inputs, for the seven E. coli strains 
harbouring the AND gate using Plac and PBAD as the two inputs. Cells were grown in 
M9-glycerol at 30 °C in a 96 well microplate and assayed after 5 hours upon 
induction. The data shown are the averages of three independent repeats with 
variations of less than 10% between biological replicates. It can be seen that the 
device does not work properly in five out of the seven tested cell chassis, i.e. the E. 
coli MC4100, MG1655, DH5α, BW25113 and BL21-DE3. As for most of the non-
working chassis, the cells have high output not only with both input inductions (1.3 
mM arabinose plus 1.6 mM IPTG) but also with only the induction of the PBAD input 
(1.3 mM arabinose). This is likely due to the interference between the host genetic 
backgrounds with the Plac promoter input of the device. The device works well in E. 
coli MC1061 as well as in E. coli Top 10, a derivative of E. coli MC1061. The levels 
of the device response upon both input inductions across the seven chassis are also 
different, which is likely due to the combined effect of the potential interference 
between Plac input and the host, and the various growth reductions observed for the 
seven hosts harbouring the same circuit as shown in Table 4.3. 
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Figure 4.21 Qualitative assays of the functionality of the engineered AND gate 
using Plac and PBAD as the two inputs in seven E. coli strains. 
 
Table 4.3 Summary of chassis compatibility assays of the AND gate in Figure 4.21. 
Chassis Function Growth 
reduction 
Note 
E. coli MC1061 Good Minor output only with two input inductions 
E. coli MC4100 Poor Heavy output with two input inductions - but also with only PBAD induction 
E. coli MG1655 Poor middle output with two input inductions - but also with only PBAD induction 
E. coli Top 10 Good Minor output only with two input inductions 
E. coli DH5α Poor Minor output with two input inductions - but also with only PBAD induction 
E. coli BW25113 Poor No output with two input inductions - but also with only PBAD induction 
E. coli BL21-DE3 Poor Minor no response for any combination of inputs 
 
 
Referring to Figure 4.22, four input conditions were studied – arabinose plus 
AHL; arabinose only; AHL only; and no inputs, for the seven E. coli strains 
harbouring the AND gate using Plux and PBAD as the two inputs. Cells were grown in 
M9-glycerol at 37 °C in a 96 well microplate and assayed after 5 hours upon 
induction. The data shown are the averages of three independent repeats with 
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variations less than 10% between biological replicates. It can be seen that the device 
works well in six out of the seven chassis except in E. coli BL21-DE3. The 
improvement of chassis compatibility is due to the elimination of the potential 
interference of the input promoter with the host genetic background by using Plux 
instead of Plac for the first driving input of the device now. The Plux is not endogenous 
in E. coli and is likely orthogonal to the genetic background of this bacteria, while the 
Plac is an endogenous E. coli promoter. The device has fluorescent outputs in E. coli 
BL21-DE3 for all four input conditions tested. This may be the result of the absence 
of the Lon protease in this cell strain, which has been shown to degrade the HrpR 
protein more prominently in Pseudomonas bacteria (Bretz et al., 2002). Thus, the 
background level of HrpR activators may tend to be higher in this cell chassis than in 
others, which leads to the leakiness on the Plux input side as observed in Figure 4.22. 
The variations of the output levels across the seven chassis are largely due to the 
different growth reductions of the hosts harbouring the same circuit as observed in the 
experiment (see Table 4.4). 
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Figure 4.22 Qualitative assays of the functionality of the engineered AND gate 
using Plux and PBAD as the two inputs in seven E. coli strains. 
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Table 4.4 Summary of chassis compatibility assays of the AND gate in Figure 4.22. 
Chassis Function Growth 
reduction 
Note 
E. coli MC1061 Good Minor output only with two input inductions 
E. coli MC4100 Good Heavy output only with two input inductions 
E. coli MG1655 Good Heavy output only with two input inductions 
E. coli Top 10 Good No output only with two input inductions 
E. coli DH5α Good Minor output only with two input inductions 
E. coli BW25113 Good No output only with two input inductions 
E. coli BL21-DE3 Poor Minor output with all four input conditions 
 
By combining the two studies above, it can be concluded that the chassis 
compatibility of the device is largely related to the particular two driving inputs 
employed (i.e. the inducible promoters) while the AND gate circuit itself is broadly 
compatible and has reliable response across many cell chassis tested. This is due to 
that some of the input promoters used are endogenous in E. coli and may interact non 
ideally with the host genetic background such as the Plac promoter. Thus the promoter 
inputs of the AND gate device need to be carefully considered to avoid the potential 
interference with the host genetic background. Ideally, all the parts used in a device 
should be orthogonal to the cell host to eliminate or minimise the potential 
interference between the engineered circuit and the chassis background. 
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4.5 Discussion 
In this chapter, a set of basic genetic elements (i.e. the promoters and RBSs) have 
been quantitatively characterised in various biophysical and genetic contexts for the 
systematic forward engineering of synthetic circuits with the modular AND gate 
function. The initial implementation of the designed genetic AND gate provides us 
with an evidence to show that rationally designed biological systems may rarely work 
as might be initially intended. This is partly because the individual parts and modules 
are not sufficiently well characterised for purpose, and so the effective coupling 
together of them is not straightforward due to their different characteristics. Moreover, 
the behaviour of component modules characterised in one context may vary quite 
differently in another working condition (Klumpp et al., 2009; Tan et al., 2009) and 
configuration (Salis et al., 2009). By quantitatively characterising a set of promoters, a 
series of RBSs and the assembled circuits in various contexts, both the biophysical 
and genetic contexts, in which they behave, were found to have a great impact on their 
functionalities. Experimental results in this chapter show that the variations of the 
behaviour of genetic parts and devices in different contexts are due to the many 
factors affecting gene expression, such as the cell chassis background, medium, 
temperature, the embedded sequence context. Thus the thorough characterisation of 
them in various conditions and configurations, particularly in the context of interest, 
are necessary for any successful wide reuse in the community and more importantly 
for facilitating the functional assembly of individual parts and modules into 
customisable large scale systems. While the creation of diverse part and module 
variants are becoming simplified and at reduced cost (Dougherty and Arnold, 2009; 
Ellis et al., 2009), high throughput and accurate technology platforms need to be 
established to accelerate the process of characterisation, like the recently established 
BIOFAB (biofab, 2010) open technology platform. 
The modular genetic AND gate engineered here works as a fundamental module 
for regulating genetic information transmission in living cells, which can integrate 
two input signals to generate one output in the digital logic AND manner. Moreover, 
the core elements of this device are from the specialised hrp gene regulatory system 
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for Type III secretion in Pseudomonas syringae, a plant pathogenic bacterium 
genetically far away from the standard E. coli chassis. Thus, the novel genetic AND 
gate module is likely orthogonal to the E. coli genetic background and can be used 
simultaneously with existing gene regulatory elements that are widely utilised for 
regulating gene expression in E. coli without any compromise. The orthogonality of 
the AND gate has been demonstrated by the experimental study in this chapter. The 
study also provides an example to exploit the diverse natural biological modules and 
to engineer them for creating novel orthogonal parts and modules to expand the 
limited toolbox of synthetic biology at the current stage. With the increase of the 
number orthogonal parts and modules in the toolbox, we can engineer more 
complicated systems which can contain many parts to enable the cells with high level 
functions.  
From the fitted transfer function of the AND gate (Figure 4.15), it was noticed 
that the fit Hill constants and coefficients for the two activators HrpR and HrpS are 
quite different. This indicates that the two enhancer binding proteins likely have 
unequal roles in the binding and activation of the σ54-dependent hrpL promoter 
although they are originally expressed from the same operon and have many sequence 
homologies. On this aspect, the work corroborates that the study of simple synthetic 
biological circuits can contribute to the uncovering of the design principles of their 
natural counterparts (Mukherji and van Oudenaarden, 2009). In addition, the 
characterisation scope for synthetic parts and devices was extended. The AND gate 
circuit was subjected to homogeneity, metabolic load and chassis compatibility assays 
respectively beyond the normal population-level phenotype assays. The thorough 
characterisation of parts and devices will enable their wide reuse in the community 
and facilitate the reliable prediction of their behaviour when integrated into other 
larger systems. 
The work in this chapter also shows that the functional assembly of component 
parts into devices and systems can be executed more predictably and reliably using 
engineered, in-context quantitatively characterised parts and sub-modules aided by 
modelling. This approach minimises the unexpected or high-order effects which could 
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occur during circuit construction by characterising components in the same 
biophysical and genetic context as anticipated in their target system. This was 
illustrated by converting an assembled non-functional logic AND circuit to be a 
functional one. The modular AND gate can be reconnected to different sensor inputs 
to detect and integrate various environmental signals (Anderson et al., 2007; 
Kobayashi et al., 2004; Voigt, 2006) or easily incorporated into a large system as a 
fundamental building block to regulate the cell signalling in a desired logic manner. 
The behaviour of the constructed modules are well captured by the parameterised 
mathematical models for their transfer functions, which are reusable for modelling the 
behaviour of larger integrated modules (Guido et al., 2006). The functional assembly 
approach described here provides an effective strategy and a guide for the engineering 
of synthetic gene circuits with predictable functions across different contexts for their 
application in many areas such as biotechnology, biocomputing and biosensors. 
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In the previous chapter, a set of parts and sub-modules have been quantitatively 
characterised in various contexts and it has shown that the functional assembly of 
BioParts into a modular genetic AND gate can be facilitated using these ‘in-context’ 
characterised components. In this chapter, to further verify this functional assembly 
approach at the device level, it proceeded to engineer a set of modular logic NOT 
gates and the combinatorial logic NAND gates, which comprise component modules 
of the AND gate and NOT gate. 
5.1 Engineering a Set of Modular NOT Gates 
5.1.1 The experimental design and construction of the NOT gates 
Here, three types of modular logic NOT gate were rationally designed on the basis of 
the three classic biological repressor modules – lacI/PLlac, tetR/Ptet and cI/Plam. As 
Figure 5.1 shows, the designed NOT gates function in the way that the expressed 
repressor proteins bind their cognate operator sites on the downstream promoter, 
which results in the inhibition of the transcription of the corresponding promoter. The 
design is modular as both the inputs and output of the designed NOT gates are 
promoters. Thus, various environment-responsive input promoters can be connected 
to the NOT gate and the output can be used to drive different cellular responses. The 
activity level of the NOT gate output is in inverse proportion to that of the input 
promoter. 
a     b            c 
lacI PLlac
SLacI
   
tetR Ptet
STetR
   
cI Plam
SCI
 
 
Figure 5.1 Design of the modular genetic NOT gates. a, The lacI/PLlac repressor 
module based NOT gate. The PLlac promoter is a hybrid regulatory region consisting 
of the promoter PL of phage lambda with the CI binding sites replaced with lacO1 
operator sites to allow strong expression (Lutz and Bujard, 1997). b, The tetR/Ptet 
based NOT gate. c, The cI/Plam based NOT gate. Plam is based on the PR promoter of 
phage lambda.  
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To construct the three types of NOT gate, the Inverters that have been 
constructed with BioBrick standard parts in the Part Registry (Registry of Standard  
Biological Parts, 2010d) were used as templates here instead of cloning their natural 
elements by PCR from scratch. Each repressor gene of the inverters (lacI/PLlac, 
tetR/Ptet and cI/Plam) from the registry has been modified with a LVA tail. The LVA 
tail (a peptide tag of AANDENYALVA) is attached to the C-terminal of the target 
protein. The resulting protein is then recognised and rapidly degraded by intracellular 
tail-specific proteases in E. coli (Andersen et al., 1998; Keiler et al., 1996). 
Consequently, the LVA tail can lead to rapid degradation of the repressor proteins in 
the inverters which enables dynamic control of the output gene expression and brings 
down the repressor background level to allow larger dynamic range of the output. The 
inverters in the registry are designed only in limited number of RBS versions and are 
not well characterised. Thus, various RBS sequences for each repressor gene construct 
were introduced with primers containing the corresponding RBS and appropriate 
restriction sites, which can modify the behaviour of the NOT gates to different extent 
and provide more choice for the construction of subsequent composite devices. The 
constructs of the NOT gates were next cloned into the expression vectors under 
appropriate inducible promoters as shown in Figure 5.2. The arabinose inducible PBAD 
promoter in pBAD18-cm vector (Guzman et al., 1995) and IPTG inducible Plac  
a        b     c 
         
 
Figure 5.2 Plasmid maps showing circuit constructs used for the characterisation 
of the NOT gates. All maps shown are NOT gates of the rbs34 version. a, The 
lacI/PLlac NOT gate was cloned under an arabinose inducible PBAD promoter in 
pBAD18-cm vector. b, The tetR/Ptet NOT gate was cloned under the IPTG inducible 
Plac promoter in pAPT110 vector. b, The cI/Plam NOT gate was cloned under the IPTG 
inducible Plac promoter in pAPT110 vector. 
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promoter in pAPT110 vector (Polard and Chandler, 1995) were used here as they 
have been quantitatively characterised in Chapter 4 and their transfer functions are 
already known. 
5.1.2 The characterisation of the NOT gates 
Here the aim is to engineer genetic logic NOT gates that can closely mimic the 
behaviour of a digital logic NOT gate, e.g. rapid output state switching across a 
narrow transition region of the input and a relatively large dynamic range of the 
output. To increase the diversity of the device behaviour and thus the flexibility for  
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rbs31lacI-PLlac NOT
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Figure 5.3 The characterisation of the lacI/PLlac based NOT gate. The NOT gate 
module was characterised under the arabinose inducible PBAD promoter using 3 
versions of RBS (rbs31, rbs33, rbs34) of various strengths. The bottom is the dose 
responses (fluorescence/OD600) of the engineered NOT gate induced by (left to right) 
0, 3.3 × 10-4, 1.3 × 10-3, 5.2 × 10-3, 2.1 × 10-2, 8.3 × 10-2, 0.33, 1.3, 5.3 and 10.7 mM 
arabinose. The data were fitted to the transfer function model of the NOT gate 
module. Error bars, s.d. (n=3). 
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selection, a device library containing eleven versions of the NOT gates using various 
RBSs were finally constructed and characterised under appropriate inducible 
promoters in the standard culturing condition (i.e. E. coli MC1061, M9-glycerol, 30 
°C). The characterised cellular responses of the three types of the NOT gates using 
various induction levels are shown in Figure 5.3, Figure 5.4 and Figure 5.5 
respectively. 
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Figure 5.4 The characterisation of the tetR/Ptet based NOT gate. The NOT gate 
module was characterised under the IPTG inducible Plac promoter using 3 versions of 
RBS (rbs31, rbs33, rbs34). The bottom is the dose responses (fluorescence/OD600) of 
the NOT gate by (left to right) 0, 3.9 × 10-4, 1.6 × 10-3, 6.3 × 10-3, 2.5 × 10-2, 0.1, 0.4, 
1.6, 6.4 and 12.8 mM IPTG. The data were fitted to the transfer function model of the 
NOT gate module. Error bars, s.d. (n=3). 
 
Referring to Figure 5.3, it can be seen that all the RBS versions of the lacI/PLlac 
NOT gate are roughly similar and show basic transition characteristics. However, the 
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transition is over a much wider inducer concentration range and there is significant 
divergence between the characteristics. Referring to Figure 5.4, the characteristics for 
two of the three RBS versions (rbs31, rbs34) of the tetR/Ptet NOT gate are similar and 
there is a clear transition from one state to the other. However, the transition is over a 
wide inducer concentration range and there is divergence between the transition 
characteristics as well. The non responsive (flat) characteristic of the rbs33 version is 
probably due to the almost no response of the Plac/rbs33 pair as shown in Chapter 4. 
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Figure 5.5 The characterisation of the cI/Plam based NOT gate. The NOT gate 
module was characterised under the IPTG inducible Plac promoter using 5 versions of 
RBS (rbs31, rbs32, rbs33, rbs34, rbsH). The bottom is the dose responses 
(fluorescence/OD600) of the NOT gate by (left to right) 0, 3.9 × 10-4, 1.6 × 10-3, 6.3 × 
10-3, 2.5 × 10-2, 0.1, 0.4, 1.6, 6.4 and 12.8 mM IPTG. The data were fitted to the 
transfer function model of the NOT gate module. Error bars, s.d. (n=3). 
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Referring to Figure 5.5, it can be seen that the cI/Plam based NOT gate exhibited the 
best characteristics overall. Four of the five versions of this NOT gate each produced 
similar responses with rapid state transition over a narrow range of inducer 
concentration, a large dynamic range and a low level of output at the “off” state when 
comparing with the lacI/PLlac and tetR/Ptet based NOT gates. 
 
Table 5.1 The model fits of the three types of NOT gates using various RBSs in the 
standard condition with 95% confidence bounds otherwise fixed at bound. cI/Plam and 
tetR/Ptet based NOT gates were characterised under the IPTG-inducible Plac promoter 
in pAPT110 vector. The lacI/PLlac based NOT gate was characterised under the 
arabinose-inducible PBAD promoter in pBAD18-cm vector. 
NOT gate    '3k  (au)       α3      n3 K3 (au)   R
2 
rbs31-cI/Plam 7.538e4 ± 0.234e4 0.0527 ± 0.0144 7.647 ± 1.379 111 ± 4.7 0.9997 
rbs32-cI/Plam 7.191e4 ± 0.385e4 0.0631 ± 0.0141 5.09 ± 0.714 47.47 ± 5.42 0.9997 
rbs33-cI/Plam 7.5e4 ± 3.55e11 0.5225 ± 5.10e6 1.005 ± 5.3e6 40.01 ± 2.2e8 2.2e-9 
rbs34-cI/Plam 7.46e4 ± 0.11e4 0.0509 ± 0.0108 2.905 ± 1.028 367.8 ± 29.2 0.9998 
rbsH-cI/Plam 7.392e4 ± 0.097e4 0.0635 ± 0.0986 2.967 ± 0.324 272.3 ± 15.3 0.9999 
rbs31-tetR/Ptet 4.484e4 ± 0.662e4 0.0181 ± 0.0873 2.299 ± 0.702 205.7 ± 18.7 0.9993 
rbs33-tetR/Ptet 4.003e4 ± 1.34e11 0.5276 ± 1.32e7 1.156 ± 8.5e6 41.02 ± 2.2e8 1.6e-9 
rbs34-tetR/Ptet 3.879e4 ± 0.114e4 0.0595 ± 0.0229 2.175 ± 0.303 690.6 ± 83.3 0.9994 
rbs31-lacI/PLlac 3.332e4 ± 0.225e4 5.65e-9 3.787 ± 1.768 4.32e4 ± 0.75e4 0.9805 
rbs33-lacI/PLlac 4.781e4 ± 0.261e4 1.45e-9 2.849 ± 1.018 5943 ± 1018 0.986 
rbs34-lacI/PLlac 2.121e4 ± 0.088e4 3.06e-10 1.866 ± 0.455 2.28e4 ± 0.42e4 0.9954 
 
The good characteristics of the rapid state transition over a narrow input range, a 
large dynamic range and a low output level at the “off” state for the NOT gate is 
important because it is intended to be combined with the AND gate to compose a 
composite NAND gate and a correct choice of the NOT gate with an appropriate RBS 
is necessary to achieve a good performance. The characterisation data of the three 
types of NOT gate using various RBSs were next fitted to the transfer function model 
of the NOT gate in the form 3 3 3'3 3 3 3 3 3([ ] ) ( ( [ ] ))
n n n
ss ssf R k K K Rα= + +  as derived in 
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Chapter 3, where 3[ ]ssR  is the concentration of the repressor at steady state, 3K and 3n  
are the Hill constant and coefficient respectively, '3k  is the maximum expression level 
due to induction and 3α  is a constant relating to the basal level of the regulated 
promoter. The steady state levels of the repressors were derived from the fitted 
transfer function of the characterised inducible promoters with the same RBS as used 
for the NOT gate characterisation. The results for the best fit coefficients with 95% 
confidence bounds using the nonlinear least square curve fitting in Matlab are listed in 
Table 5.1, where shows the favouring characteristics of the cI/Plam based NOT gate as 
well. 
 
5.2 Engineering the Modular Composite NAND Gates 
5.2.1 The experimental design and construction of the NAND gates 
On the basis of the characterised component gate modules and parts, the 
combinatorial NAND gate designed in Chapter 3 was subsequently constructed. As 
shown in Figure 5.6 and Figure 5.7, the NAND gate was assembled from the 
characterised AND gate and NOT gate modules and the pertinent characterised parts. 
As the individual component parts and device modules have been well characterised 
in their corresponding contexts, the behaviour of the composite NAND gate can be 
simulated directly using the parameterised models of the characterised components. 
The transfer function of the NAND gate can be derived by coupling the derived 
transfer functions of the individual modules, i.e. the NOT gate, AND gate and 
environment-responsive promoters, in the system. The output of a forward module 
acts as the input of the next module in the system cascade. As the model derivation in 
Chapter 3 shows, the NAND gate transfer function is give by  
3 3 3'
NAND 3 3 3 3 3 3[ ] ([ ]) ( ( [ ] ))
n n n
ssG f R k K K Rα= = + +              (5.1) 
where 3 ANDmax
([ ] ) ([ ] )
[ ] ([ ] ,  [ ] ) [ ]
(1 ([ ] ) )(1 ([ ] ) )
SR
SR
nn
ss ss SR
ss ss ss nn
ss R ss S
R K S K
R f R S G
R K S K
= = + + . 
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where 1 1 1'1 1 1 1 1 1[ ] or [ ] ([ ])  ( [ ] ( [ ] ))
n n nR S f I k I K Iα= = + + , 1I  is the inducer of the 
inducible promoter for the regulation of hrpR or hrpS in the AND gate. All parameters 
in this transfer function has the same meanings as in their individual transfer functions 
derived previously for the environment-responsive promoters, the AND gate and the 
NOT gate. The only difference is the fit value of ANDmax[ ]G , which needs to be 
adjusted according to the corresponding RBS used in the NOT gate because the 
previous fit is based on the rbs30-gfp reporter used for the AND gate characterisation. 
Figure 5.6a and Figure 5.7a are the computational predictions of two versions of 
the modular composite NAND gate, which shows the desired NAND gate 
characteristics. The first NAND gate comprises the characterised AND gate using Plac 
and PBAD as the inputs and the rbs34-cI/Plam based NOT gate, and the prediction of the 
device behaviour is based on their fitted transfer functions in the standard condition. 
The second NAND gate comprises the characterised AND gate using Plux and PBAD as 
the inputs and the rbs32-cI/Plam based NOT gate, and the prediction of the device 
behaviour is based on their fitted transfer functions at 37 °C in the otherwise standard 
condition for the inducible input promoters. For the second device, it was assumed 
that the characteristic of cI/Plam based NOT gate does not change much at the two 
temperatures 30 °C and 37 °C. The cI/Plam based NOT gate module is used because 
this type of NOT gate exhibits the best characteristic among all characterised NOT 
gates as shown in the previous section. 
Based on the model predictions, the NAND gates were constructed by directly 
assembling the appropriate modules and parts. The two environment-responsive 
inputs and the output are carried on three compatible plasmids respectively as shown 
in Figure 5.6b and Figure 5.7b. The hrpL followed by a NOT gate module with gfp 
reporter was carried on pSB4A3 (pSC101 ori, Ampr) (Shetty et al., 2008) as the 
output plasmid. The two input plasmids for driving hrpR and hrpS are the same as 
used in the characterised AND gates. The use of separate plasmids for the inputs and 
output allows for the easy exchange of the individual environment-responsive inputs 
and the output gene, and facilitates the assembly of them into one functional device. 
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Input 1      Input 2                Output 
                
 
Figure 5.6 Two-input NAND gate using Plac and PBAD inputs, and the cI/Plam 
based NOT gate. a, The composite modular NAND gate comprising the 
characterised AND gate using inducible promoter Plac and PBAD as the inputs and the 
rbs34-cI/Plam based NOT gate, rbs30-gfp as the output reporter. The bottom is the 
model prediction of the NAND gate response based on the fitted models of the 
component gate modules at 30 °C. b, Plasmid maps showing circuit constructs for this 
NAND gate device. 
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Figure 5.7 Two-input NAND gate using Plux and PBAD inputs, and the cI/Plam 
based NOT gate. a, The composite modular NAND gate comprising the 
characterised AND gate using inducible promoter Plux and PBAD as the inputs and the 
rbs32-cI/Plam based NOT gate, rbs30-gfp as the output reporter. The bottom is the 
model prediction of the NAND gate response based on the fitted models of the 
component gate modules at 37 °C. b, Plasmid maps showing circuit constructs for this 
NAND gate device. 
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5.2.2 The characterisation of the NAND gates 
The two assembled devices were next characterised in their corresponding conditions. 
The devices were first fully characterised by fluorometric assays in a fluorometer as 
the results shown in Figure 5.8a and Figure 5.9a. It can be seen that the responses of 
the two versions of the NAND gate mimic the digital logic NAND function well, 
where the outputs of gates are in the “off” state (Point A) only when both inputs are 
high. Points B, C and D show high fluorescence and point A low fluorescence, which 
are the outputs corresponding to the four logic input conditions. The experimental 
results are close to the model predictions apart from the slight difference at the corner 
with low IPTG and high arabinose induction (Point B, Figure 5.8a) on the two 
dimensional map of full characterisation and, similarly, in Figure 5.9a, the corner with 
low AHL and high arabinose induction. The slight inhibition at Point B might be due 
to the small leaky expression of HrpR from the corresponding input inducible 
promoters. 
The NAND gate circuits were then subject to flow cytometry assay under four 
logic input conditions and borne out to work at individual cellular level as well 
(Figure 5.8b and Figure 5.9b), where the data were acquired 16 hours after induction 
from the cultures inoculated from a single colony containing the circuit. Referring to 
Figure 5.8b and Figure 5.9b, the entire cell population is turned off only when both 
inputs are highly induced (low fluorescent lane A corresponding to the Point A in the 
fluorometric assay). When either input is not induced, the entire population is 
switched on (high fluorescent lanes B, C and D). The high fluorescence of a small 
portion of the cells at lane A of the second NAND gate (Figure 5.9b) might be due to 
a not fully induced cell population under the induction conditions employed (i.e. 1.3 
mM arabinose plus 100 nM AHL). Particularly, this might be due to the non-
homogenous input promoter PBAD which displays all or none (bimodal) activity at 
subsaturating arabinose conditions in E. coli MC1061 as shown in Section 4.4.1. 
Overall, the results are consistent with the full characterisation results at the 
population level by fluorometric assay as shown in Figure 5.8a and Figure 5.9a. 
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Figure 5.8 The systematic characterisation of the first composite NAND gate. a, 
The NAND gate responses by fluorometric assay for 64 combinations of input 
inductions by (left to right) 0, 3.9 × 10-4, 1.6 × 10-3, 6.3 × 10-3, 2.5 × 10-2, 0.1, 0.4 and 
1.6 mM IPTG, and induction by (bottom to top) 0, 3.3 × 10-4, 1.3 × 10-3, 5.2 × 10-3, 
2.1 × 10-2, 8.3 × 10-2, 0.33 and 1.3 mM arabinose. Data are the normalised average of 
three repeats in E. coli MC1061 in M9-glycerol at 30 °C with variations less than 10% 
between biological repeats. b, FACS assay of the NAND gate under four logic 
combinations of input inductions: A - 1.3 mM arabinose plus 1.6mM IPTG; B - 1.3 
mM arabinose; C - 1.6mM IPTG; D - none. 
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Figure 5.9 The systematic characterisation of the second composite NAND gate. 
a, The NAND gate responses by fluorometric assay for 64 combinations of input 
inductions by (left to right) 0, 2.4 × 10-2, 9.8 × 10-2, 3.9 × 10-1, 1.6, 6.3, 25 and 100 
nM AHL , and by (bottom to top) 0, 3.3 × 10-4, 1.3 × 10-3, 5.2 × 10-3, 2.1 × 10-2, 8.3 × 
10-2, 0.33 and 1.3 mM arabinose. Data are the normalised average of three repeats in 
E. coli MC1061 in M9-glycerol at 37 °C with variations less than 10% between 
biological repeats. b, FACS assay of the NAND gate under four input inductions: A - 
1.3 mM arabinose plus 100 nM AHL; B - 1.3 mM arabinose; C - 100 nM AHL; D - 
none.  
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The long growth time of the cell cultures for this FACS assay is used because 
the NAND gate default output is high without input inductions, which can lead to high 
fluorescence background after short time growth upon induction, due to inoculating 
cells carrying over high GFP levels. As shown in Figure 5.10a-c, the cells harbouring 
the first composite NAND gate were subject to the flow cytometry assay after 5 hours 
growth with various input inductions. It can be seen that the output in terms of 
fluorescence is reduced when both input inducers are present, but the lowest output is 
still high even when both inputs are fully induced.  By extending the growth time to 7 
hours, the lowest fluorescent output of the device is reduced further under the full 
induction of both inputs, as Figure 5.10d shows. This is due to the cells with initial 
high fluorescence having undergone a longer period of growth with more cell 
divisions, which resulted in more dilutions of the background fluorescent proteins in 
each cell. Thus, the assay cell cultures were finally inoculated from a single bacterial 
colony for long time growth (16 h) to completely dilute out the background 
fluorescent proteins. The complete dilution of the initial background GFPs is 
corroborated by the FACS assay results of these cultures (Figure 5.8b and Figure 
5.9b). 
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Figure 5.10 FACS assays of the engineered composite NAND gate using Plac and 
PBAD as the two inputs in E. coli MC1061 after 5 hours (a-c) or 7 hours (d) 
growth in M9-glycerol at 30 °C. a, FACS assay of the NAND gate with full 
induction of the PBAD input (1.33 mM arabinose) and graded induction of the Plac 
input by (bottom to top) 0, 3.9 × 10-4, 1.6 × 10-3, 6.3 × 10-3, 2.5 × 10-2, 0.1, 0.4 and 1.6 
mM IPTG. b, FACS assay of the NAND gate with full induction of the Plac input (1.6 
mM IPTG) and graded induction of the PBAD input by (bottom to top) 0, 3.3 × 10-4, 
1.3 × 10-3, 5.2 × 10-3, 2.1 × 10-2, 8.3 × 10-2, 0.33  and 1.33 mM arabinose. c, FACS 
assay of the NAND gate with graded inductions for both of the inputs Plac and PBAD. d, 
FACS assay of the NAND gate after 7 hours growth under four logic combinations of 
input inductions. 
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5.3 Discussion 
This chapter describes the engineering and quantitative characterisation of a set of 
modular genetic logic NOT gates as well as the combinatorial modular NAND gates. 
Particularly, the composite NAND gates are directly assembled from the characterised 
component gate modules, i.e. the AND and NOT gates, whose behaviour can be 
accurately predicted from the fitted transfer functions of the individual modules in the 
corresponding contexts. This further demonstrate that the assembly of BioParts into 
functional devices and systems can be executed predictably and reliably using 
previously ‘in-context’ quantitatively characterised parts and submodules guided by 
modelling. Combining the results in Chapters 4 and 5, they show that the functional 
assembly approach proposed in this thesis not only works at the basic part level, but 
also at the device level.  
Strictly speaking, the component modules should be characterised in the exact 
same biophysical and genetic context as in their final target system. This will 
minimise the variations arising from the difference of contexts. However, the same 
genetic context is more difficult to achieve than the same biophysical context. For 
instance, the 5' UTR sequence in the context for characterising the module might be 
different from the one in the target system. Thus, it will be significantly beneficial to 
standardise the 5' UTR sequence before the RBS site used for the characterisation. 
Unfortunately, there is no work on this aspect currently in the synthetic biology 
community. As shown in Chapter 4, the difference of genetic context such as the 5' 
UTR can lead to the large variations of the absolute activities of parts and modules. It 
will be worthwhile to systematically design several standard 5' UTRs of various 
lengths and secondary structures to investigate their impact on characterisation 
brought by these variations. In addition, a set of standard inducible characterisation 
systems need to be developed to standardise the characterisation of synthetic parts and 
modules, i.e. in the same genetic context and biophysical (abiotic) context. This will 
enable the reuse and exchange of the characterisation data between different labs. The 
PBAD, Plac and Ptet inducible promoters are the good candidates for such systems. 
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Ideally, these inducible promoters need to be placed in a standard robust vector to 
minimise the variations of plasmid copy numbers.  
The engineered modular NOT and NAND gates are reusable and can be 
reconnected to different sensor inputs to detect and integrate various environmental 
signals or easily incorporated into a large system as fundamental building blocks to 
regulate the genetic information processing in a specified logic manner. The NOT and 
NAND gates are the basic modules for engineering genetic circuits with desired logic 
functions just as their counterparts in electronic circuit engineering. To expand the 
toolbox of synthetic biology, more orthogonal modules with logic functions need to 
be engineered from diverse natural biological modules. As a result, multiple modules 
with the same logic can be used in one composite system, and large systems with 
increasingly complicated logic functions can be developed just like the combinatorial 
logic circuits seen in electronic engineering.  
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In this chapter, on the basis of the gene circuits engineered in the previous chapters, a 
microbe-based biosensing application platform was then built. As mentioned before, 
the constructed AND, NOT and NAND gate devices are all modular and promoter-
input based. Thus, various promoters that are responsive to specific environmental 
signals can be connected to these modular devices, and the E. coli hosts harbouring 
the device can respond with a corresponding output when the signal in the 
environment appears or a specific logic combination of multiple signals is detected. In 
this sense, the engineered microbe-based biosensor encompasses the three equivalent 
modules of a traditional sensor, i.e. the sensory, regulatory and the actuation modules, 
which are the parts corresponding to the environment-responsive input promoters, the 
engineered gene circuits and the output genes in the biosensor. The biosensor 
conforms to a modular structure because each module is within limits independent 
and exchangeable in the chosen framework.  
On the other hand, the natural world has shown that more complex tasks can be 
performed precisely through the cooperation of otherwise separated individuals, such 
as the developmental pattern formation in some eukaryotes and the quorum sensing 
mechanism found in some specific bacteria (Bassler, 2002; Surette and Bassler, 1998; 
Waters and Bassler, 2005). Usually, the coordinated jobs are completed through the 
communication of biochemical signals between them (Taga and Bassler, 2003), which 
are regulated by the underlying gene circuits in each host. Thus, to program the cells 
with high level functions, we need to exploit these natural cell-cell communication 
circuits and to engineer a function that is dependent on the behaviour of the entire 
population instead of only the individuals. Here in Section 6.1, a module was 
engineered in E. coli, which regulates gene expression as a function of the density of 
the whole population. The cell density-dependent module is inspired from the quorum 
sensing mechanism in Vibrio fischeri, a marine symbiotic bacterium. Based on this 
cell density-dependent module and other engineered parts and modules in the previous 
chapters, an E. coli based cell density-dependent biosensor was then constructed in 
Section 6.2, which integrates its own cell density signal through a cell-cell 
communication module and a second environmental signal in a logic AND manner, 
with green fluorescent protein level as the output readout. 
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6.1 Quorum Sensing and the Engineering of a Cell Density-
dependent Module 
6.1.1 The quorum sensing mechanism in Vibrio fischeri 
It is now known that the ability to communicate is essential for the survival and 
interaction of many different species of bacteria in their natural habitats. One cell-cell 
communication mechanism, named quorum sensing, was first discovered and 
described in the marine symbiotic bacterium Vibrio fischeri about 35 years ago 
(Fuqua and Greenberg, 2002; Miller and Bassler, 2001). V. fischeri usually exists in 
two states. When in the free-living state, it swims freely in seawater at a low cell 
density (approximately 100 cells or less per ml) and emits almost no light.  When in 
its symbiotic light organ of some eukaryotic hosts, like the Hawaiian squid Euprymna 
scolopes, the bacteria can grow up to a concentration of 1010 to 1011 cells per ml and 
emit light. This autoinduction of light emission is intertwined with cell-cell 
communication and cell density. Due to its correlation to the population density, the 
mechanism underlying this behaviour is referred to as quorum sensing. The host and 
the bacteria are in a symbiotic relationship. The bacteria can get nutrients 
continuously from the host while the host uses the bacterial bioluminescence for 
various specific purposes like the squid avoiding its potential predators by counter 
illumination.  
The quorum sensing system was first identified by the direct transfer of a 9 kb 
fragment from V. fischeri to E. coli (Engebrecht et al., 1983), and the transformed 
cells surprisingly showed bioluminescence. Following this work, the quorum sensing 
system has been extensively studied and the basic regulatory structure is found 
conserved in a variety of other bacterial species as well. Figure 6.1 shows the 
disclosed gene regulatory circuit underlying the quorum sensing mechanism in V. 
fischeri. The mechanism is controlled by the lux regulatory system, which comprises 
the left luxR operon and right luxI operon. The right operon transcribes a set of six 
genes (luxICDABE) encoding the luciferase enzymes required for light production, in 
which the LuxI proteins expressed from luxI are the synthase for the signalling 
molecule acyl-homoserine lactone (AHL). The signalling molecule AHL can freely  
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Figure 6.1 The quorum sensing circuit in Vibrio fischeri and the regulatory 
region of lux operon. a, The quorum sensing circuit in V. fischeri comprises two lux 
operons transcribed in two directions respectively. The five luciferase structural genes 
(luxCDABE) and two regulatory genes (luxR and luxI) are required for the cell 
density-dependent bioluminescence in V. fischeri through a positive feedback circuit. 
b, The 218 bp intergenic region between the left and right lux operons represents the 
control region for the bioluminescent system. The regulatory region contains the two 
promoters for the two operons, and the crp box and lux box which are the binding 
sites of CRP-cAMP and LuxR-AHL complexes respectively. The left promoter has 
the full -10 and -35 binding sites for σ70 whilst the right promoter only contains the     
-10 site. 
 
diffuse across the cell membrane. The left operon encodes the LuxR proteins under a 
separate constitutive promoter. The constitutively expressed LuxR binds its cognate 
AHL molecule to form the LuxR-AHL complex, which can bind a site, named lux box, 
on the regulatory region of the lux operon and activate the transcription of the right 
operon. Thus, at low cell densities, the right luxI operon is transcribed at a low basal 
level and a low level of the autoinducer AHL is produced. Since the genes encoding 
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luciferase are located downstream of the luxI gene, only a low level of light is 
produced. When V. fischeri culture grows to a certain density, the AHL molecules 
accumulate to a threshold in the culture and AHL can then bind its cognate LuxR 
proteins to activate the transcription of the rightward operon. Due to the positive 
feedback, it results in an exponential increase in both the AHL production and 
bioluminescence. The LuxR-AHL complex also negatively regulates the left promoter 
for LuxR expression as a compensatory mechanism which decreases the expression of 
the genes in the rightward operon in response to the positive feedback circuit (Miller 
and Bassler, 2001). 
The detailed regulatory region for the lux system is shown in Figure 6.1b. The 
regulatory region includes the two regulatory promoters and the two conserved 
binding sites, i.e. the crp box and lux box, for the CRP-cAMP complex and LuxR-
AHL complex respectively. The crp box allows the catabolite repression of the left 
luxR operon. The lux box is a 20 bp palindromic sequence centred approximately 40 
bp upstream from the transcription start site of the right operon (Stevens and 
Greenberg, 1997), which is a conserved binding site for the LuxR-like family proteins. 
The specificity in response to a signalling molecule is encoded in the N-terminal 
regulatory domain of LuxR-like proteins, and the signaling molecule used in V. 
fischeri is N-3-oxohexanoyl-L-homoserine lactone. 
 
6.1.2 The engineering of a cell density-dependent module 
In this section, a genetic module for cell-cell communication in a cell density-
dependent manner was designed and constructed on the basis of the lux quorum 
sensing regulatory system in V. fischeri as introduced in Section 6.1.1. 
Figure 6.2 shows the design of the genetic module. The module was created on 
the basis of the synthetic Plux promoter that has been characterised in Chapter 4 and 
the luxR and luxI regulatory genes from the lux quorum sensing system. Although the 
natural lux regulatory system has been isolated and demonstrated to have the 
population density-dependent behaviour, a modular design approach was taken here in 
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building the module using standardised BioBrick parts based on the intrinsic 
mechanisms of quorum sensing (see Section 6.1.1). The module is different from the 
natural one, but, essentially, employs the same positive feedback mechanism. The Plux 
promoter contains the lux box and the right PluxI promoter from the native lux system. 
The luxR gene is constitutively expressed under the Ptet promoter. The luxI and gfp are 
expressed as an operon under the regulation of the Plux promoter. Thus, when at low 
cell densities, LuxI and GFP proteins are expressed at low levels and the AHL 
molecules synthesised from LuxI is also at a low level and can not sufficiently bind 
LuxR to activate the transcription from Plux. When the cells continue to grow, the 
AHL accumulates in the environment and reaches a threshold at a certain cell density, 
at which it sufficiently binds LuxR to activate the positive feedback loop as shown in 
the graph and then more LuxI and GFP proteins are expressed. As a result, the output 
in terms of fluorescence increases with cell density, and the module has the 
population density-dependent behaviour. 
To conform to the BioBrick standard, all the module components (promoters 
and genes) were obtained from the Registry of Standard Biological Parts and were 
assembled on the BioBrick standard vector pSB3K3 as shown on the right of Figure 
6.2a. Since the luxI and gfp are expressed as an operon in the module, the gfp 
expression level is likely different from the one that is first expressed downstream 
from the Plux promoter even with the same RBS used. Polarity is known to occur in 
bacterial systems, and later transcribed genes in an operon are often not as highly 
expressed as those initially transcribed. Such effects can be due to changes in the 
amounts of message where the message is degraded from its 3' end, competing RNA 
structures that disfavour translation, and so on. This view is borne out by the initial 
experimental results which showed that, for the constructs with rbs33-gfp or rbsH-gfp 
downstream the luxI gene, there were nearly no fluorescent outputs of the cells 
harbouring the module for all 6 RBSs (rbs30 - rbsH) used for luxI (data not shown). 
Thus, the strong RBS – rbs30 was finally chosen for obtaining measurable levels of 
gfp expression, which gave a clear fluorescent output for cells harbouring the module. 
The weak RBS – rbs33 for luxI in the final construct was chosen from the screenings 
which showed that, for all 6 RBSs (rbs30 – rbsH) used for luxI gene (luxI-rbs30-gfp), 
Chapter 6 - Engineering a Modular Cell Density-dependent Microbe-based Biosensor 
 
 
136
a 
Plux
luxR GFPluxI
Ptet
rbs34 rbs33 rbs30
AHL
luxR luxR
luxI
              
 
b 
     
10-2 10-1 100
0
10
20
30
40
50
60
70
80
90
100
OD600
M
ea
n 
flu
or
es
ce
nc
e 
(a
u)
 
sample culture of the module
 
 
Figure 6.2 The engineering of a cell density-dependent module. a, The regulatory 
module is designed on the basis of the synthetic AHL-responsive Plux promoter and 
the luxI gene, which forms a positive feedback loop in response to the density of the 
cell population. On the left is the plasmid construct of the module. The luxI gene is 
modified with a LVA degradation tag. b, The characterised results of the module in E. 
coli MC1061 after 5 hours growth in M9-glycerol at 37 °C. The sample cultures are 
initially inoculated with various numbers of cells of OD600 at (bottom to top) 1 × 10-4, 
3 × 10-4, 5 × 10-4, 1 × 10-3, 2 × 10-3, 5 × 10-3, 1 × 10-2, 2 × 10-2 and 5 × 10-2. The 
negative control is the culture of cells carrying the gfp-free construct, and the positive 
control is the culture of cells carrying the functional construct induced with 100 nM 
AHL. The inoculation density for both the negative and positive controls is of OD600 
at 0.02. On the right is the plotted curve for the module output (mean fluorescence 
from FL1 filter) as a function of cell density for the FACS assays. 
 
where there was only significant output difference between the non-induced culture 
and fully induced culture (by 100 nM AHL) for cells harbouring the module with 
rbs33-luxI-rbs30-gfp. Therefore, the rbs33 and rbs30 were finally selected for luxI and  
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gfp respectively in the module to achieve the cell density-dependent output property. 
The constructed module (Figure 6.2a) was next characterised in E. coli MC1061 
by FACS assay and the results are shown in Figure 6.2b. To prepare the day cultures, 
the overnight cultures were pelleted by centrifugation, and re-suspended in pre-
warmed M9 media and left for 10 mins before being diluted into the day cultures at 
various cell densities. This washing step is important for removing the AHL 
molecules expected to have built up in the media because the overnight culture was 
likely saturated with high level of AHL molecules after a long time of growth. The 
diluted day cultures were next grown at 37 °C for 5 hours to various cell densities 
(measured by spectrophotometer at 600 nm) before being harvested for analysis by 
flow cytometry. Referring to Figure 6.2b, it shows that the cells containing the 
engineered module displayed the desired cell density-dependent property. The 
fluorescent outputs of the sample cultures with various initial cell densities varied 
from each other after the same length of time of growth, and the output increases with 
the density of the cell culture. Extrapolating back towards a fully “off” low density 
cell culture, it seems that the positive feedback of the module was already partly 
switched on at a lower cell density than the lowest density shown in the graph. 
However, due to the detection limit of the spectrophotometer used, the lowest OD600 
that can be accurately measured for the cell culture is 0.01. Although the completely 
“off” culture was not directly observed during the experiment, the cell cultures 
analysed indeed exhibited the density-dependent behaviour. It is known that AHL 
(Acyl-homoserine lactones) molecules are quite stable in mildly acidic or neutral pH 
environments (Leadbetter and Greenberg, 2000). The quorum-sensing signalling 
molecules AHL are found to degrade significantly only in some specific bacterial 
species like Bacillus bacteria which can express the AiiA enzyme to degrade the 
signalling molecules (Dong et al., 2000) or in Variovorax paradoxus which can 
metabolise the signalling molecules (Leadbetter and Greenberg, 2000). Thus, the 
effect of AHL degradation can be negligible in the E. coli chassis used here. However, 
if used in an E. coli chassis expressing the AiiA degrading enzyme, it might slow 
down the accumulation of AHL in the media and lead to a delayed density switching 
response, i.e. switching at a higher cell density. 
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6.2 Engineering a Modular Cell Density-dependent 
Microbial Biosensor 
In this section, a microbe-based biosensing application platform is described which 
uses the biological parts and modules that have been engineered in this project. 
Specifically, an E. coli-based biosensor has been constructed, which can sense in the 
environment (i) its own cell density and (ii) the arabinose concentration. The observed 
GFP level was the output readout for the device. The design and construction of the 
biosensing system is introduced in Section 6.2.1 and the characterisation results are 
described in Section 6.2.2. 
6.2.1 System design and construction 
Figure 6.3a shows the detailed structure of the designed microbe-based biosensing 
system, which consists of three independent and exchangeable modules (i.e. the 
sensory module, the internal regulatory module and the reporter module). The input 
sensors are inducible promoters which can respond to specific molecules either inside 
the cell or outside the cell via a signalling pathway. The regulatory module is an 
engineered genetic circuit that can transmit and integrate the changes from the input 
promoters to generate a single output signal in a pre-determined way. The reporter 
module is an output gene that is expressed in proportion to the signal level from the 
regulatory module. The reporter protein, e.g. GFP, usually can be detected by a 
traditional biophysical or biochemical assay. Thus, the microbial biosensor is modular 
and can be easily customised to detect various environmental signals and generate a 
quantifiable output in a desired logic manner according to different applications. Here, 
a cell density-dependent biosensor was constructed which uses the cell density-
dependent module engineered in the previous section and the arabinose-responsive 
PBAD promoter as the two sensor inputs, the logic AND gate engineered in Chapter 4 
as the internal regulatory circuit, and the gfp as the output reporter.  
As shown in the graph (Figure 6.3a), the first sensor input of the device is the 
LuxI/LuxR quorum sensing module, which can synthesise and detect the AHL 
signalling molecules. The positive feedback in the module enables the response level  
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Figure 6.3 The engineering of a cell density-dependent microbe-based biosensor. 
a, The biosensor is designed to comprise three exchangeable modules, i.e. the 
promoter-based input sensors, the internal circuit for regulating genetic information 
transmission, and the output gene reporter. Here, the two sensor inputs used are for 
detecting the cell density and the arabinose (PBAD) respectively. b, Plasmid maps 
showing the circuit constructs used for the characterisation of the biosensor. 
 
to be a function of the cell density. The second sensor input, the inducible PBAD 
promoter, detects and responds to arabinose in the environment. The AND gate circuit 
integrates the levels of the two sensor inputs in the specific logic AND gate manner as 
characterised before, and drives the expression of the gfp reporter. As a result, the 
biosensor will generate a clear output (fluorescence) when both the cell population 
density and the arabinose concentration are sufficiently high and reach the detection 
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thresholds used by the device. This tight control property is useful for some 
applications in which we would like the cells to produce a product in large amounts 
and in a desired environment while the product is toxic to the cells. The desired 
environmental condition could be defined by the second sensor input of the biosensor, 
such as using an engineered pH sensitive promoter to specify the acidic condition. 
Therefore, the cells will not produce the product until they reach a certain high density 
to avoid the growth inhibition effect induced by the product during the early growth 
phase. 
Figure 6.3b shows the plasmid constructs of the cell density-dependent 
biosensor capable of arabinose sensing. The system was assembled directly from the 
individual modules that have been characterised (see Chapters 4-6). The three 
plasmids represent the cell density-dependent input (Input 1, plasmid pBW630luxI-
hrpR driving hrpR), the arabinose input (Input 2, plasmid pBW213ara-hrpS driving 
hrpS) and the output (plasmid pBW400hrpL-gfp driving gfp) respectively. The 
plasmid separation of the two inputs and output allows modular and quick exchange 
of the sensor inputs and the output responsive gene. 
 
6.2.2 Characterisation: results and analysis 
The plasmid constructs of the biosensor were next transformed in E. coli MC1061, 
which was subject to flow cytometry assay. Figure 6.4 shows the characterisation 
results, where the sample cultures were initially inoculated from the same overnight 
culture, but with various numbers of cells and were grown to different cell densities 
after the same length of time. As explained in the previous section, the overnight 
cultures were washed with M9 media before being diluted into the day sample 
cultures. The biosensor was first assayed under the condition of full induction by 1.3 
mM arabinose (Figure 6.4a, c). It shows that the output (in terms of fluorescence) of 
the biosensor sample cultures varied after the same length of time of growth, and the 
output increases with the cell density of the culture. The biosensor was next assayed 
under the condition of no arabinose induction (Figure 6.4b, c). The results show that 
there is nearly no output response without the presence of arabinose in the culture  
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Figure 6.4 Characterisation of the cell density-dependent biosensor. The cells (E. 
coli MC1061) harbouring the engineered biosensor were assayed by flow cytometry 
after 5 hours growth in M9-glycerol at 37 °C. The negative control is the culture of 
cells containing the gfp-free constructs with inoculation cell density of OD600 = 0.05. 
a, FACS assay of sample cultures with 1.3 mM arabinose. The sample cultures were 
initially inoculated with various numbers of cells from the same overnight culture at 
OD600 of (bottom to top) 5 × 10-4, 1 × 10-3, 2 × 10-3, 1 × 10-2, 2 × 10-2, 3 × 10-2, 5 × 10-
2, 1 × 10-1 and 2 × 10-1. b, FACS assay of sample cultures without arabinose. The 
sample cultures were initially inoculated with various numbers of the cells from the 
same overnight culture at OD600 of (bottom to top) 5 × 10-4, 1 × 10-3, 1 × 10-2, 5 × 10-2, 
and 2 × 10-1. c, The plotted curves of the biosensor output (mean fluorescence from 
FL1 filter) as a function of cell density for the assays of a and b.  
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whatever the cell density of the culture is. Combing the two assay results leads to 
conclusion that the engineered biosensor exhibits the cell density-dependent sensory 
property as well as the arabinose sensing capability. This means that the engineered 
biosensor will not output with high fluorescence until both the cell density and the 
arabinose concentration are sufficiently high and each reach a certain threshold. 
As seen in the characterisation of the cell density-dependent module, the 
completely “off” culture of the biosensor was not observed under the condition of 
high arabinose concentration (Figure 6.4a). This might be due to the cells harbouring 
the biosensor switch still in an “on” state even at a lower cell density than the lowest 
cell density shown in the graph. Working below this already low cell density is below 
the detection limit of the spectrophotometer used, and so seeking a fully “off” cell  
population is technically not easy unless cell density was checked by e.g. manually  
counting cells directly in a microscope or through colony viable counting. The partly 
“on”  population of cells studied here is reflected by the two peaks of GFP levels seen 
in the sample culture of OD600 of 0.010, one showing low fluorescence (“off” state 
cells) while the other higher fluorescence (“on” state cells). The two subpopulations 
were also observed on the scatter graphs of the FACS assays. Figure 6.5 shows the 
side-scattering and forward-scattering graphs for the first four sample cultures (Figure 
6.4a) with OD600 of 0.010, 0.020, 0.034 and 0.088. The same gate was applied to each 
graph for calculating the fluorescent outputs of the samples. The first graph clearly 
shows that there are two populations corresponding to the high and low fluorescence 
respectively. With the increase of the cell culture density, the low fluorescent 
subpopulation gradually disappears and the high fluorescent subpopulation begins to 
dominate as shown in Figure 6.5 b-d. 
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Figure 6.5 FACS side-scattering and forward-scattering graphs of the cells (E. 
coli MC1061) harbouring the engineered biosensor. The sample cultures are from 
the assays in Figure 6.4a, which were initially inoculated with various numbers of 
cells and grown to various densities after 5 hours growth in M9-glycerol at 37 °C. a, 
FACS scatter graph for the sample culture of OD600 = 0.010. b, FACS scatter graph 
for the sample culture of OD600 = 0.020. c, FACS scatter graph for the sample culture 
of OD600 = 0.034. d, FACS scatter graph for the sample culture of OD600 = 0.088. 
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6.3 Discussion 
In this chapter, a cell-cell communication module was successfully engineered with 
the cell density-dependent sensory property, which is based on the lux quorum sensing 
system in Vibrio fischeri. By integrating the biological parts and modules that have 
been engineered in the project, a scalable application platform for microbe-based 
biosensors was built. Due to the modular structure of the platform, these promoter-
based microbial biosensors can be engineered to detect and integrate various 
environmental conditions precisely using various input-specific promoters, and 
initiate different cellular responses on demand. Specifically, an Escherichia coli based 
biosensor were constructed, which can sense its own cell density signal and a second 
environmental signal (arabinose concentration) and integrate them in a logic AND 
gate manner, with GFP level as the output readout. The work here further validates 
the modular functional assembly approach proposed in this thesis. It also represents 
the capability that we can design an engineered version of the naturally discovered 
biological circuits using standardised biological components. In addition, we could 
program emergent, high level functions into the living cells through the 
communication and coordination of the individuals instead of just the standalone 
cellular behaviour. Up to now, various advanced functions have been implemented by 
synthetic biologists using multiple cell populations or species that have been 
engineered with different dedicated circuits and thus can communicate with each 
other in a pre-determined manner, such as programmed pattern formation (Basu et al., 
2005), artificial ecosystems (Balagadde et al., 2008; Brenner et al., 2007; Song et al., 
2009; Weber et al., 2007) and synchronised oscillation (Danino et al., 2010).  
However, the experimental results show that the transition region of the 
engineered cell density-dependent module is not completely within the readily 
observable range of cell densities. It seems that the positive feedback in the module 
switches on at a lower threshold of density than the lowest one shown in the 
experiment. This is largely due to that the current architecture of the module is not 
optimised for the experimentally observable region of cell density (OD600 between 
0.01 and 1.00). Thus as an alternative to studying cells at very low cell density, three 
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modified architectures of the cell density-dependent module are proposed here for 
future improvement as Figure 6.6 shows. In the first architecture (Figure 6.6a), by 
using a weak RBS for luxR instead of the currently strong RBS (rbs34), the density of 
the induction threshold of the module will increase and thus likely falls in the 
observable range of cell density. The effect of altering luxR RBS strength has been 
shown in a study of shuffling the architecture of the natural lux operon (Haseltine and 
Arnold, 2008). In the second architecture (Figure 6.6b), luxI and gfp (output gene) are 
expressed separately under the same Plux promoter instead of as an operon. This will 
improve the modularity and predictability of the module because the balanced 
expression of multiple genes in an synthetic operon are difficult to achieve (Pfleger et 
al., 2006). As observed in the experiment, the second gene (gfp) expression in the 
operon of the engineered module has varied a lot compared to the single gene (gfp) 
expression directly under the inducible promoter Plux. In the third architecture (Figure 
6.6c), the luxR is regulated by the Plux promoter instead of the Ptet constitutive 
promoter. Thus, luxR expression is under the positive feedback control as well as the 
expression of luxI and gfp. This structure will increase the transition sharpness of the 
module as shown in a relevant study (Haseltine and Arnold, 2008), but might lead to a 
bistable response due to the increased strength of the positive feedback.  
It will be of great value to investigate the behaviour of the three proposed 
architectures above. The study will assist the engineering of a genetic module with 
customised cell density-dependent property for its wide application in many areas, for 
example in biotechnology including fermentation. 
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Figure 6.6 Potential improved architectures for the cell density-dependent 
module. 
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7.1 Overview 
Synthetic biology represents a new, interdisciplinary field at the interface between 
engineering and biology. The initial proof-of-principle examples in this area are 
encouraging and exhibit the great potential of designing de novo genetic circuits from 
modular biological elements, under the guidance of some engineering principles. 
However, the materials that are to be engineered in gene circuits are fundamentally 
different from their engineering counterparts. The living biological materials are 
inhabited in a complex, yet orderly, aqueous environment, self-replicable and subject 
to continuous background fluctuations. Thus many engineering principles may not be 
directly applicable to the entire process of synthetic gene circuit engineering. In 
addition, the complexity of natural biological systems can be overwhelming and we 
still do not know enough details of their design principles and underlying components. 
This is reflected in the relatively slow progress made towards engineering large 
complex biological circuits, with desired properties, during the past decade. The 
complexities of currently bottom-up constructed systems appear to enter into a 
platform with no more than six regulatory elements in one system (Purnick and Weiss, 
2009). To a large extent, engineering of a simple biological system, even with just a 
few components, is still an ad hoc research process with a number of trial-and-error 
steps and some retrospective empirical tinkering (Kwok, 2010; Lu et al., 2009). 
Several major challenges remain to be solved before the engineering of biology has 
the same predictability and reliability as seen in other mature engineering disciplines. 
Therefore, the study in this thesis has been centred on overcoming some current 
bottlenecks in gene circuit design and construction.  
The thesis introduces the design methodology for engineering modular and 
orthogonal biological devices to tackle the modularity and orthogonality problems. A 
novel genetic logic AND gate was designed and implemented in Escherichia coli by 
redesigning the natural HrpR/HrpS hetero-regulation motif in the specific hrp system 
of Pseudomonas syringae pv tomato DC3000. The essential gene components of the 
AND gate are exogenous and thus orthogonal to the E. coli genetic background. Both 
inputs and output of the AND gate are promoters and thus the device is designed to be 
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modular and reusable. The inputs can be easily rewired for various input promoters 
and the output can be connected to different genes to drive various cellular responses. 
Furthermore, the AND gate applies an alternative regulation mode, i.e. the σ54-
dependent gene transcription, to allow tight control of the underlying transcriptional 
activation and closely mimic digital logic AND behaviour. The successful engineering 
of this device sets an example for harnessing the diverse natural biological networks 
to design modular and orthogonal devices to expand the currently limited toolbox of 
synthetic biology. 
The thesis determines the effect of context on part and device behaviour through 
the systematic quantitative characterisation of a series of biological parts and devices, 
e.g. the three inducible promoters (Plac, PBAD and Plux) and six ribosome binding sites 
(rbs30-rbsH), in various biophysical and genetic contexts. It shows that both the 
biophysical (e.g. media, temperature, carbon source) and genetic (e.g. chassis 
background, embedded genetic sequence context) contexts in which the parts and 
devices behave have a large impact on their behaviour. This suggests that we should 
take into account the context effect when designing and characterising synthetic parts 
and devices. This is corroborated by the forward engineering of the designed logic 
AND gate. The current characterisation scope for parts and devices were extended by 
characterising the homogeneity, metabolic load and chassis compatibility of the 
engineered AND gate beyond the normal population-averaged behaviour. The results 
show that that the engineered AND gate is homogenous, though the whole device 
relies on the homogeneities of the input promoters. It imposes a negligible metabolic 
load on the tested host chassis (E. coli MC1061) and functions compatibly across the 
majority of the seven tested E. coli strains. Thorough characterisation of parts and 
devices is also of great importance for their wide reuse within the synthetic biology 
community. 
The thesis presents a new effective strategy for assembling individual synthetic 
parts and devices into functional biological systems using engineered ‘in-context’ 
quantitatively characterised modules. By characterising the candidate component parts 
and modules in the same biophysical and genetic context as anticipated for their final 
target system, it eliminates or reduces the behavioural variations arising from the 
Chapter 7 - Overview and Future Work 
 
 
150
difference of working contexts and thus increases the predictability of circuit 
construction. As a result, this approach minimises the unexpected and other high-
order effects which are likely to occur during circuit construction. Following this 
functional assembly approach, the modular logic AND gate was successfully 
engineered with behaviour that can be precisely predicted from the components parts 
(i.e. promoters and RBSs) characterised in various contexts. The subsequent fit of the 
abstract AND gate model to the characterisation data showed that the two enhancer 
binding activators HrpR and HrpS are likely to play unequal roles in the cooperative 
activation of the σ54-dependent hrpL promoter. A set of modular logic NOT gates (i.e. 
the lacI/PLlac, tetR/Ptet and cI/Plam based inverters) were also constructed and 
characterised with different RBS versions. Under the guidance of modelling, a set of 
composite combinatorial logic NAND gates were then assembled from the AND and 
NOT gate modules with behaviour that can be quantitatively predicted from the 
individual transfer function models of the component, ‘in-context’ characterised parts 
and submodules. Hence, the proposed functional assembly method was demonstrated 
to work not only at the basic part level, but also at the device level. 
Lastly, the thesis presents the design and construction of a cell density-
dependent module using standard modular biological parts on the basis of the Vibrio 
fischeri lux operon. The module allows the cell population to co-ordinate local cellular 
behaviour through cell-cell communication, although the density transition region of 
the module remains to be improved. By assembling the multiple parts and modules 
that have been engineered in this study, a cell density-dependent microbe-based 
biosensor was constructed. This performs as a logic AND gate by integrating its own 
cell density signal, through a synthetic cell communication module, and a second 
input signal, through an environment-responsive promoter. The successful 
construction of this in vivo biosensing platform signifies that more advanced 
biological devices can be engineered through cellular cooperation and the integration 
of many modular biological parts and devices with practical applications. 
Thus the work in this thesis describes the steps I have taken towards the goal of 
making routine the engineering of synthetic gene circuits. There is a major focus on 
the design and engineering of modular and orthogonal biological parts and devices, as 
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well as their predictable functional assembly. Though many challenges remain to be 
overcome, the task of making biology easier to engineer will continue since the 
benefits of programming cells by customised gene circuits are enormous ranging from 
practical applications in industry and medicine, to uncovering the design principles of 
natural biological circuits.  
 
7.2 Future Work 
This section discusses future research directions relating to the work of the thesis and 
other potential research projects arising from the current study.  
 
1. Part/device characterisation and improvement of modularity 
As shown in the thesis, the context in which the biological parts and devices behave 
has a large impact on their behaviour. The majority of currently constructed synthetic 
biological parts and devices often only work for their own specific purposes in a 
particular context, and lack sufficient modularity and reusability. Thus the future 
direction of part (device) standardisation and characterisation should be directed 
towards the decoupling of context dependency, in particular the dependency on the 
embedded sequence context, to improve their modularity. For instance, it would be 
advantageous to design several standard 5' UTR sequences ahead of the RBS site in 
order to lower the interference with adjacent parts, i.e. the promoters and RBSs. In 
addition, the functional modularity of the parts and modules can be improved by 
deploying some insulator sequences between their physical connections. These 
insulator sequences should be designed to have the least interaction with their 
adjacent parts. This would isolate the function of individual parts and modules 
sufficiently to eliminate or reduce the sequence context-dependency effect. As a result, 
the predictability of assembling genetic parts and modules into functional biological 
systems would be greatly improved without the need of re-characterisation in a new 
sequence context. This is illustrated in a recent example (Davis et al., 2010), in which 
a set of insulated constitutive promoters was designed to act more predictably in 
different 5′- or 3′-sequence contexts. 
Chapter 7 - Overview and Future Work 
 
 
152
Another component pertaining to characterisation could be automation. The 
thorough characterisation of many parts and modules in various contexts is a large 
amount of work if done manually, and manual characterisation is not totally 
reproducible. Therefore, automated, high throughput platform (e.g. liquid handing 
machines) should be established to speed up the characterisation process and to 
generate detailed data sheets for each part or module. 
 
2. Optimising the quorum sensing module of the microbial biosensor 
The transition region of the engineered cell density-dependent module in this study is 
not completely within the readily observable range of cell densities. Therefore the 
next step is to optimise the module to have customisable cell density-dependent 
characteristics. As discussed at the end of Chapter 6, the current architecture of the 
module is not optimised. The three architectures described in Chapter 6 could be 
explored to improve the switching characteristic, as well as the modularity, of this 
quorum sensing module. By doing this, the module which is an important component 
of the cell density-dependent microbial biosensor will enable the biosensor to have 
customised quorum sensing thresholds. As a demonstration for its application in 
potential biotechnological or environmental areas, an engineered pH-responsive 
promoter such as the P170 and P1 promoters in Lactococcus lactis (Madsen et al., 
2005) can be coupled to the second input of the biosensor to detect or specify the 
acidic condition of the environment.  
 
3. Device diversification with orthogonality 
As mentioned at the beginning of Chapter 3, there is a pressing need to enrich and 
diversify the current device library of synthetic biology to produce many orthogonal 
modules for constructing larger and more complex biological circuitry. It has been 
shown in the thesis that the engineering of novel modular and orthogonal devices can 
be implemented by exploiting new regulation motifs in other bacterial species (e.g. 
the HrpR/HrpS hetero-regulation motif in P. syringae) and utilising alternative 
regulation modes (e.g. the σ54-dependent gene transcription). However, an alternative 
approach could potentially be to use additional distinct orthologs for device 
diversification. Taking the engineered AND gate as an example, it might be 
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diversified using orthologous motifs appearing in other Pseudomonas species. The 
hrp regulatory system has evolved and diverged among a number of species of the 
plant P. syringae pathovars and other related bacteria such as P. mendocina and P. 
viridiflava, but the majority conserves the hetero-regulated HrpR/HrpS motif 
(Jovanovic et al., 2011). Thus the various orthologs of this motif among these 
bacterial species can be extracted out to test their functionality and orthogonality as 
logic AND gates in E. coli. As a result, a device library containing many orthogonal 
logic AND gates might be generated. This method has advantages over random 
evolution to generate functional orthogonal modules because the evolution space for 
random mutations of a genetic module is generally too large and thereby limits the 
likelihood to produce desired mutants.  
 
4. Engineering a distributed bacterial optimiser 
One potential research project arising from the current study is to engineer a 
distributed bacterial optimiser as an upgrade of the cell density-dependent biosensor. 
This cellular optimiser aims to use living cells as the computing agents to demonstrate 
a high level biocomputing function – optimising (Amos et al., 2007). Figure 7.1 
shows the design principle of this optimiser. Imagine the optimisation task is to seek 
the optimal solution (x, y) that maximises the function f(x, y), which is the 
distribution of the concentration of a specific ligand in a two dimensional space 
(defined by x and y) as shown in Figure 7.1a. Using engineered gene circuits, it may 
be possible to harness the parallel and distributed power of living cells to accomplish 
the search process and locate the position with the highest ligand concentration.  
The bacterial cells are engineered by integrating multiple functional modules, i.e. 
the genetic logic circuit module, sensory module, cell-cell communication module and 
the chemotactic navigation module, to push the limit of gene circuit engineering. As 
Figure 7.1b shows, the bacterial optimiser will use the logic AND gate to integrate the 
input signal from the sensory module and the cell density signal from the 
communication module to drive the chemotaxis module such as cheZ output in a cheZ 
knockout E. coli strain (Tan et al., 2007; Topp and Gallivan, 2007). Consequently, the 
cells will be programmed to sense the ligand concentration gradient and migrate 
Chapter 7 - Overview and Future Work 
 
 
154
towards the position with higher ligand concentration and higher cell density. As a 
result, the engineered cells will aggregate around the point with highest concentration 
of the target ligand to complete the optimisation task. Because the cells work in 
parallel, the efficiency of this optimisation process is much higher than serial 
searching. In addition, three of the four modules in this system have been engineered 
as part of the work described in this thesis. Therefore, the focus will be the coupling 
of the chemotactic module to the output of the cell density-dependent biosensor and 
the fine tuning of these individual modules. 
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Figure 7.1 The design of the distributed bacterial optimiser. The cellular optimiser 
is engineered to migrate towards the location with the highest ligand concentration, i.e. 
the optimal solution. a, The optimiser’s objective is to locate the position of highest 
ligand concentration on a surface. b, The designed architecture of the optimiser. 
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Appendix A: Plasmids 
 
Table A.1 The plasmid DNAs used in this study. 
Plasmid Notes Reference 
pAPT110 IPTG inducible Plac promoter expression vector 
p15A ori, Kanr 
Polard et al., 1995 
pBAD18-cm arabinose inducible PBAD  promoter expression vector 
pBR322 ori, Cmr 
Guzman et al., 1995 
pSB4A3 BioBrick vector, pSC101 ori, Ampr BioBrick Registry 
pSB3K3 BioBrick vector, p15A ori, Kanr BioBrick Registry 
pSB1A2 BioBrick vector, pMB1 ori, Kanr BioBrick Registry 
pSB2K3 BioBrick vector, F΄ ori, P1 lytic ori under Plac, Kanr BioBrick Registry 
pGA15hrpR GENEART cloning vector harbouring synthesised 
hrpR, pUC ori, Kanr 
From GENEART 
pGA14hrpS GENEART cloning vector harbouring synthesised 
hrpS, Col E1 ori, Ampr 
From GENEART 
pGA18hrpL GENEART cloning vector harbouring synthesised 
hrpL, Col E1 ori, Ampr 
From GENEART 
pBW1A2-30G pSB1A2 harbouring rbs30-gfp-ter A gift from K. Jensen 
pBW100lac-gfp  pAPT110 encoding rbs30-gfp-ter This study 
pBW101lac-gfp pAPT110 encoding rbs31-gfp-ter This study 
pBW102lac-gfp pAPT110 encoding rbs32-gfp-ter This study 
pBW103lac-gfp pAPT110 encoding rbs33-gfp-ter This study 
pBW104lac-gfp pAPT110 encoding rbs34-gfp-ter This study 
pBW105lac-gfp pAPT110 encoding rbsH-gfp-ter This study 
pBW200ara-gfp  pBAD18-cm encoding rbs30-gfp-ter This study 
pBW201ara-gfp pBAD18-cm encoding rbs31-gfp-ter This study 
pBW202ara-gfp pBAD18-cm encoding rbs32-gfp-ter This study 
pBW203ara-gfp pBAD18-cm encoding rbs33-gfp-ter This study 
pBW204ara-gfp pBAD18-cm encoding rbs34-gfp-ter This study 
pBW205ara-gfp pBAD18-cm encoding rbsH-gfp-ter This study 
pBWI20260 pSB3K3 harbouring BioBrick Part I20260 (rbs32-gfp-
ter under the constitutive BBa_J23101 promoter) 
BioBrick Registry 
pBWBBF2620 pSB1A2 harbouring BioBrick Part BBa_F2620 
(synthetic AHL inducible Plux promoter) 
BioBrick Registry 
pBWF2620 pSB3K3 harbouring BBa_F2620 BioBrick Part  This study 
pBW300lux-gfp pBWF2620 encoding rbs30-gfp-ter This study 
pBW301lux-gfp pBWF2620 encoding rbs31-gfp-ter This study 
pBW302lux-gfp  pBWF2620 encoding rbs32-gfp-ter This study 
pBW303lux-gfp pBWF2620 encoding rbs33-gfp-ter This study 
pBW304lux-gfp pBWF2620 encoding rbs34-gfp-ter This study 
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pBW305lux-gfp pBWF2620 encoding rbsH-gfp-ter This study 
pBWBBP1010 pSB4A3 harbouring BioBrick BBa_P1010 (ccdB gene) BioBrick Registry 
pBW1A2-30I pSB1A2 harbouring BioBrick BBa_K081008 (rbs30-
luxI-LVA) 
BioBrick Registry 
pBW1A2-34I pSB1A2 harbouring BioBrick BBa_C0261 (rbs34-
luxI-LVA) 
BioBrick Registry 
pBWBBQ04510 pSB2K3 harbouring BioBrick BBa_Q04510 (rbs34-cI-
ter-Plam) 
BioBrick Registry 
pBWBBQ01510 pSB2K3 harbouring BioBrick BBa_Q01510 (rbs31-cI-
ter-Plam) 
BioBrick Registry 
pBWBBQ04400 pSB2K3 harbouring BioBrick BBa_Q04400 (rbs34-
tetR-ter-Ptet) 
BioBrick Registry 
pBWBBQ03400 pSB2K3 harbouring BioBrick BBa_Q03400 (rbs33-
tetR-ter-Ptet) 
BioBrick Registry 
pBWBBQ01400 pSB2K3 harbouring BioBrick BBa_Q01400 (rbs31-
tetR-ter-Ptet) 
BioBrick Registry 
pBWBBQ04121 pSB2K3 harbouring BioBrick BBa_Q04121 (rbs34-
lacI-ter-Plac) 
BioBrick Registry 
pBWBBQ03121 pSB2K3 harbouring BioBrick BBa_Q03121 (rbs33-
lacI-ter-Plac) 
BioBrick Registry 
pBWBBQ01121 pSB2K3 harbouring BioBrick BBa_Q01121 (rbs31-
lacI-ter-Plac) 
BioBrick Registry 
pBW110lac-hrpR  pAPT110 encoding rbs30-hrpR-ter This study 
pBW111lac-hrpR pAPT110 encoding rbs31-hrpR-ter This study 
pBW112lac-hrpR pAPT110 encoding rbs32-hrpR-ter This study 
pBW113lac-hrpR pAPT110 encoding rbs33-hrpR-ter This study 
pBW114lac-hrpR pAPT110 encoding rbs34-hrpR-ter This study 
pBW115lac-hrpR pAPT110 encoding rbsH-hrpR-ter This study 
pBW310lux-hrpR pBWF2620 encoding rbs30-hrpR-ter This study 
pBW311lux-hrpR pBWF2620 encoding rbs31-hrpR-ter This study 
pBW312lux-hrpR pBWF2620 encoding rbs32-hrpR-ter This study 
pBW313lux-hrpR pBWF2620 encoding rbs33-hrpR-ter This study 
pBW314lux-hrpR pBWF2620 encoding rbs34-hrpR-ter This study 
pBW315lux-hrpR pBWF2620 encoding rbsH-hrpR-ter This study 
pBW210ara-hrpS pBAD18-cm encoding rbs30-hrpS-ter This study 
pBW211ara-hrpS pBAD18-cm encoding rbs31-hrpS-ter This study 
pBW212ara-hrpS pBAD18-cm encoding rbs32-hrpS-ter This study 
pBW213ara-hrpS pBAD18-cm encoding rbs33-hrpS-ter This study 
pBW214ara-hrpS pBAD18-cm encoding rbs34-hrpS-ter This study 
pBW215ara-hrpS pBAD18-cm encoding rbsH-hrpS-ter This study 
pBW145lac-hrpS pAPT110 encoding rbsH-hrpS-ter This study 
pBW343lux-hrpS pBWF2620 encoding rbs33-hrpS-ter This study 
pBW243ara-hrpR pBAD18-cm encoding rbs33-hrpR-ter This study 
pBW4A3hrpL pSB4A3 harbouring synthesised hrpL This study 
pBW400hrpL-gfp  pSB4A3 encoding hrpL-rbs30-gfp-ter This study 
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pBWLAC32cI  pAPT110 harbouring rbs32-cI-ter-Plam (XbaI/KpnI) This study 
pBWLAC33cI  pAPT110 harbouring rbs33-cI-ter-Plam (XbaI/KpnI) This study 
pBWLACHcI  pAPT110 harbouring rbsH-cI-ter-Plam (XbaI/KpnI) This study 
pBW3K3-32cI  pSB3K3 harbouring rbs32-cI-ter-Plam (XbaI/PstI) This study 
pBW3K3-33cI  pSB3K3 harbouring rbs33-cI-ter-Plam (XbaI/ PstI) This study 
pBW3K3-HcI  pSB3K3 harbouring rbsH-cI-ter-Plam (XbaI/ PstI) This study 
pBWLAC31cIG  pAPT110 (EcoRI/KpnI) harbouring rbs31-cI-ter-Plam-
rbs30-gfp-ter  
This study 
pBWLAC32cIG pAPT110 (EcoRI/KpnI) harbouring rbs32-cI-ter-Plam-
rbs30-gfp-ter  
This study 
pBWLAC33cIG pAPT110 (EcoRI/KpnI) harbouring rbs33-cI-ter-Plam-
rbs30-gfp-ter  
This study 
pBWLAC34cIG  pAPT110 (EcoRI/KpnI) harbouring rbs34-cI-ter-Plam-
rbs30-gfp-ter  
This study 
pBWLACHcIG  pAPT110 (EcoRI/KpnI)  harbouring rbsH-cI-ter-Plam-
rbs30-gfp-ter 
This study 
pBW121lac-cIgfp  pAPT110 (XbaI/KpnI) encoding rbs31-cI-ter-Plam-rbs30-
gfp-ter  
This study 
pBW122lac-cIgfp pAPT110 (XbaI/KpnI) encoding rbs32-cI-ter-Plam-rbs30-
gfp-ter  
This study 
pBW123lac-cIgfp pAPT110 (XbaI/KpnI) encoding rbs33-cI-ter-Plam-rbs30-
gfp-ter  
This study 
pBW124lac-cIgfp pAPT110 (XbaI/KpnI) encoding rbs34-cI-ter-Plam-rbs30-
gfp-ter  
This study 
pBW125lac-cIgfp pAPT110 (XbaI/KpnI) encoding rbsH-cI-ter-Plam-rbs30-
gfp-ter  
This study 
pBW412hrpL-cIgfp  pSB4A3 encoding hrpL-rbs32-cI-ter-Plam-rbs30-gfp-ter This study 
pBW414hrpL-cIgfp pSB4A3 encoding hrpL-rbs34-cI-ter-Plam-rbs30-gfp-ter This study 
pBWLAC31tetRG  pAPT110 (EcoRI/KpnI) harbouring rbs31-tetR-ter-Ptet-
rbs30-gfp-ter  
This study 
pBWLAC33tetRG pAPT110 (EcoRI/KpnI) harbouring rbs33-tetR-ter-Ptet-
rbs30-gfp-ter  
This study 
pBWLAC34tetRG  pAPT110 (EcoRI/KpnI) harbouring rbs34-tetR-ter-Ptet-
rbs30-gfp-ter  
This study 
pBW131lac-tetRgfp  pAPT110 (XbaI/KpnI) encoding rbs31-tetR-ter-Ptet-
rbs30-gfp-ter  
This study 
pBW133lac-tetRgfp pAPT110 (XbaI/KpnI) encoding rbs33-tetR-ter-Ptet-
rbs30-gfp-ter  
This study 
pBW134lac-tetRgfp pAPT110 (XbaI/KpnI) encoding rbs34-tetR-ter-Ptet-
rbs30-gfp-ter  
This study 
pBWLAC31lacIG  pAPT110 (EcoRI/KpnI) harbouring rbs31-lacI-ter-Plac-
rbs30-gfp-ter  
This study 
pBWLAC33lacIG pAPT110 (EcoRI/KpnI) harbouring rbs33-lacI-ter-Plac-
rbs30-gfp-ter 
This study 
pBWLAC34lacIG  pAPT110 (EcoRI/KpnI) harbouring rbs34-lacI-ter-Plac-
rbs30-gfp-ter 
This study 
pBW221ara-lacIgfp  pBAD18-cm (NheI/KpnI) encoding rbs31-lacI-ter-Plac-
rbs30-gfp-ter 
This study 
pBW223ara-lacIgfp pBAD18-cm (NheI/KpnI) encoding rbs33-lacI-ter-Plac-
rbs30-gfp-ter 
This study 
pBW224ara-lacIgfp  pBAD18-cm (NheI/KpnI) encoding rbs34-lacI-ter-Plac-
rbs30-gfp-ter 
This study 
pBW1A2-31I pSB1A2 harbouring rbs31-luxI-LVA This study 
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pBW1A2-32I pSB1A2 harbouring rbs32-luxI-LVA This study 
pBW1A2-33I pSB1A2 harbouring rbs33-luxI-LVA This study 
pBW1A2-HI pSB1A2 harbouring rbsH-luxI-LVA This study 
pBW1A2-30I33G pSB1A2 harbouring rbs30-luxI-LVA-rbs33-gfp-ter This study 
pBW1A2-31I33G pSB1A2 harbouring rbs31-luxI-LVA-rbs33-gfp-ter This study 
pBW1A2-32I33G pSB1A2 harbouring rbs32-luxI-LVA-rbs33-gfp-ter This study 
pBW1A2-33I33G pSB1A2 harbouring rbs33-luxI-LVA-rbs33-gfp-ter This study 
pBW1A2-34I33G pSB1A2 harbouring rbs34-luxI-LVA-rbs33-gfp-ter This study 
pBW1A2-HI33G pSB1A2 harbouring rbsH-luxI-LVA-rbs33-gfp-ter This study 
pBW1A2-30I30G pSB1A2 harbouring rbs301-luxI-LVA-rbs30-gfp-ter This study 
pBW1A2-31I30G pSB1A2 harbouring rbs31-luxI-LVA-rbs30-gfp-ter This study 
pBW1A2-32I30G pSB1A2 harbouring rbs32-luxI-LVA-rbs30-gfp-ter This study 
pBW1A2-33I30G pSB1A2 harbouring rbs33-luxI-LVA-rbs30-gfp-ter This study 
pBW1A2-34I30G pSB1A2 harbouring rbs34-luxI-LVA-rbs30-gfp-ter This study 
pBW1A2-HI30G pSB1A2 harbouring rbsH-luxI-LVA-rbs30-gfp-ter This study 
pBW503luxI-gfp pBWF2620 encoding rbs30-luxI-LVA-rbs33-gfp-ter This study 
pBW513luxI-gfp pBWF2620 encoding rbs31-luxI-LVA-rbs33-gfp-ter This study 
pBW523luxI-gfp pBWF2620 encoding rbs32-luxI-LVA-rbs33-gfp-ter This study 
pBW533luxI-gfp pBWF2620 encoding rbs33-luxI-LVA-rbs33-gfp-ter This study 
pBW543luxI-gfp pBWF2620 encoding rbs34-luxI-LVA-rbs33-gfp-ter This study 
pBW553luxI-gfp pBWF2620 encoding rbsH-luxI-LVA-rbs33-gfp-ter This study 
pBW500luxI-gfp pBWF2620 encoding rbs30-luxI-LVA-rbs30-gfp-ter This study 
pBW510luxI-gfp pBWF2620 encoding rbs31-luxI-LVA-rbs30-gfp-ter This study 
pBW520luxI-gfp pBWF2620 encoding rbs32-luxI-LVA-rbs30-gfp-ter This study 
pBW530luxI-gfp pBWF2620 encoding rbs33-luxI-LVA-rbs30-gfp-ter This study 
pBW540luxI-gfp pBWF2620 encoding rbs34-luxI-LVA-rbs30-gfp-ter This study 
pBW550luxI-gfp pBWF2620 encoding rbsH-luxI-LVA-rbs30-gfp-ter This study 
pBW630luxI-hrpR pBWF2620 encoding rbs33-luxI-LVA-rbs30-hrpR-ter This study 
pBW631luxI-hrpR pBWF2620 encoding rbs33-luxI-LVA-rbs31-hrpR-ter This study 
pBW632luxI-hrpR pBWF2620 encoding rbs33-luxI-LVA-rbs32-hrpR-ter This study 
pBW633luxI-hrpR pBWF2620 encoding rbs33-luxI-LVA-rbs33-hrpR-ter This study 
pBW634luxI-hrpR pBWF2620 encoding rbs33-luxI-LVA-rbs34-hrpR-ter This study 
pBW635luxI-hrpR pBWF2620 encoding rbs33-luxI-LVA-rbsH-hrpR-ter This study 
pBW620luxI-hrpR pBWF2620 encoding rbs32-luxI-LVA-rbs30-hrpR-ter This study 
pBW621luxI-hrpR pBWF2620 encoding rbs32-luxI-LVA-rbs31-hrpR-ter This study 
pBW622luxI-hrpR pBWF2620 encoding rbs32-luxI-LVA-rbs32-hrpR-ter This study 
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Table B.1 The oligo DNAs (primers) used in this study. 
Primer (Set) Sequence (5’ – 3’) Usage 
gfp-C  F 
gfp-C  R 
CCGGAATTCGCGGCCGCTTCTAGAG 
GGGGTACCCTGCAGCGGCCGCTACTAG 
PCR gfp to be cloned into 
the three expression 
vectors 
gfp-S  F 
gfp-S  R 
CAAGAGTGCCATGCCCGAAG 
AATGGTTGTCTGGTAAAAGG 
Middle sequencing primers 
for gfp 
pBAD18-cm  F 
pBAD18-cm  R 
ATGCCATAGCATTTTTATCC  
GATTTAATCTGTATCAGG 
pBAD18-cm vector 
sequencing primer set 
BioBrick  F 
BioBrick  R 
TGCCACCTGACGTCTAAGAA 
ATTACCGCCTTTGAGTGAGC 
Sequencing or analyzing 
parts in BioBrick vectors 
pAPT110  F 
pAPT110  R 
GGCTTTACACTTTATGCTTC  
GAATTGATCCGGTGGATGAC 
pAPT110 vector 
sequencing primer set 
hrpR  F 
hrpR  R 
GTGGATCTGCGGATCATTGC 
CTTCAATTCGCGGATGTTGC 
Middle sequencing primers 
for hrpR 
hrpS  F 
hrpS  R 
CGACGATCAAGCTGGATATC 
CAAACATCGGGAACGGGAAC 
Middle sequencing primers 
for hrpS 
RBS30_gfp  F CGTCTAGAGATTAAAGAGGAGAAATACTAG 
ATGCGTAAAGGAGAAGAAC 
PCR gfp with RBS30 and 
relevant restriction sites  
RBS31_gfp  F CGTCTAGAGTCACACAGGAAAGTACTAGATG 
AGTACAGGCATCGATAAG 
PCR gfp with RBS31 and 
relevant restriction sites 
RBS32_gfp  F CGTCTAGAGTCACACAGGAAACCTACTAGATG 
AGTACAGGCATCGATAAG 
PCR gfp with RBS32 and 
relevant restriction sites 
RBS33_gfp  F CGTCTAGAGTCACACAGGACTACTAGATG 
AGTACAGGCATCGATAAGG 
PCR gfp with RBS33 and 
relevant restriction sites 
RBS34_gfp  F CGTCTAGAGAAAGAGGAGAAATACTAGATG 
AGTACAGGCATCGATAAGG 
PCR gfp with RBS34 and 
relevant restriction sites 
RBSH_gfp  F CGTCTAGAAGGAGATATACCATG 
AGTACAGGCATCGATAAGGACGTC 
PCR gfp with RBSH and 
relevant restriction sites 
RBS30-H_GRS  R GGGGTACCCTGCAGCGGCCGCTACTAGTATATA
AA 
Reverse primer for gfp, 
hrpR, hrpS with the 6 
RBSs of various strengths 
RBS30_hrpR  F CGTCTAGAGATTAAAGAGGAGAAATACTAG 
ATGAGTACAGGCATCGATAAG 
PCR hrpR with RBS30 and 
relevant restriction sites 
RBS31_hrpR  F CGTCTAGAGTCACACAGGAAACCTACTAG 
ATGAGTACAGGCATCGATAAG 
PCR hrpR with RBS31 and 
relevant restriction sites 
RBS32_hrpR  F CGTCTAGAGTCACACAGGAAAGTACTAG 
ATGAGTACAGGCATCGATAAG 
PCR hrpR with RBS32 and 
relevant restriction sites 
RBS33_hrpR  F CGTCTAGAGTCACACAGGACTACTAG 
ATGAGTACAGGCATCGATAAGG 
PCR hrpR with RBS33 and 
relevant restriction sites 
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RBS34_hrpR  F CGTCTAGAGAAAGAGGAGAAATACTAG 
ATGAGTACAGGCATCGATAAGG 
PCR hrpR with RBS34 and 
relevant restriction sites 
RBSH_hrpR  F CGTCTAGAAGGAGATATACC 
ATGAGTACAGGCATCGATAAGGACGTC 
PCR hrpR with RBSH and 
relevant restriction sites 
RBS30_hrpS  F CGTCTAGAGATTAAAGAGGAGAAATACTAG 
ATGAGTCTTGATGAAAGGTTTG 
PCR hrpS with RBS30 and 
relevant restriction sites 
RBS31_hrpS  F CGTCTAGAGTCACACAGGAAACCTACTAG 
ATGAGTCTTGATGAAAGGTTTG 
PCR hrpS with RBS31 and 
relevant restriction sites 
RBS32_hrpS  F CGTCTAGAGTCACACAGGAAAGTACTAG 
ATGAGTCTTGATGAAAGGTTTG 
PCR hrpS with RBS32 and 
relevant restriction sites 
RBS33_hrpS  F CGTCTAGAGTCACACAGGACTACTAG 
ATGAGTCTTGATGAAAGGTTTG 
PCR hrpS with RBS33 and 
relevant restriction sites 
RBS34_hrpS  F CGTCTAGAGAAAGAGGAGAAATACTAG 
ATGAGTCTTGATGAAAGGTTTG 
PCR hrpS with RBS34 and 
relevant restriction sites 
RBSH_hrpS  F CGTCTAGAAGGAGATATACC 
ATGAGTCTTGATGAAAGGTTTGAGGATG  
PCR hrpS with RBSH and 
relevant restriction sites 
RBS31_luxI  F CGTCTAGAGTCACACAGGAAACCTACTAG 
ATGACTATAATGATAAAAAAATCG 
PCR luxI with RBS31 and 
relevant restriction sites 
RBS32_luxI  F CGTCTAGAGTCACACAGGAAAGTACTAG 
ATGACTATAATGATAAAAAAATCG 
PCR luxI with RBS32 and 
relevant restriction sites 
RBS33_luxI  F CGTCTAGAGTCACACAGGACTACTAG 
ATGACTATAATGATAAAAAAATCG 
PCR luxI with RBS33 and 
relevant restriction sites 
RBSH_luxI  F CGTCTAGAAGGAGATATACC 
ATGACTATAATGATAAAAAAATCGGATTTTTTG
PCR luxI with RBSH and 
relevant restriction sites 
RBS31-H_luxI  R GGTACCCTGCAGCGGCCGCTACTAGTA 
TTATTAAGCTACTAAAGCGTAG 
Reverse primer for PCR 
luxI with the 4 RBSs 
(RBS31-H) 
RBS32_cI  F CGTCTAGAGTCACACAGGAAAGTACTAG 
ATGAGCACAAAAAAGAAACC 
PCR cI with RBS32 and 
relevant restriction sites 
RBS33_cI  F CGTCTAGAGTCACACAGGACTACTAG 
ATGAGCACAAAAAAGAAACC 
PCR cI with RBS33 and 
relevant restriction sites 
RBSH_cI  F CGTCTAGAAGGAGATATACC 
ATGAGCACAAAAAAGAAACCATTAACAC 
PCR cI with RBSH and 
relevant restriction sites 
RBS31-H_cI  R GGTACCCTGCAGCGGCCGCTACTAGTA 
GCAACCATTATCACCGCCAG 
Reverse primer for PCR cI 
with the 3 various RBSs 
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Appendix C: Essential DNA Sequences 
 
The sequences of the essential gene elements used in this study are listed below. 
 
hrpL promoter sequence: 
>Part-only sequence, 208 bp 
GCCGGATTATGTCCGCTGAGTGGGTCACGGTCCCGGATCAGTTCCCTTGCGAAGCTGACCGATGTTTTT
GTGCCAAAAGCTGTTGTGGCAAAAAACGGTTTGCGCAAAGTTTTGTATTACAAAGAATTTCACATTTTA
AAATATCTTTATAAATCAATCAGTTATTTCTATTTTTAAGCTGGCATGGTTATCGCTATAGGGCTTGTA
C    
 
hrpR gene in BioBrick format: 
>Part-only sequence, 948 bp 
ATGAGTACAGGCATCGATAAGGACGTCCGAGAGTGTTGGGGCGTAACTGCATTATCAGCGGGTCATCAA
ATTGCAATGAATAGCGCGTTTCTGGATATGGACTTGCTGTTGTGCGGGGAAACCGGCACCGGCAAGGAC
ACACTGGCCAACCGCATTCACGAGTTGTCCAGCAGGTCGGGACCCTTTGTGGGCATGAACTGCGCCGCC
ATTCCCGAGTCGCTGGCAGAGAGCCAGTTATTCGGTGTGGTCAACGGTGCATTCACCGGCGTATGCCGG
GCTCGCGAGGGCTACATAGAGGCCTCCAGTGGTGGCACCTTGTACCTGGATGAAATCGACAGCATGCCG
TTGAGCCTGCAAGCCAAACTGCTGCGTGTGTTGGAGAGTCGAGGTATCGAGCGTCTGGGCTCGACCGAA
TTTATCCCGGTGGATCTGCGGATCATTGCCTCGGCCCAGCGGCCACTGGATGAACTGGTGGAACAAGGA
CTTTTCCGTCGCGACCTGTTTTTTCGGCTCAACGTGCTGACGCTTCACTTGCCAGCCTTGCGCAAACGT
CGTGAACAGATCCTGCCATTGTTCGACCAGTTCACCCAGGGTATCGCTGCCGAGTTCGGACGTCCCGCT
CCTGCGCTGGACAGCGGGCGTGTGCAGCTGCTGCTCAGCCACGACTGGCCGGGCAACATCCGCGAATTG
AAGTCTGCGGCCAAGCGCTTCGTACTCGGCTTCCCCTTGCTGGGCGCCGACCCTGTGGAAGCGCTTGAC
CCTGCCACGGGGCTGCGCACGCAAATGCGCATCATCGAGAAAATGCTCATCCAGGATGCCTTGAAGCGG
CACAGGCACAATTTCGACGCGGTGCTTCAGGAGTTGGAGTTGCCAAGACGCACCCTGTATCACCGCATG
AAGGAACTGGGAGTTGCAGCGCCGATCGCTGCGACGGCCGGGGTCTAATAA 
 
hrpS gene in BioBrick format: 
>Part-only sequence, 912 bp 
ATGAGTCTTGATGAAAGGTTTGAGGATGATCTGGACGAGGAGCGGGTTCCGAATCTGGGGATAGTTGCC
GAAAGTATTTCGCAACTGGGTATCGACGTGCTGCTATCGGGTGAGACCGGCACGGGCAAAGACACGATT
GCCCGACGGATTCATGAGATGTCAGGCCGCAAAGGGCGCCTGGTGGCGATGAATTGCGCGGCCATTCCG
GAGTCCCTCGCCGAGAGCGAGTTATTCGGCGTGGTCAGCGGTGCCTACACCGGCGCTGATCGCTCCAGA
GTCGGTTATGTCGAAGCGGCGCAGGGCGGCACGCTGTACCTGGATGAGATCGATAGCATGCCGCTGAGC
CTGCAAGCCAAATTGCTGAGGGTGCTGGAAACCCGAGCGCTTGAACGGCTGGGTTCGACGTCGACGATC
AAGCTGGATATCTGCGTGATCGCCTCCGCCCAATGCTCGCTGGACGACGCCGTCGAGCGGGGGCAGTTT
CGTCGCGATCTGTATTTTCGCCTGAACGTCCTGACACTCAAGCTTCCTCCGCTACGTAACCAGTCTGAT
CGCATAGTTCCCCTGTTCACACGTTTTACGGCCGCCGCCGCGAGGGAGCTCGGTGTTCCCGTTCCCGAT
GTTTGCCCACTGCTGCACAAAGTGCTGCTGGGCCACGACTGGCCCGGCAATATCCGTGAGCTCAAGGCG
GCAGCCAAACGCCATGTGCTGGGTTTCCCCTTGCTGGGCGCCGAGCCGCAGGGCGAAGAGCACTTGGCC
TGTGGGCTCAAATCGCAATTGCGAGTGATCGAAAAAGCCCTGATTCAGGAGTCGCTCAAGCGCCACGAC
AATTGTGTGGATTCGGTAAGCCTGGAACTGGACGTGCCACGCCGTACGCTCTATCGACGCATCAAAGAA
TTGCAGATCTAATAA 
 
gfpmut3b gene in BioBrick format: 
>BBa_E0040 Part-only sequence, 720 bp 
ATGCGTAAAGGAGAAGAACTTTTCACTGGAGTTGTCCCAATTCTTGTTGAATTAGATGGTGATGTTAAT
GGGCACAAATTTTCTGTCAGTGGAGAGGGTGAAGGTGATGCAACATACGGAAAACTTACCCTTAAATTT
ATTTGCACTACTGGAAAACTACCTGTTCCATGGCCAACACTTGTCACTACTTTCGGTTATGGTGTTCAA
TGCTTTGCGAGATACCCAGATCATATGAAACAGCATGACTTTTTCAAGAGTGCCATGCCCGAAGGTTAT
GTACAGGAAAGAACTATATTTTTCAAAGATGACGGGAACTACAAGACACGTGCTGAAGTCAAGTTTGAA
GGTGATACCCTTGTTAATAGAATCGAGTTAAAAGGTATTGATTTTAAAGAAGATGGAAACATTCTTGGA
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CACAAATTGGAATACAACTATAACTCACACAATGTATACATCATGGCAGACAAACAAAAGAATGGAATC
AAAGTTAACTTCAAAATTAGACACAACATTGAAGATGGAAGCGTTCAACTAGCAGACCATTATCAACAA
AATACTCCAATTGGCGATGGCCCTGTCCTTTTACCAGACAACCATTACCTGTCCACACAATCTGCCCTT
TCGAAAGATCCCAACGAAAAGAGAGACCACATGGTCCTTCTTGAGTTTGTAACAGCTGCTGGGATTACA
CATGGCATGGATGAACTATACAAATAATAA 
 
tetR/Ptet Inverter: 
>Part-only sequence, 884 bp, tetR-LVA 
ATGTCCAGATTAGATAAAAGTAAAGTGATTAACAGCGCATTAGAGCTGCTTAATGAGGTCGGAATCGAA
GGTTTAACAACCCGTAAACTCGCCCAGAAGCTAGGTGTAGAGCAGCCTACATTGTATTGGCATGTAAAA
AATAAGCGGGCTTTGCTCGACGCCTTAGCCATTGAGATGTTAGATAGGCACCATACTCACTTTTGCCCT
TTAGAAGGGGAAAGCTGGCAAGATTTTTTACGTAATAACGCTAAAAGTTTTAGATGTGCTTTACTAAGT
CATCGCGATGGAGCAAAAGTACATTTAGGTACACGGCCTACAGAAAAACAGTATGAAACTCTCGAAAAT
CAATTAGCCTTTTTATGCCAACAAGGTTTTTCACTAGAGAATGCATTATATGCACTCAGCGCTGTGGGG
CATTTTACTTTAGGTTGCGTATTGGAAGATCAAGAGCATCAAGTCGCTAAAGAAGAAAGGGAAACACCT
ACTACTGATAGTATGCCGCCATTATTACGACAAGCTATCGAATTATTTGATCACCAAGGTGCAGAGCCA
GCCTTCTTATTCGGCCTTGAATTGATCATATGCGGATTAGAAAAACAACTTAAATGTGAAAGTGGGTCC
GCTGCAAACGACGAAAACTACGCTTTAGTAGCTTAATAACACTGATAGTGCTAGTGTAGATCACTACTA
GAGCCAGGCATCAAATAAAACGAAAGGCTCAGTCGAAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGT
CGGTGAACGCTCTCTACTAGAGTCACACTGGCTCACCTTCGGGTGGGCCTTTCTGCGTTTATATACTAG
AGTCCCTATCAGTGATAGAGATTGACATCCCTATCAGTGATAGAGATACTGAGCAC 
 
lacI/PLlac Inverter: 
>Part-only sequence, 1352 bp, lacI-LVA 
ATGGTGAATGTGAAACCAGTAACGTTATACGATGTCGCAGAGTATGCCGGTGTCTCTTATCAGACCGTT
TCCCGCGTGGTGAACCAGGCCAGCCACGTTTCTGCGAAAACGCGGGAAAAAGTGGAAGCGGCGATGGCG
GAGCTGAATTACATTCCCAACCGCGTGGCACAACAACTGGCGGGCAAACAGTCGTTGCTGATTGGCGTT
GCCACCTCCAGTCTGGCCCTGCACGCGCCGTCGCAAATTGTCGCGGCGATTAAATCTCGCGCCGATCAA
CTGGGTGCCAGCGTGGTGGTGTCGATGGTAGAACGAAGCGGCGTCGAAGCCTGTAAAGCGGCGGTGCAC
AATCTTCTCGCGCAACGCGTCAGTGGGCTGATCATTAACTATCCGCTGGATGACCAGGATGCCATTGCT
GTGGAAGCTGCCTGCACTAATGTTCCGGCGTTATTTCTTGATGTCTCTGACCAGACACCCATCAACAGT
ATTATTTTCTCCCATGAAGACGGTACGCGACTGGGCGTGGAGCATCTGGTCGCATTGGGTCACCAGCAA
ATCGCGCTGTTAGCGGGCCCATTAAGTTCTGTCTCGGCGCGTCTGCGTCTGGCTGGCTGGCATAAATAT
CTCACTCGCAATCAAATTCAGCCGATAGCGGAACGGGAAGGCGACTGGAGTGCCATGTCCGGTTTTCAA
CAAACCATGCAAATGCTGAATGAGGGCATCGTTCCCACTGCGATGCTGGTTGCCAACGATCAGATGGCG
CTGGGCGCAATGCGCGCCATTACCGAGTCCGGGCTGCGCGTTGGTGCGGATATCTCGGTAGTGGGATAC
GACGATACCGAAGACAGCTCATGTTATATCCCGCCGTTAACCACCATCAAACAGGATTTTCGCCTGCTG
GGGCAAACCAGCGTGGACCGCTTGCTGCAACTCTCTCAGGGCCAGGCGGTGAAGGGCAATCAGCTGTTG
CCCGTCTCACTGGTGAAAAGAAAAACCACCCTGGCGCCCAATACGCAAACCGCCTCTCCCCGCGCGTTG
GCCGATTCATTAATGCAGCTGGCACGACAGGTTTCCCGACTGGAAAGCGGGCAGGCTGCAAACGACGAA
AACTACGCTTTAGTAGCTTAATAACTCTGATAGTGCTAGTGTAGATCTCTACTAGAGCCAGGCATCAAA
TAAAACGAAAGGCTCAGTCGAAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCT
ACTAGAGTCACACTGGCTCACCTTCGGGTGGGCCTTTCTGCGTTTATATACTAGAGAATTGTGAGCGGA
TAACAATTGACATTGTGAGCGGATAACAAGATACTGAGCAC 
 
cI/Plam Inverter: 
>Part-only sequence, 969 bp, cI-LVA 
ATGAGCACAAAAAAGAAACCATTAACACAAGAGCAGCTTGAGGACGCACGTCGCCTTAAAGCAATTTAT
GAAAAAAAGAAAAATGAACTTGGCTTATCCCAGGAATCTGTCGCAGACAAGATGGGGATGGGGCAGTCA
GGCGTTGGTGCTTTATTTAATGGCATCAATGCATTAAATGCTTATAACGCCGCATTGCTTGCAAAAATT
CTCAAAGTTAGCGTTGAAGAATTTAGCCCTTCAATCGCCAGAGAAATCTACGAGATGTATGAAGCGGTT
AGTATGCAGCCGTCACTTAGAAGTGAGTATGAGTACCCTGTTTTTTCTCATGTTCAGGCAGGGATGTTC
TCACCTGAGCTTAGAACCTTTACCAAAGGTGATGCGGAGAGATGGGTAAGCACAACCAAAAAAGCCAGT
GATTCTGCATTCTGGCTTGAGGTTGAAGGTAATTCCATGACCGCACCAACAGGCTCCAAGCCAAGCTTT
CCTGACGGAATGTTAATTCTCGTTGACCCTGAGCAGGCTGTTGAGCCAGGTGATTTCTGCATAGCCAGA
CTTGGGGGTGATGAGTTTACCTTCAAGAAACTGATCAGGGATAGCGGTCAGGTGTTTTTACAACCACTA
AACCCACAGTACCCAATGATCCCATGCAATGAGAGTTGTTCCGTTGTGGGGAAAGTTATCGCTAGTCAG
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TGGCCTGAAGAGACGTTTGGCGCTGCAAACGACGAAAACTACGCTTTAGTAGCTTAATAACGCTGATAG
TGCTAGTGTAGATCGCTACTAGAGCCAGGCATCAAATAAAACGAAAGGCTCAGTCGAAAGACTGGGCCT
TTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCTACTAGAGTCACACTGGCTCACCTTCGGGTGGGC
CTTTCTGCGTTTATATACTAGAGTAACACCGTGCGTGTTGACTATTTTACCTCTGGCGGTGATAATGGT
TGC 
 
The AHL-responsive synthetic Plux promoter (BBa_F2620): 
>BBa_F2620 Part-only sequence, 1061 bp 
TCCCTATCAGTGATAGAGATTGACATCCCTATCAGTGATAGAGATACTGAGCACTACTAGAGAAAGAGG
AGAAATACTAGATGAAAAACATAAATGCCGACGACACATACAGAATAATTAATAAAATTAAAGCTTGTA
GAAGCAATAATGATATTAATCAATGCTTATCTGATATGACTAAAATGGTACATTGTGAATATTATTTAC
TCGCGATCATTTATCCTCATTCTATGGTTAAATCTGATATTTCAATCCTAGATAATTACCCTAAAAAAT
GGAGGCAATATTATGATGACGCTAATTTAATAAAATATGATCCTATAGTAGATTATTCTAACTCCAATC
ATTCACCAATTAATTGGAATATATTTGAAAACAATGCTGTAAATAAAAAATCTCCAAATGTAATTAAAG
AAGCGAAAACATCAGGTCTTATCACTGGGTTTAGTTTCCCTATTCATACGGCTAACAATGGCTTCGGAA
TGCTTAGTTTTGCACATTCAGAAAAAGACAACTATATAGATAGTTTATTTTTACATGCGTGTATGAACA
TACCATTAATTGTTCCTTCTCTAGTTGATAATTATCGAAAAATAAATATAGCAAATAATAAATCAAACA
ACGATTTAACCAAAAGAGAAAAAGAATGTTTAGCGTGGGCATGCGAAGGAAAAAGCTCTTGGGATATTT
CAAAAATATTAGGTTGCAGTGAGCGTACTGTCACTTTCCATTTAACCAATGCGCAAATGAAACTCAATA
CAACAAACCGCTGCCAAAGTATTTCTAAAGCAATTTTAACAGGAGCAATTGATTGCCCATACTTTAAAA
ATTAATAACACTGATAGTGCTAGTGTAGATCACTACTAGAGCCAGGCATCAAATAAAACGAAAGGCTCA
GTCGAAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCTACTAGAGTCACACTGG
CTCACCTTCGGGTGGGCCTTTCTGCGTTTATATACTAGAGACCTGTAGGATCGTACAGGTTTACGCAAG
AAAATGGTTTGTTATAGTCGAATAAA 
 
luxI gene – the synthase of AHL molecule: 
>BBa_C0061 Part-only sequence, 618 bp, luxI-LVA 
ATGACTATAATGATAAAAAAATCGGATTTTTTGGCAATTCCATCGGAGGAGTATAAAGGTATTCTAAGT
CTTCGTTATCAAGTGTTTAAGCAAAGACTTGAGTGGGACTTAGTTGTAGAAAATAACCTTGAATCAGAT
GAGTATGATAACTCAAATGCAGAATATATTTATGCTTGTGATGATACTGAAAATGTAAGTGGATGCTGG
CGTTTATTACCTACAACAGGTGATTATATGCTGAAAAGTGTTTTTCCTGAATTGCTTGGTCAACAGAGT
GCTCCCAAAGATCCTAATATAGTCGAATTAAGTCGTTTTGCTGTAGGTAAAAATAGCTCAAAGATAAAT
AACTCTGCTAGTGAAATTACAATGAAACTATTTGAAGCTATATATAAACACGCTGTTAGTCAAGGTATT
ACAGAATATGTAACAGTAACATCAACAGCAATAGAGCGATTTTTAAAGCGTATTAAAGTTCCTTGTCAT
CGTATTGGAGACAAAGAAATTCATGTATTAGGTGATACTAAATCGGTTGTATTGTCTATGCCTATTAAT
GAACAGTTTAAAAAAGCAGTCTTAAATGCTGCAAACGACGAAAACTACGCTTTAGTAGCTTAATAA 
 
The BioBrick double terminator BBa_B0015: 
>BBa_B0015 Part-only sequence, 129 bp 
CCAGGCATCAAATAAAACGAAAGGCTCAGTCGAAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGG
TGAACGCTCTCTACTAGAGTCACACTGGCTCACCTTCGGGTGGGCCTTTCTGCGTTTATA 
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